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ABSTRACT
CHARACTERIZATION OF THE IMPACT OF PRENATAL CIGARETTE SMOKE EXPOSURE ON
AGE- AND SEX-SPECIFIC SIRT1-MEDIATED HEPATIC MOLECULAR PHENOTYPE IN
C57BL/6 MICE
Kendall Stocke
December 2, 2019
In the U.S., 7.2% of women still report having smoked at some point during pregnancy
despite known risks to fetal health. Prenatal cigarette smoke exposure (CSE) in children puts
them at risk for low birth weight, premature birth, and other adverse impacts on developmental
and postnatal health. Children subjected to prenatal CSE have a higher risk of adulthood
metabolic disease predicted by the Barker Hypothesis. The hepatic molecular phenotype
associated with this risk is unknown. This dissertation characterizes the prenatal CSE-induced
hepatic molecular phenotype during three key life stages.
We used a murine model of prenatal CSE utilizing a Teague TE-10C cigarette smoking
apparatus that induces low birth weight with catch-up growth. This model was used in a
preliminary study to observe the hepatic metabolic phenotype of prenatal (gestational day 6-18)
CSE offspring during adulthood in conjunction with a high-fat diet (HFD) or control low-fat diet
(CD) feeding for three months. The hepatic molecular phenotype was characterized by the
expression of SIRT1, a Class III deacetylase NAD+ sensor, and associated genes and proteins.
Female CSE offspring maintained on a HFD exhibited exacerbated weight gain and body fat
accumulation while male CSE offspring exhibited decreased SIRT1-related protein expression.
Follow up studies subjected offspring to prenatal (GD1-18) CSE and measured their
hepatic molecular phenotype at the neonatal and post-weaning periods. Male CSE offspring at
1.5 weeks of age exhibited signs of elevated SIRT1 signaling independent of the main SIRT1
regulatory loop. Female CSE 1.5-week old offspring exhibited signs of delayed functional liver
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ontogeny via depressed expression of Sirt1, related enzymes, and serum glucose levels.
Weaned fed male CSE offspring exhibited mixed expression in SIRT1-regulatory pathways.
Fasted male CSE offspring exhibited signs of an exacerbated fasting response via increased
SIRT1-related gluconeogenic mRNA expression. Fed female CSE offspring exhibited an
exacerbated fed response and untimely gluconeogenic mRNA expression. Fasted female CSE
offspring exhibited signs of an exacerbated fasting response via SIRT1-related mRNA and protein
expression and untimely lipogenic mRNA expression. This work attempted to extend the Barker
Hypothesis by characterizing the hepatic molecular phenotype at key life stages in offspring
subjected to prenatal CSE.
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CHAPTER I: INTRODUCTION

Direct Cigarette Smoke Exposure
The prevalence of smoking in the U.S. population remains a significant public health issue
despite campaigns to minimize or eliminate this behavior. The 2016 smoking prevalence among
U.S. adults 18 years or older was 15.5%, with the rate being unequal between men (17.5%) and
women (13.5%) [1]. The smoking prevalence among age groups varies with the highest being at
18.0% in middle-aged individuals (45-64 years), followed by 17.6% in adults (25-44 years), 13.1%
in young adults (18-24 years), and 8.8% in the elderly (65 years or older) [1].

Alaskan

Natives/Native Americans smoke at nearly double the rate of White or Black individuals (31.8%,
16.6%, and 16.5% respectively) [1]. The smoking prevalence decreased with higher levels of
educational attainment [1]. Of those individuals who held a graduate degree, 4.5% were smokers
[1]. The prevalence of smoking in people with a high school degree was 19.7%, while it was 40.6%
for those who received a GED [1]. This difference in smoking prevalence between equivalent
academic achievements suggests there was some other underlying factor that educational
attainment alone did not fully capture. The prevalence of smoking in people below the poverty line
was 56.5% higher than in individuals at or above the poverty line [1]. The prevalence of smoking
in self-reported disabled adults was 21.2% versus 14.4% in non-disabled people [1]. Smoking
prevalence was higher for people who exhibited serious psychological distress as rated on the
Kessler Scale (35.8%) as compared to individuals who scored low on this clinical measure (14.7%)
[1]. It is evident that the prevalence of smoking is not evenly distributed in the U.S. population
because certain demographic groups are more likely to engage in this health-adverse behavior.
Smoking occurred at a significant rate in the U.S. in 2008 in both high school (8.1%) [2]
and middle school (1.8%) [2], although it was not as common as in adults (13.7%) [3]. The rates
of smoking any tobacco product in high school and middle school students have declined since
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2014-2015 [2]. However, there has been a tremendous resurgence in the rate of using any tobacco
product between 2017-2018 in high school students (from 19.6% to 27.1%) and middle school
students (from 5.6% to 7.2%) [2]. The prevalence of smoking e-cigarettes or vaping has gone
down overall from 2014 to 2018 (from 3.7% to 3.2%, respectively), although it is projected to
increase in the future [4]. This upward trend in the prevalence of smoking e-cigarettes or vaping
behaviors is likely due to increased numbers of young adults (18-24 years old) engaging in these
behaviors [4]. E-cigarette use is particularly concerning in high school students, in which it has
increased from 2011 to 2018 (from 1.5% to 20.8%, respectively) [5]. Rates of e-cigarette usage
has also increased in middle school students from 2011 to 2018 (from 0.6% to 4.9%, respectively)
[5]. It is evident that the previously declining rates of smoking in adolescents are exhibiting a
resurgence due to increasing rates of e-cigarette smoking or vaping behaviors that will undoubtedly
contribute to future health problems.
Smoking is still responsible for numerous deaths in the U.S. population. For the period
spanning 2010-2014, approximately 638,500 deaths from lung cancer in the U.S. were attributed
to smoking (818,500 deaths if including all cancers) [6].

Between the years 2010-2014, an

additional 803,000 deaths from cardiovascular and metabolic disease in the U.S. were attributed
to smoking and 565,500 deaths from pulmonary diseases [6].

In 2014, 448,865 U.S. adults aged

35 years or older died due to smoking-related causes [7]. The percent attributable fraction of deaths
due to smoking in the same age group of U.S. adults in 2014 was highest in Kentucky (22.1%)
followed by Arkansas (21.5%), Nevada (21.3%), Tennessee (21.1%), West Virginia (20.6%),
Oklahoma (20.2%), and Missouri (20.1%) [7]. The relative risk of death from various diseases in
adults 55-64 years old was exacerbated due to smoking [6]. For lung cancer, the relative risk of
death for smokers versus non-smokers was 19.03 for men and 18.95 for women [6]. The relative
risk of smokers versus non-smokers of dying due to COPD was 84.76 for men and 22.58 for women
[6]. The relative risk for male and female smokers versus non-smokers dying from stroke was 2.07
and 3.27, respectively [6]. The relative risk of dying from coronary heart disease in male smokers
versus non-smokers was 2.99, while the relative risk in female smokers versus non-smokers was
3.25 [6]. The risk of death due to other heart disease was 2.50 and 1.49 times higher in male and
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female smokers vs non-smokers, respectively [6]. Smoking caused a clear majority of deaths from
lung cancer and COPD [6], which was unsurprising due to smoking being smoking the primary
cause of COPD [6]. Smoking increased the risk of several cancers including lung, liver and
colorectal cancer [6]. A report on the 2015 Global Burden of Disease Study found that 11.5% of
global deaths were attributable to smoking [8]. A more recent report found that in 2016, smokingattributable deaths from 1990 to 2016 increased by 20.1% worldwide [9]. This same report also
found that smoking was the second and sixth leading risk factor for deaths in men and women,
respectively [9]. Despite ongoing efforts to curb this health-adverse behavior in the U.S. and
beyond, it is evident that smoking continues to exert a heavy death toll.
Smoking is a significant risk factor for the development of type 2 diabetes. According to a
2007 meta-analysis utilizing 25 cohort studies, there was a higher risk for Type 2 diabetes in heavy
smokers compared to light or former smokers [10]. A more recent meta-analysis in 2015 utilizing
88 prospective studies found that the relative risk for Type 2 diabetes current smokers compared
to non-smokers was 1.37 [11]. This same meta-analysis found this increase in risk for Type 2
diabetes was dose-dependent with the relative risk being highest in heavy smokers (1.57) followed
by moderate (1.34) and light smokers (1.21) [11]. A meta-analysis published in 2017 utilizing 22
studies found that the pooled relative risk of developing Type 2 diabetes was 1.38 in current
smokers versus non-smokers and 1.19 for former smokers versus non-smokers [12]. That same
meta-analysis found that smoking-attributable cases of Type 2 diabetes in men and women were
18.8% and 5.4%, respectively [12]. A prospective cohort study published in 2010 following Korean
adults 30-95 years old found that the risk for outpatient treatment for diabetes was 1.55 times higher
for current smokers (20 cigarettes per day or more) compared to non-smokers [13].

That

prospective cohort study also found that the effect of smoking on outpatient diabetes treatment risk
was lower in women compared to men [13]. Considering that the CDC found diabetes in the U.S.
was the seventh leading cause of deaths in 2015 and lead to $245 billion in medical expenses in
2012 [14], it is evident that smoking has tremendous potential to negatively impact public health.
Smoking has several adverse reproductive effects such as but not limited to decreased
sperm quality [15, 16] and decreased probability of getting pregnant or achieving a live birth [17].
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A cross-sectional study published in 2015 found that women who actively smoked had increased
odds for spontaneous abortion (1.16 times higher), stillbirths (1.44 times higher), and ectopic
pregnancies (1.43) [18]. In a meta-analysis in 2014 utilizing 98 studies, the risk of miscarriage in
mothers who actively smoked during pregnancy was 1.32 times higher compared to non-smokers
[19]. A meta-analysis published in 2016 utilizing 142 studies found that the risk of either stillbirth
or neonatal death was 1.33 times higher for mothers who were active smokers versus non-smokers
[20]. A case-control study using Cameroonian women found that smoking increased the odds of
ectopic pregnancy by 2.68 fold. [21]. Impacts of cigarette smoke exposure on the fetus and infants
are discussed in the section on secondhand cigarette smoke exposure. It is evident that aiding
women in abstaining from smoking is critical to preventing adverse reproductive health outcomes.
Smoking has a substantial cost not just on health, but economically as well. Smoking
comprised 8.7% of aggregated annual healthcare spending in U.S. by the year 2010 [22].
Approximately two-thirds of this cost was being paid by the public through Medicaid, Medicare, and
other governmental programs [22].

It was found in a 2018 report that a positive return on

investment of 78.4% on Medicaid plans after four years and 30.6% on Medicare plans after three
years could be generated by utilizing the recommended smoking cessation prescription coverage
given by the Affordable Care Act [23]. It is evident that minimizing or eliminating smoking not only
has the potential to alleviate public health burdens, but also to recoup financial loses in combating
smoking-attributable disease.

Secondhand Cigarette Smoke Exposure
Secondhand cigarette smoke exposure has a significant effect on health outcomes.
Between 2010-2014, secondhand smoke in the U.S. was attributable to 206,420 deaths [6]. One
study found that secondhand smoke exposure increased the hazard ratio of dying from
cardiovascular disease (1.38), coronary heart disease (1.31), and any circulatory disease (1.28)
[24]. A positive dose-response relationship was found between secondhand smoke and death from
circulatory disease [24]. It was found that people who lived with a partner who smoked more than
30 cigarettes each day were associated with a hazard ratio of 2.94 for circulatory disease-related
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death [24]. A pooled analysis performed by the International Lung Cancer Consortium utilizing 18
case-control studies demonstrated that the odds of developing any lung cancer from being exposed
to any amount of secondhand smoke was 1.31 times higher than never being exposed [25].
Notably, secondhand smoke is associated with 2.11 times higher odds of developing small cell
carcinoma compared to non-small cell carcinoma [25].

A meta-analysis utilizing 24 studies

demonstrated a higher relative risk due to secondhand smoke exposure for developing COPD
(1.66), stroke (1.35), and ischemic heart disease (1.27) [26]. It is evident that not only do smokers
present a clear danger to their own health by engaging in cigarette smoking, but they also endanger
the health of others. It is clearly in the interest of improving public health to provide assistance and
encouragement in aiding smoking cessation efforts.
There are several reproductive health outcomes related to secondhand smoke. A crosssectional analysis found that non-smoking women who were exposed to secondhand smoke had
higher odds for spontaneous abortion (1.17 times higher), stillbirths (1.55 times higher), and ectopic
pregnancies (1.61) [18]. In a meta-analysis in 2014 utilizing 98 studies, the risk of miscarriage in
mothers who actively smoked during pregnancy was 1.11 times higher compared to non-smokers
[19]. A study published in 2017 found that non-smoking women who lived with at least two smokers
had 1.25 higher odds of experiencing pregnancy loss [27]. It is evident that in order to ensure
optimal reproductive outcomes, it is essential to continue informing smokers that their behavior not
only impacts their own health but also the health of others around them.
A primary outcome of cigarette smoke exposure during pregnancy is intrauterine growth
retardation, which presents itself as low birth weight [28, 29]. It has been found that prenatal
cigarette smoke exposure was associated with increased diagnoses of attention deficit
hyperactivity disorder in children [30]. A meta-analysis conducted in 2011 using 172 studies found
that in utero cigarette smoke exposure increased the rate of congenital disabilities including
orofacial clefts, congenital heart defects, gastroschisis, craniosynostosis, clubfoot, anorectal
atresia, musculoskeletal defects, hernias, and undescended testes [31]. It has been found that
exposure to cigarette smoke in utero doubled the risk of Sudden Infant Death Syndrome in infants
[32]. The Ottawa Prenatal Prospective Study Cohort has shown that male children exposed to
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prenatal cigarette smoke have an earlier onset of puberty as measured by the age at which the
voice differentiates and the age of onset of shaving [33]. A prospective cohort study found that
female children exposed to cigarette smoke in utero exhibited earlier age of menarche that was
exacerbated the more cigarettes smoked per day by their mother [34]. It is without question that
failure to prevent expectant mothers from engaging in cigarette smoking results in adverse health
consequences for their children.
It has been found that mouse models of prenatal CSE exhibit low birth weight [35-41],
decreased crown-rump length [41] as well as decreased somite number [42]. Low birth weight has
also been documented in rat models of prenatal CSE [43]. Animal models have found alterations
in behavioral development such as reference memory, spatial learning, and decreased anxiety [44].
Mice subjected to in utero cigarette smoke exposure exhibited enhanced airway hyperreactivity,
inflammation from pulmonary eosinophils, and airway secretion following stimulation by house dust
mite inhalation [45]. One study found that female mice subjected to in utero cigarette smoke
exposure exhibited increased body weight and both high- and low-density lipoprotein [46]. That
same study also found that male offspring exposed in utero to cigarette smoke and maintained on
a high-fat diet for two weeks exhibited increased weight, total cholesterol, and high-density
lipoprotein [46]. This data indicates that in utero cigarette smoke exposure sensitizes offspring to
the effects of high-fat diet consumption, which can only contribute to the likelihood of developing
metabolic disease in adulthood. It is evident that animal models of prenatal cigarette smoke
exposure also exhibit adverse health outcomes in offspring.
During 2016 in the U.S., 7.2% of women reported smoking at any point during pregnancy
[47], which was a decrease from the previous rate of 8.4% overall in 2014 [48] and 9.7% overall in
2008 [49]. Assuming one child per pregnancy, a rate of smoking during pregnancy of 7.2% in the
U.S. translates to at least 284,000 fetuses that were subjected to prenatal secondhand cigarette
smoke in 2016 [47]. Of those women who smoked during pregnancy, the highest prevalence
occurred in women 20-24 years old, followed by 15-19 years old and 25-29 years old [47]. Native
Indians and Alaskan Natives are most at risk of smoking during pregnancy, followed by White,
Black, Native Hawaiian/Pacific Islander, Hispanic, and Asian [47]. Those more likely to smoke
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during pregnancy had a high school (or equivalent) degree or less, with the prevalence being lowest
for lowest for individuals with at least a Bachelor’s degree [47]. Although many states in 2016 had
a low smoking prevalence in expectant mothers (5% or less), states such as Kentucky (18.4%) and
West Virginia (25.1%) had much higher rates of smoking during pregnancy [47]. These rates are
lower than the 2014 rates in Kentucky (20.7%) and West Virginia (27.1%) [48]. These rates were
even lower still than the 1999 rates in Kentucky (24.5%) and West Virginia (26.1%) [50]. The trends
in these rates highlight the fact that while in some states the rate has been steadily going down, in
other places, the rate has not changed much. Even more alarming is the fact that smoking while
pregnant has been underreported, with an analysis of 1999-2006 NHANES data indicating that
22.9% of pregnant women did not report their current smoking status [51]. Women who smoked
while pregnant in the U.S. in 1983 incurred an estimated $267 million in neonatal healthcare costs
[52]. It has been estimated that smoking during pregnancy in the U.S. in 1996 was attributed to
$244 million of neonatal expenses in Medicaid programs[53]. Using U.S. data from 2001-2002, an
estimated $122 million in costs for delivery of all infants were attributable to maternal smoking
during pregnancy [54]. It is evident that the prevalence of smoking during pregnancy is not evenly
distributed in the U.S. population because certain demographic groups are more likely to engage
in this costly health-adverse behavior.
Even maternal secondhand smoke exposure is enough to induce in utero changes to the
fetus. One study found that pregnant women exposed to secondhand smoke had 2.71 times higher
odds of delivering a low birth weight infant [55]. Another study found that the effects of secondhand
smoke on low birth weight may, in part, be due to decreased placenta size [56]. A cross-sectional
study published in 2019 found that the children of mothers exposed to secondhand smoke exhibited
a birth weight that was, on average, 205.6 grams lower than normal [57]. A case-control study
found that fathers who smoked while their partner was pregnant were associated with 1.15 higher
odds of having children that developed childhood acute lymphoblastic leukemia [58]. A Hong Kong
birth cohort found that secondhand smoke exposure during pregnancy resulted in increased
behavioral problems at 11 years old according to the Revised Parent’s Rutter Scales, which
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measure conduct, emotional, and inattention/hyperactivity problems [59]. It is essential to ensure
that smokers are aware of the impact that their smoking has on children before they are even born.

Cigarette Smoke Components
According to the U.S. Food and Drug Administration, there are 93 established harmful and
potentially harmful constituents in tobacco smoke [60], but one of the most important and addictive
is the alkaloid nicotine. The content of nicotine and other alkaloids in tobacco is dependent on how
it is processed, the use of specific blends, sun curing, and additive use to alter the pH of the
generated smoke [61]. Nicotine exerts its addictive effects by competitively binding acetylcholine
targets, which has several effects including the release of dopamine [62] and β-opioids [63] along
with inhibition of long term GABA secretion [64]. Nicotine has also been shown to increase levels
of serotonin acutely while decreasing serotonin levels chronically [65]. Prenatal nicotine exposure
also recapitulates key impacts of prenatal smoke exposure. For example, it has been hypothesized
that prenatal nicotine exposure induces adrenal alterations to increase the risk of hypoxia-induced
Sudden Infant Death Syndrome [66].

Specifically, 6 mg/kg/day maternal infusion of nicotine

through an osmotic minipump from gestational day 5 to parturition found offspring exhibited
inhibited catecholamine release in response to hypoxic challenge alterations [66]. Prenatal nicotine
injections twice daily with 2 mg/kg free base nicotine resulted in offspring with non-sex-specific low
birth weight and subsequent catch-up growth by postnatal day 10 [67]. Xu et al. [68] demonstrated
that injecting pregnant Wistar rats twice daily with 1 mg/kg nicotine from gestational day ten results
in lower offspring body weight one week after birth. The offspring from this same study also
exhibited subsequent catch-up growth in addition to the development of metabolic syndrome when
exposed to a high-fat diet [68]. That same study did note some differences in timing of the catchup growth, in which it started in female offspring around postnatal week 11 and in male offspring
starting around postnatal week 16 [68]. It has also been found that injecting dams with 1 mg/kg/day
nicotine bitartrate starting two weeks before mating through weaning results in increased offspring
serum and lipid triglycerides [69]. Injecting female Wistar rats with 1 mg/kg/day nicotine during
pregnancy through lactation resulted in lost offspring pancreatic beta-cell mass [70]. This same
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study also found in these offspring glucose intolerance without changes in insulin levels or weight
[70]. Prenatal nicotine exposure through maternal subcutaneous injection with 1-3 mg/kg/day
nicotine hydrogen tartrate resulted in lower fetal rat weight [71]. This same study also found
proportional decreased fetal brain weight, loss of brain cells and histological abnormalities such as
mitochondrial swelling and intracytoplasmic edema in the hippocampal CA1 region of the brain [71].
Infusion of pregnant rat dams with 6mg/kg/day nicotine hydrogen tartrate via an implanted osmotic
pump starting on gestational day 12 and onward inhibited male offspring brain aromatase activity,
which plays an important role in rodent developmental brain masculinization [72]. Specifically, this
inhibition of brain aromatase activity in exposed male offspring occurred in the preoptic area,
hypothalamus, and amygdala, thereby disrupting brain sexual differentiation [72]. We have not
noted any similar published findings in female offspring, which do not depend on prenatal
aromatase activity for brain sexual differentiation [73]. As we discuss in more detail in a later
section, changes to the hypothalamus can have important consequences on hepatic metabolic
development. It is evident that not only does prenatal nicotine exposure have generalized systemic
impacts on offspring, but in particular results in lower birth weight and catch-up growth with
indications of perturbed metabolic health later in life.
Another principal cigarette constituent is tobacco-specific nitrosamines (TSNAs). These
compounds vary in concentration based on processing methods mentioned previously [74] as well
as the use of nitrogen-containing fertilizer [75]. The TSNA 4-(methylnitrosamino)-1-(3-pyridyl)-1butanone (NNAL) has been found both in the urine [76-78] and in the amniotic fluid of offspring
born to mothers who smoked during pregnancy [79]. Nicotine-derived nitrosamine ketone (NNK)
has also been detected in the urine of newborn children exposed in utero to cigarette smoke [78].
N-nitrosamines, of which TSNAs are a part, have known carcinogenic effects. Specifically, NNK
and N-nitrosonornicotine (NNN), which are two important TSNAs in tobacco smoke, have been
found to cause lung tumors and esophageal tumors, respectively [80]. We did not note at this time
any published association of TSNAs with low birth weight or long-term effects such as metabolic
syndrome. Given how TSNAs can be transferred to the fetus, it is essential for future studies that
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the potential of TSNAs to induce low birth weight with catch-up growth or adulthood metabolic
effects be thoroughly investigated.
Polycyclic aromatic hydrocarbons (PAHs), including benzo[a]pyrene and benzo(a)pyrene
diol epoxide, are a class of compounds produced from the incomplete combustion of organic matter
[81]. One main factor affecting PAH content in tobacco leaves is the level of nitrates in the soil [82,
83]. The levels of n-nitrosamines and PAHs have been found to be inversely related in tobacco
leaves since higher levels of nitrates in the soil lowers the amount of PAHs produced but increases
the levels of n-nitrosamines [84]. Levels of benzo[a]pyrene (BaP), in particular, can be used as a
surrogate for total PAH levels, as research has indicated that BaP and total PAH levels are
correlated [85]. The primary mechanism of BaP carcinogenicity is the formation of DNA adducts
induced by the metabolic byproduct benzo(a)pyrene diol epoxide (BPDE) [86]. Prenatal exposure
to PAHs has been associated with small for gestational age in children [87, 88]. Prenatal exposure
to BaP has been shown to cause low birth weight in children [89]. Another study [90] found that
daily oral gavage of pregnant dams with BaP during gestational day 7-16 resulted in increased
obesity-related measures in adult female offspring such as increased weight gain, visceral fat, and
hepatic lipid deposition. However, the authors from that study admitted the dosage of BaP they
used is 36-fold higher than what is experienced by women exposed throughout pregnancy to a high
amount of PAHs from cigarette smoke or other sources [90]. We did not note any published studies
regarding catch-up growth and prenatal exposure to PAHs. It is evident that exposure in utero to
PAHs such as BaP manifest some key characteristics predicted by the Barker Hypothesis including
low birth weight and increased obesity-related measures in adulthood, but more studies should be
done to confirm this is the case.
Volatile organic compounds (VOCs) in cigarettes are produced from the incomplete
combustion of organic matter, much like PAHs. The exact composition of VOCs present in cigarette
smoke, however, varies significantly based on burning conditions such as the amount of O2 present
and the temperature at the cigarette tip [91]. Notable VOCs include benzene and aldehydes such
as acetaldehyde, acrolein, and formaldehyde [92]. Benzene, in particular, is a potent carcinogen
contributing 9.5% to the cancer risk index of cigarette smoke, with aldehydes and other VOCs

10

contributing 43.6% [93]. VOCs [94], including formaldehyde [95] and benzene [96], have been
associated with low birth weight in children. Although we did not note any published studies on the
development of metabolic syndrome or obesity following prenatal exposure to VOCs, studies
should be done to examine this because of how often low birth weight has been associated with
obesity in adulthood.
Heavy metals are present in tobacco because of absorption from the soil [97, 98].
Cadmium [99], lead [99], and mercury [100] are readily absorbed by tobacco plants, which is
correlated with the concentration found in the soil. Both cadmium and lead are easily transferred
from tobacco into smoke [101, 102].

In cigarette smoke, cadmium is mostly in the particulate

phase, while lead is split into both gas and particulate phases in equal proportions [103]. In addition
to being carcinogenic, cadmium has been proposed as an agent contributing to in utero cigarette
smoke exposure-induced low birth weight [104, 105]. It has been hypothesized that cadmium
causes this by interfering with placental zinc and copper transfer [104] and inhibiting placental
progesterone production [105]. Five-year-old children exposed in utero to cadmium were recently
shown to be associated with approximately 25-fold increased odds of being obese [106]. Prenatal
lead exposure has been shown to result in delayed infant growth during the first two years of life,
especially if their mothers consumed less than average amounts of calcium [107]. A recent study
examining maternal red blood cell lead levels revealed 1.65 times increased odds of having an
overweight or obese child by eight years of age on average [108]. It is evident that heavy metals,
as well as other components of cigarette smoke discussed in this section, have great potential to
cause manifestations of the Barker Hypothesis. This potential makes it all the more prudent to
examine the effects of in utero cigarette smoke exposure on the development of adulthood
metabolic disease.

Barker Hypothesis
The Barker Hypothesis, more broadly known as the Developmental Origins of Health and
Disease, states that adverse in utero environmental factors result in an increased risk of adultonset diseases [109]. Specifically, it appears that it is low birth weight and not preterm birth that
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results in this increased risk later in life [110]. The amount of nutrition received by the developing
fetus has a direct impact on birth weight. It has been shown that children affected by maternal
caloric restriction during pregnancy exhibited an increased risk of obesity [111-114], heart disease
[112, 115-118], diabetes [115, 119-122], and hypertension [115, 123-125]. Further studies in
animals [126-134] and human epidemiological studies [135-137] support the Barker Hypothesis by
illustrating instances of maternal caloric insufficiency leading to adulthood manifestations of
metabolic disease.
Children exposed to active maternal smoking during pregnancy [138-142] or environmental
tobacco smoke after birth [143-147] have been found to have an increased risk of obesity and
metabolic syndrome. A recent meta-analysis in 2018 utilizing 16 studies found the odds of children
(the mean age of the children ranged from 3.8 to 15 years old) being overweight were increased
when mothers smoked 1-15 cigarettes each day [148]. A proposed mechanism for this increased
risk of metabolic syndrome development in children is from the Barker Hypothesis-derived concept
of the “thrifty phenotype” [149]. This hypothesis predicts in the context of placental insufficiency
that the fetus responds to maternal smoking in a manner that is analogous to caloric restriction
[150]. Nicotine, acting as a vasoconstrictor, limits blood flow from the mother to the placenta and
results in caloric restriction of the developing fetus [150]. It is predicted that as a result, the fetus
will develop metabolic adaptations to survive nutrient scarcity. A term that has been coined to
describe this phenomenon is predictive adaptive response (PAR) [151]. In other words, the fetus
detects through the mother facets of the in utero environment it expects to be born into and
undergoes adaptations such as altered insulin activity to promote increased success or survival
after birth [151].

Increased peripheral insulin resistance in conjunction with lowered insulin

secretion have been posited as adaptations of the thrifty phenotype [152]. Subsequent exposure
to a postnatal environment of calorie-dense food induces catch-up growth in these low birth weight
offspring [150]. This process of catch-up growth increases the risk of developing metabolic
syndrome in response to a high-fat Western diet in adulthood [150]. Further, this hypothesis
predicts that male offspring will be more adversely affected by prenatal CSE since they are typically
larger and more vulnerable to starvation during fetal development [150]. Considering the significant
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ongoing exposure to in utero cigarette smoke, it is prudent to examine the potential impact on
additional metabolic syndrome and obesity burden.

Metabolic Syndrome and Obesity
Metabolic syndrome, at its simplest, is a condition characterized by obesity, dyslipidemia,
and insulin resistance/hyperglycemia [153]. This syndrome is hypothesized to occur because each
of these symptoms share underlying pathology and collectively contribute to the risk of developing
cardiovascular disease and type 2 diabetes [153]. Over the years, metabolic syndrome has been
defined in several ways. The World Health Organization in 1998 required that insulin resistance
as measured by fasting glucose or another appropriate method be accompanied by at least two of
the following: increased waist/hip ratio or BMI, increased triglycerides or HDL-C, hypertension, or
microalbuminuria [154]. A more recent definition from the 2005 revision of the definition established
by the National Cholesterol Education Program (NCEP) Adult Treatment Panel III (ATP III) requires
3 out of the following criteria: increased waist circumference, elevated fasting blood glucose,
elevated triglyceride levels, lowered HDL cholesterol levels, or elevated systolic or diastolic blood
pressure [155]. The International Diabetes Foundation (IDF) requires central obesity to be present,
with two of the following: increased fasting blood glucose, triglyceride levels, systolic or diastolic
blood pressure, or decreased HDL cholesterol levels [156]. It should be noted that there are
multiple additional definitions in current clinical use in addition to the ones mentioned here [153].
According to a recent report from the Centers for Disease Control and Prevention (CDC)
that analyzed data between 1992-2012 in the United States from the National Health and Nutrition
Examination Survey (NHANES), the prevalence of metabolic syndrome in adults 18 years or older
as defined by the NCEP ATP III criteria increased from 25.3% to 34.2% [157]. This same CDC
report also found that age had a positive association with the prevalence of metabolic syndrome
while education level was negatively associated with metabolic syndrome prevalence [157]. At
least 50% of men and 60% of women by 70 years old had metabolic syndrome as reported in the
2007-2012 NHANES population [157]. Given that the rate of obesity in adults in the U.S. between
2000-2016 has risen from 30.5% to 39.6%, as well as the rate of obesity in youth going from 13.9%
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to 18.5% within the same time period [158], it seems likely that the rate of metabolic syndrome will
continue rising unless drastic measures are taken.
The rates of both obesity and metabolic syndrome have been associated with offspring
exposed in utero to cigarette smoke. One study found that 5 year old children born to mothers that
smoked during pregnancy were three times more likely to be overweight as defined by BMI [159].
A meta-analysis performed in 2010 utilizing 17 studies found a pooled odds ratio of 1.52 for children
becoming obese as a result of exposure in utero to cigarette smoke [160]. Another meta-analysis
conducted in 2008 utilizing 14 studies found that children exposed to prenatal cigarette smoke have
an increased odds ratio (1.40) for being overweight [138]. Adult women that were exposed in utero
to cigarette smoke exhibited elevated triglycerides and lowered HDL cholesterol (two criteria from
the NCEP ATP III metabolic syndrome definition) [161]. Both BMI and the prevalence of being
overweight or obese were higher in 14-year-old children of mothers who smoked during pregnancy
in a 2006 Australian cohort study after adjustment for several factors such as the reported diet of
the child [162]. A United Kingdom-based cross-sectional survey also found that mothers who
smoked ten or more cigarettes per day during pregnancy had children that exhibited higher BMI
and were more likely to be obese at 5-11 years old [163]. Another study found that children that
were on average 9.9 years old and exposed to cigarette smoke at any point in utero exhibited
higher BMI and total fat mass [164]. Mothers who smoked early in pregnancy went on to have
children that were at greater risk of being overweight, and exhibiting a higher BMI and systolic blood
pressure at three years old with no evident confounding by child diet [140]. A cohort of 17-19 year
old Swedish men followed between 1983-1988 whose mothers smoked during pregnancy were
found to have significantly higher systolic and diastolic blood pressure during adolescence [165].
A cohort of two-month old Netherlander infants whose mothers smoked during pregnancy was
found to have a significantly increased systolic blood pressure after adjusting for confounders such
as childhood nutrition [166]. Ten year old children exposed to prenatal CSE had higher insulin
levels and insulin resistance, even more so if their mothers exclusively breastfed [167]. It is evident
that cigarette smoke exposure in utero is contributing to obesity and metabolic disease in
adulthood, but what is the underlying mechanism driving this pathogenesis?
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Liver Development and Function
We established in the prior section the import of obesity and metabolic syndrome
concerning in utero exposure to cigarette smoke. The question that has yet to be satisfactorily
answered is what occurs in the liver of prenatal cigarette smoke-exposed children that results in
this increased risk of adulthood metabolic disease? To better understand the potential impacts
that prenatal toxicants have on the liver, it is necessary to review facets of hepatic development
and function. Liver organogenesis occurs around gestational day 8.5-9 in mice and 23-26 days
into human pregnancy, when the liver diverticulum forms from the anterior foregut endoderm that
is adjacent to the cardiac mesoderm [168]. It is within this liver diverticulum in which the septum
transversum and hepatoblasts begin to appear [168]. These hepatoblasts begin migration into
the septum transversum and proliferate while expressing alpha-fetoprotein and albumin [169172], production of the latter being one of the critical functions of the liver. Around the same time
that the liver diverticulum is forming, a ring of endothelial cells encircling the diverticulum help to
promote liver bud formation and migration of hepatoblasts into the septum transversum at
gestation day 9.5 in mice and 26-32 days in humans [168]. Once the liver bud starts forming,
hematopoietic progenitor cells begin migrating into the liver bud to establish fetal hematopoietic
function around ten days of gestation in mice and week five in humans [173, 174]. Hepatoblasts
are bipotential progenitor cells that can either differentiate into hepatocytes or cholangiocytes,
which occurs around gestational day 13.5 in mice and 56-57 days in humans [168]. Together,
these two cell types make up the majority of the cell mass of the liver; cell fate depends on
proximity to the portal vein [168]. Hepatoblasts adjacent to the portal vein will differentiate into
cholangiocytes, while hepatocytes located away from the portal vein will form hepatocytes [175].
Cholangiocytes eventually start budding off from the ductal plate surrounding the portal vein and
then form bile ducts around gestational day 17.5 in mice and 14 weeks in humans where the
remaining cholangiocytes in the ductal plate regress [168, 176]. This process finally ends at
about 30 weeks of gestation in the human fetus and within the first ten days after birth in mice
[168, 177]. This process sets up the production of bile, a critical function of the liver during
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development and after birth. During development, the fetal liver in both mice and humans acts as
the source of hematopoietic cells between gestational days 9.5-15 in mice and days 60-195 in
humans [178]. After this period, hematopoiesis is shifted to the bone morrow while it is
decreased in the liver [178]. It is apparent how prenatal toxicants could have lasting
consequences on the liver if they occur at key hepatic developmental stages.
The final phase of maturation for hepatocytes occurs within hepatic lobule zones, which
specify the location of hepatocytes relative to the portal and central veins. This process begins
after the differentiation of hepatoblasts into hepatocytes and continues after birth [178]. In
particular, the expression of many phase I and phase II metabolic enzymes are low in fetal livers
but increase after birth [178]. The hepatocyte population becomes heterogeneous in nature with
respect to what lobular zone they occupy [179]. Those closest to the portal vein in which higher
oxygen concentrations are found become more focused on oxidative processes such as fatty acid
oxidation and glutathione production [179]. Lobular zones surrounding the central vein and
thereby have a lower concentration of oxygen becomes focused more on non-oxidative
processes like glycolysis and lipogenesis [179]. Other primary functions of the liver that have not
been mentioned, which are described in further detail in subsequent paragraphs, are synthesizing
and storing glycogen as well as urea synthesis from nitrogen-containing compounds such as
ammonia. It is evident how prenatal toxicants could impact hepatic function by disrupting the
organization of hepatoblasts into metabolic functional units.
The mature liver is vital for glucose metabolism and maintaining blood glucose levels.
After the consumption of a meal, glucose is taken up in hepatocytes after being brought into the
liver via the portal vein from the small intestine [180]. After being brought into hepatocytes,
glucose is is phosphorylated into glucose-6-phosphate by glucokinase, which effectively prevents
glucose from diffusing out of hepatocytes [180]. It is at this point that glucose can meet several
different fates depending on physiological needs. One pathway glucose enters after a meal is
glycogenesis in which glycogen is stored in the liver via the conversion of glucose-6-phosphate
into glucose-1-phosphate [181] followed by production of UDP-glucose [182]. Glycogen is formed
from the conversion of UDP-glucose by glycogen synthase [183]. During development, the drive
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for glycogen storage is induced by expression of a large amount of Hexokinase I, which ensures
glycogen is produced and stored regardless of circulating glucose levels [184]. Glycogen can
also be converted back into glucose-6-phosphate and glucose can then be secreted into the
circulatory system to maintain blood glucose levels [183]. Glucose-6-phosphate can also be used
as a substrate for glycolytic and tricarboxylic acid pathways to produce ATP to power various
cellular functions [183] or utilized in fatty acid synthesis [185]. Additionally, glucose-6-phosphate
can be used to produce UDP-glucuronate [186] and UDP-galactose [183] which serve as
monosaccharide donors for the glycosylation of proteins to induce differential activity [183]. The
last significant fate of glucose-6-phosphate is the pentose phosphate pathway, in which NADPH
is produced as a cofactor for many synthetic reactions [187]. The NADPH produced by the
pentose phosphate pathway is also utilized in the synthesis of the ribose-5-phosphate necessary
to produce nucleic acids [187]. The liver also produces glucose, particularly during fasting, and
can do so via two pathways. The first of these pathways which has already been mentioned is
glycogenolysis, in which glycogen is broken down into glucose-1-phosphate then converted back
to glucose-6-phosphate [188]. After these steps, glucose-6-phosphate is dephosphorylated into
glucose [189] that can leave the liver and go into circulation [188]. The other pathway produces
glucose via gluconeogenesis, which can take several substrates like lactate or alanine and
convert them to pyruvate [183]. This pyruvate can then be combined with acetyl-CoA to form
oxaloacetate [190], then converted to phosphoenolpyruvate [191], then enter the glycolytic
pathway in reverse until it reaches fructose-1,6-bisphosphate [183]. The next step is irreversible
and converts fructose-1,6-bisphosphate into fructose-6-phosphate [192]. After this step, glucose6-phosphate is formed and can be dephosphorylated to glucose [189] and can then be shunted
back into circulation [183]. During the initial stages of fasting, glycogenolysis is the principal
source of glucose production, but as glycogen stores are depleted, gluconeogenesis becomes
predominant and by 48 hours is the primary source of glucose synthesis [193]. It is evident how
prenatal toxicants that affect the liver have the potential to perturb normal glucose metabolic
activity and increase the risk of adulthood metabolic disease.
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Lipid metabolism is a crucial function of the liver, as it allows for the long-term storage of
energy obtained from food [194]. Lipid metabolism also provides substrates used for the
synthesis of specialized lipids for plasma membranes and bile acid production [194]. After dietary
fat has been digested, the resultant fatty acids are converted into triacylglycerols (TAG) [194].
TAGs are stored in hepatocytes as lipid droplets or they are shuttled out into general circulation
as very-low-density lipoprotein (VLDL) [194]. De novo lipogenesis is another essential source of
fatty acids that are derived from the hepatic conversion of glucose into fatty acids after feeding.
Glucose is initially metabolized through the glycolytic pathway until it becomes pyruvate after
which it is converted into acetyl-CoA in the mitochondria [194]. Acetyl-CoA combines with
oxaloacetate to form citrate which is then converted in the cytoplasm back into acetyl-CoA and
oxaloacetate [194]. Once out in the cytoplasm, acetyl-CoA is converted into malonyl-CoA [195],
which serves as a 2-carbon substrate for the NADPH-powered synthesis of fatty acids [196],
specifically palmitic acid [194]. Note that this process of lipogenesis only occurs after feeding
when excess glucose and glycogen stores have been replenished [197]. During a fasted state, a
process called lipolysis linked with β-oxidation is utilized to produce ATP as well as substrate for
gluconeogenesis [194]. TAGs are initially broken down into glycerol and fatty acids, in which the
glycerol unit is able to be used as a gluconeogenic input [194]. The fatty acids are then broken
down within mitochondria via β-oxidation, where two-carbon atom units are repeatedly removed
from the terminal end of the fatty acid until it is completely broken down [198]. Each round of βoxidation produces ATP as well as an acetyl-CoA molecule, which can be used as an input into
the TCA cycle to produce even more ATP [198]. It is evident how prenatal toxicants that affect
the liver can increase the risk of adulthood metabolic disease by their potential to disrupt lipid
metabolism.
Detoxification of both endogenous and exogenous compounds is an important task
performed by the liver and is carried out in two primary phases. The first of these phases is
referred to as phase I reactions, which serve to add a reactive site to compounds through
processes such as hydroxylation [199], though other reaction types are used as well, such as
carboxylation [200]. The purpose of this phase is to render chemically inert compounds to be
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susceptible to conjugation by other enzymes [200]. The family of enzymes responsible for
carrying out phase I reactions are collectively known as the cytochrome P450 enzymes. These
enzymes are comprised of heme-thiolate proteins, of which there are numerous members. The
naming convention for these enzymes typically follow the letters CYP followed by a number for
their family, which were historically Roman numerals [201]. Following these first parts is the
subfamily letter and then the subfamily member number as each member is reported to the P450
Nomenclature Committee (CYP1A1 would be the very first P450 enzyme, for example) [201]. It is
hypothesized that the evolution of this family of enzymes came about mainly for the processing of
endogenous compounds [200]. The fact that these enzymes are useful for processing
exogenous and xenobiotic compounds is due mainly to structural similarity to endogenous
compounds [200]. It is also hypothesized that P450 enzyme diversity was also driven in part by
the employment of toxic compound synthesis in plants to counteract herbivory, resulting in
herbivore adaptation by employing an expanding repertoire of P450 enzymes to neutralize toxic
plant compounds [202, 203]. Given the sheer number of compounds that are found in cigarette
smoke, it is evident how prenatal exposure to these compounds during development when liver
phase I enzyme function has not fully formed can result in hepatic toxicity.
The second set of major detoxification enzymes carry out phase II reactions in which the
compounds initially processed by phase I enzymes are then conjugated with hydrophilic
molecules [204]. Generally, these conjugation reactions render compounds more water-soluble
so they can be excreted through the bile or the excretory system [204]. One of the most
significant phase II enzyme families is the UDP-glucuronosyltransferases, which catalyze the
conjugation of compounds with glucuronic acid using UDP glucuronic acid [205, 206]. This family
of enzymes is estimated to be responsible for approximately 40-75% of xenobiotic detoxification
[205, 206]. Sulfotransferases (SULTs) are another critical group of phase II enzymes that
conjugate a hydrophilic group onto compounds, specifically a sulfuryl group [207, 208]. This
reaction is applied to either hydroxyl or amine residues and generally render a compound more
hydrophilic as well as less toxic or biologically active [207]. Glutathione-S-Transferases (GSTs)
conjugate compounds with a molecule of glutathione in response to electrophiles or electrophile-
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generating compounds and reactive oxygen species (ROS) [209]. It is hypothesized that GST
induction occurs as an adaptive response ROS and thereby results in GST reactions with
hydroxyl, carbonyl, peroxide, and epoxide residues [210, 211]. Another major family of phase II
enzymes are N-acetyl transferases (NATs) that conjugate aromatic amine- or hydrazinecontaining compounds with acetyl groups [212]. Polymorphisms in NAT-related genes can
manifest different acetylator phenotypes in which slow acetylators have been associated with an
increased risk of developing liver and colon cancer [213]. NAT-related gene polymorphisms have
even been associated with cleft palate risk in infants with mothers that did not take prenatal
multivitamins [214]. The last major group of phase II detoxification enzymes is the
methyltransferases, which conjugate a methyl group onto compounds by using methionine from
S-adenosylmethionine (SAMe) [212]. The two types of methyltransferases are thiopurine
methyltransferase (TPMT) and catechol-O-methyltransferase (COMT) [212]. COMTs are
essential not just in the inactivation of catecholamines such as dopamine, epinephrine, and
norepinephrine [212, 215], but also inactivation of catechol-estrogens and metabolites [216].
TPMT prototypically metabolizes thiopurine drugs such as azathioprine [217]. Polymorphisms
affecting TPMT activity are essential in determining the toxicity of thiopurine drugs like 6mercaptopurine [218]. It is evident how prenatal exposure to cigarette smoke compounds during
a time in which phase II enzymatic activity may not be fully developed can result in fetal hepatic
toxicity.
Throughout development and after birth, there are multiple trajectory types with respect
to drug-metabolizing enzyme expression: high expression during gestation with decreased
expression after birth (Class 1), constant expression pre- and postnatally (Class 2), and low
expression during gestation followed by increased expression after birth (Class 3) [219].
Examples of Class 1 enzymes include CYP3A7 [220, 221] and SULT1E1 [222] which have been
hypothesized to follow a Class 1 pattern because they serve a necessary function during
gestation that is no longer needed after birth [219]. For example, SULT1E1 has been
hypothesized to inactivate estrogens in order to promote androgenic activity at critical male
gonadal developmental windows [223]. Class 2 enzyme examples include CYP2B6 [224] and
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SULT1A1 [222], and while there is not a particular hypothesis about why these enzymes are
expressed continuously during both gestation and after birth, it is thought that they serve different
roles before and after birth or they carry out the same function during both life stages [219].
Examples of Class 3 enzymes include CYP3A4 [220, 221] and SULT2A1 [225] and are predicted
to express high levels after birth but not during gestation because of more contact with various
environmental hazards and thereby need to be able to handle these exposures when
encountered [219]. It is evident how prenatal exposure to cigarette smoke exposure can be
variable depending on the enzymes responsible for metabolizing a particular cigarette smoke
compound and when those enzymes are normally expressed.
Bile acids are amphipathic compounds synthesized in the liver from cholesterol, where
the rate-limiting enzyme is CYP7A1 [226]. Bile acids emulsify fats, cholesterol, and fat-soluble
vitamins in the small intestine to aid in the maximal absorption by enterocytes [227]. Typically,
~95% of bile acids are reabsorbed in the small intestine after which they are transported to the
liver via the portal vein for reabsorption and subsequent resecretion into enterohepatic circulation
[227]. The remaining 5% is excreted and replaced by compensatory hepatic synthesis [227].
Primary bile acids, such as chenodeoxycholic (CDCA) and cholic acid (CA), are produced in the
liver [227]. These primary bile acids are then conjugated with either taurine or glycine to be
stored in the gallbladder for postprandial secretion into the duodenum of the small intestine [227].
Conjugation of bile acids occurs is carried out by enzymes such as BACS [228] and BAT [229],
as well as other conjugation enzymes typically utilized for detoxification, including SULT2A1 [230]
and UGT2B4 [231]. Conjugation by these enzymes render primary bile acids more hydrophilic
and amphipathic [232]. In the rat small intestine, taurine-conjugated bile acids are the majority in
both the duodenum and ileum, whereas the large intestine is enriched in unconjugated bile acids
[233]. Gut microbiota deconjugate bile acids via bile salt hydrolase and result in the release of
glycine or taurine; conversion of primary bile acids into more hydrophobic secondary bile acids
such as deoxycholic acid (DCA) occurs via 7α-dehydroxylase [234-236]. It is evident that
prenatal exposure to toxicants that can disrupt the development of the liver could result in
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perturbed bile acid metabolism in offspring, thereby potentially resulting in an altered bile acid
pool composition with physiological consequences.
Sexual differentiation is an important developmental facet that helps determine the
functional hepatic phenotype. Back in the 1930s it was noted that male rats given the same dose
per kilogram of bodyweight of hexobarbital slept for a shorter duration than female rats and that
this difference was abolished when male rats were castrated [237, 238]. Since then, it has been
found that one of the significant determinants for these sex differences in hepatic function is the
patterning of growth hormone (GH) secretion from the anterior pituitary gland. By using an
osmotic pump to mimic female-specific constant GH secretion in male mice in which the secretion
of GH has been eliminated by the neonatal administration of monosodium glutamate, the hepatic
expression of CYP2A4, CYP2B9, CYP2B10, CYP3A41 was increased while CYP2D9 was
decreased [239]. Conversely, female mice with GH secretion eliminated via neonatal
monosodium glutamate administration that were given twice daily GH injections to mimic the male
GH secretion profile resulted in suppressed hepatic expression of CYP2A4, CYP2B9, CYP2B10,
and CYP3A4 while promoting expression of CYP2D9 [239]. Other recent studies have also
demonstrated this system of sex-specific GH secretion-induced hepatic gene expression for
hepatic gene methylation [240], regulation of miRNA expression [241], and direct and indirect
mediation by hepatic STAT5b and HNF4α [242-244]. Given the sex-specific effects on hepatic
gene expression and function, an examination of the sex-specific hepatic impacts of prenatal
cigarette smoke exposure should be performed to fully characterize the risk of metabolic
disorders in offspring.

Non-Alcoholic Fatty Liver Disease
Non-alcoholic fatty liver disease (NAFLD), which at its simplest is the presence of hepatic
steatosis (or fat accumulation in the liver), requires two criteria in order to be diagnosed [245].
The first criterion is confirmed evidence of hepatic steatosis either by imaging such as through
ultrasound or by liver biopsy, which is considered to be the gold standard for identifying hepatic
steatosis [245]. The second criterion is that nothing else is present which could cause hepatic fat
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accumulation such as significant alcohol consumption, a genetic disorder, or the use of
medication that is known to cause steatosis such as corticosteroids, tamoxifen, amiodarone, and
others [245]. NAFLD commonly presents with mild to moderate steatosis and hepatocellular
ballooning [246]. When non-alcoholic steatohepatitis (NASH) is present in NAFLD patients, it
presents with lobular inflammatory that manifests as immune cell infiltration by mononuclear and
polymorphonuclear cells [246]. When the condition of NASH has progressed into the fibrotic
stage, it often presents in a pericellular manner [246]. Given the potential severity of NAFLD and
NASH, it is essential to investigate the possibility of prenatal cigarette smoke exposure to
increase the risk of developing these conditions during adulthood.
NAFLD is increasingly becoming a global problem and is currently the most significant
cause of chronic liver disease in the world. The global prevalence of NAFLD was estimated to be
25.24% by a meta-analysis published in 2016 utilizing 86 studies [247]. This same meta-analysis
found the prevalence of NALD was lowest in Africa (13.48%), followed by Europe (23.71%), North
America (24.13%), Asia (27.37%), South Africa (30.45%), and the Middle East (31.79%) [247].
This meta-analysis also made clear that NAFLD was often accompanied by related metabolic
disorders such as obesity (51.34%), hyperlipidemia (69.16%), hypertension (39.34%), Type 2
diabetes (22.51%), and metabolic syndrome (42.54%) [247]. These comorbidities were even
more prevalent when NASH was present, where obesity occurred with NASH at 81.83%,
hyperlipidemia at 72.13%, hypertension at 67.97%, type 2 diabetes at 43.63%, and metabolic
syndrome at 70.65% [247]. NASH was suspected of having an overall prevalence of somewhere
between 1.5% and 6.45%, but had a prevalence of 59.1% in biopsy-confirmed NAFLD patients
[247]. Progression of fibrosis in NASH patients was found to occur at an average annual rate of
0.09% [247]. The annual incidence of HCC in NAFLD patients was found to be 0.44 per 1,000
person-years and 5.29 per 1,000 person-years for NASH patients [247]. The severity of NASH
relative to NAFLD can be seen explicitly with the incidence rate ratio (IRR) for liver-specific
mortality and overall mortality. NAFLD and NASH patients had an IRR for liver-specific mortality
of 1.94 and 64.6, respectively, while NAFLD and NASH patients had an IRR for overall mortality
of 1.05 and 2.56, respectively [247]. This data only serves to confirm precisely why the
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increasing rates of NAFLD and, subsequently, NASH are so disconcerting. The evidence clearly
underlines the health burden on morbidity and mortality these diseases and their comorbidities
will have on the global population. These data are especially concerning due to NASH-related
cirrhosis being the second leading cause for liver transplants in the U.S. between 2004-2013
[248]. This same study found that the 90-day survival rate for NASH patients on the transplant
waitlist was lower than patients with alcoholic liver disease, hepatitis C infection, or patients with
both alcoholic liver disease and hepatitis C [248]. This lower survival rate in NASH patients was
due to their lower likelihood to receive a liver transplant at 90 days compared to other patients
[248]. NASH patients that were added to the waitlist for liver transplantation went up by 170%
between 2004-2013, whereas it increased by only 45% for alcoholic liver disease patients and
14% for hepatitis C patients [248]. If the current trend of ever increasing NAFLD and NASH
prevalence continues unabated, the already strained supply of liver transplants will become a fullblown crisis.
Cigarette smoke exposure also has been known to impact the development and severity
of NAFLD. A retrospective study looking at the development of NAFLD in patients over a 10-year
period demonstrated that smoking (1.91 adjusted OR) in addition to being male (1.46 adjusted
OR), having a BMI 25 or higher (3.08 adjusted OR), and dyslipidemia (1.79 adjusted OR) all
increased the odds of NAFLD diagnosis [249]. Additionally, the odds of developing NAFLD were
higher in patients with a Brinkman Index, defined by the product of cigarettes smoked daily and
the duration of smoking in years, between 1-399 (1.77 times higher) or 400 and higher (2.04
times higher), which clearly demonstrated a dose-dependent effect [249]. A study utilizing the
NASH Clinical Research Network found that NAFLD patients with a history of ten or more years
of smoking was associated with odds 1.63 times higher for advanced fibrosis [250]. This study
also found that these same NAFLD patients had increased odds for each year of age (1.06 times
higher), or were diagnosed with diabetes (2.44 times higher) [250]. There has even been
evidence that genetic polymorphisms for Adiponectin and GPx-1 that were positively associated
with cigarette smoking-induced NAFLD risk [251]. If even some of the effects of cigarette smoke
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exposure on the development of NAFLD are also present with in utero cigarette smoke exposure,
it is all the more essential to study the impacts of prenatal CSE on adulthood metabolic disease.
Pediatric cases of NAFLD differ from the typical presentation of this disease in a couple
of ways. In particular, the steatosis tends to be more severe with a lower frequency of
hepatocytic ballooning, and any associated inflammation is found more in the portal regions while
fibrosis is present more in the periportal regions [246]. This is in contrast to adult NAFLD cases
in which any associated inflammation is more lobular in location while fibrosis is detected more
often within pericellular regions [246]. The number of pediatric NAFLD cases that resemble an
adult presentation were small, but the majority of pediatric cases presented themselves as
previously described [246]. The remainder of the pediatric NAFLD cases that do not manifest
themselves in the previously mentioned ways had some mixture that was between the typical
adult and pediatric NAFLD presentation [246]. A meta-analysis found that the prevalence of
pediatric NAFLD overall was 7.6% in the general population [252]. However, when considering
studies using a clinically obese population, the prevalence was 34.2%, which was over four times
higher than the general prevalence [252]. The odds of children having NAFLD were higher in
males than females in a general population (1.63 times higher) and in clinical populations (2.02
times higher) [252]. The prevalence of NAFLD in clinical pediatric populations was found to be
higher in Asia (62.3%) compared to North America (39.2%), the Middle East (36.5%), Europe
(29.8%), and South America (17.1%) [252]. RNAseq analysis of human fetal livers from 12-19
weeks of gestation found that a number of NAFLD-related pathways were upregulated, such as
steatosis and liver inflammation, in response to prenatal cigarette exposure [253]. As far as we
know, it has not been explicitly studied if prenatal cigarette smoke exposure results in increased
rates of pediatric NAFLD cases. However, we may be able to infer the risk of pediatric NAFLD
from in utero cigarette smoke exposure from examining the effect of intrauterine growth restriction
on pediatric NAFLD risk, which the literature suggests is induced via increased insulin resistance
[254]. It is evident that prenatal cigarette smoke exposure may have an impact on the
development of not only adulthood NAFLD risk, but potentially childhood NAFLD risk as well. It is
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essential to examine effects of in utero cigarette smoke exposure on metabolic disease
development in adulthood, but also at other life stages.

Hepatic Metabolic Regulation by SIRT1
SIRT1 is NAD+-dependent class III deacetylase [255]. SIRT1 activity induces deacetylation
of various transcription factors as a result of sensing low energy status through levels of
NAD+/NADH [255]. This deacetylation action, as a part of the fasting response, results in the
induction of gluconeogenesis, fatty acid oxidation, as well as the suppression of lipogenesis [255].
Feeding results in a high energy state, in which there are lower levels of NAD+, thereby lowering
the activity of SIRT1 [255]. Consumption of a high-fat diet, which also results in a high energy
state, lowers SIRT1 activity as well via decreased levels of NAD+ [255].

In general, the

deacetylation of proteins by SIRT1 is opposed by p300-induced acetylation [256]. SIRT1-induced
deacetylation of FXR enhances FXR’s transactivation activity on its downstream targets by
increasing the frequency in which FXR interacts with its partner heterodimer Retinoid X Receptor
alpha (RXRα) [256]. In addition to SIRT1’s metabolic actions, NF-kB deacetylation by SIRT1
results in lowering NF-kB’s transactivation activity on the expression of various pro-inflammatory
mediators, thereby affecting immune function [257]. Given how prenatal CSE is hypothesized to
induce caloric restriction by limiting blood flow to the developing fetus, it would be highly pertinent
to investigate any impact of in utero cigarette smoke exposure on SIRT1 activity.
SIRT1-induced deacetylation also affects protein stability.

CRTC2, an essential

component in the promotion of gluconeogenesis, becomes more susceptible to ubiquitin-mediated
proteasomal degradation once it has been deacetylated [258].

Deacetylation by SIRT1 can

promote protein stabilization, a prime example of which is FOXO protein deacetylation, which
inhibits their phosphorylation and their ubiquitination-mediated proteasomal degradation [259, 260].
The final mechanism in which deacetylation by SIRT1 affects proteins is by histone deacetylation.
Histone deacetylation causes the adjacent DNA to be more tightly associated with its histones,
thereby limiting the accessibility of this DNA for transcription. SIRT1 downregulates the expression
of miR-34a via this mechanism of histone deacetylation [261]. This action of SIRT1 is particularly
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of note since miR-34a inhibits SIRT1 activity via the inhibition of NAD+ production by NAMPT [262].
miR-34a also directly inhibits transcription of SIRT1 by binding to the 3’-UTR of Sirt1 mRNA [261,
263], thereby affecting both the production and activity of SIRT1. It is evident that characterizing
the impact of prenatal CSE on the deacetylation of protiens would be an effective way of
investigating how in utero cigarette smoke exposure may be influencing SIRT1 activity in affected
offspring.
SIRT1 activity and subsequent downstream pathway activation can be altered by several
modulators. As will be discussed later, there is a regulatory positive feedback loop shared with
FXR that has a considerable impact on SIRT1 deacetylation activity and system-wide protein
acetylation status [256, 261, 264, 265]. The main factor in terms of regulation of SIRT1 activity is
the availability of NAD+, which is a necessary cofactor for SIRT1-catalyzed deacetylation [266].
This factor is essential to consider when examining SIRT1 activity since a lack of NAD+ can result
in a failure of deacetylation to be carried out by SIRT1 even in the presence of excess SIRT1
protein levels [267]. This mechanism is how miR-34a negatively regulates SIRT1 via inhibition of
NAMPT, an NAD+-producing enzyme [262].

Likewise, AMPK positively upregulates SIRT1

deacetylation activity by promoting the transcription of NAMPT [268]. Other factors that affect the
availability of NAD+ can also influence SIRT1 activity. This is the case with Poly ADP-Ribose
Polymerase 1 (PARP-1) [269] and CD38 [270] consumption of NAD+ pools, thereby indirectly
inhibiting SIRT1 activity. SIRT1 is modulated by various protein interactions, such as the binding
of AROS to the n-terminus of SIRT1 that further activates SIRT1-induced deacetylation [271].
DBC1 that is bound to SIRT1’s catalytic domain is capable of directly impairing SIR1’s deacetylase
activity [272]. SIRT1 activity can also be modulated by various post-translational modifications.
SUMOylation of SIRT1, for example, increases the half-life of SIRT1 protein by promoting its
stability [273]. Ubiquitination results in SIRT1 translocation into the nucleus [274], which increases
the rate of deacetylation of nuclear proteins. SIRT1 can also be phosphorylated, which results in
increased SIRT1-induced deacetylation [275]. Although it has been shown that SIRT1 is a crucial
regulator of metabolic activity during caloric restriction, these modifications can occur even during
a well-fed state, indicating that SIRT1 has regulatory functions outside of metabolism [273-275]. It
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is evident that investigation of the impact of prenatal CSE on SIRT1 deacetylase activity can be
characterized in part by any perturbations caused by in utero cigarette smoke exposure found in
factors known to modulate SIRT1-induced deacetylation.
SIRT1 is involved in a regulatory feedback loop with FXR and miR-34a. SIRT1 increases
the downstream activity of FXR through deacetylation, which increases the expression of the FXR
target protein SHP. This increase in SHP protein expression has an inhibitory effect on p53, which
results in less expression of miR-34a, a known direct and indirect inhibitor of SIRT1. Inhibition of
miR-34a transcription allows higher SIRT1 expression as well as greater SIRT1 deacetylation
activity. This regulatory feedback loop comes into play in many metabolic processes, which is
mainly exhibited in rodent models of obesity [256, 262]. One study showed that obesity caused an
increase in miR-34a expression [262], which lead to a decrease in activity from both SIRT1 and
FXR [256, 262]. This decrease in SIRT1 and FXR activity induced metabolic changes including
increased expression of lipogenic genes [256, 262], decreased levels of bile acid export proteins
[256], increased levels of serum VLDL and LDL, and decreased serum HDL levels [256]. These
SIRT1-related pathways are illustrated in more detail in Figure 1. Examining the SIRT1 regulatory
loop with FXR and miR-34a and impacted downstream targets provide an opportunity to
characterize impacts that prenatal CSE may have on SIRT1 activity in affected offspring.
There are recent examples in the literature suggesting that hepatic SIRT1 plays a vital role
in the development of NAFLD. In one study, it was found that mice fed a high-fat diet for 16 weeks
resulted in greater PARP activation and lower levels of NAD+ [276]. These changes ultimately
contributed to lower levels of SIRT1 activity and higher levels of lipogenic SREBP-1 activity [276].
Mice with disabled SIRT1 catalytic activity that were fed a high-fat diet for 34 weeks exhibited higher
levels of SREBP-1 protein expression with decreased phosphorylation of the pro-SIRT1 factors
AMPK and LKB1 [277]. Mice given a NAMPT inhibitor and fed a high-fat diet for 12 weeks resulted
in lower levels of NAD+, which led to attenuated SIRT1 activity and levels along with decreased
deacetylation of the pro-lipogenic transcription factor SREBP-1 [278]. One study found that the
expression of miR-181b, which inhibits transcription of Sirt1 as well as its translation into protein,
was increased in NAFLD patients in addition to decreased SIRT1 expression [279]. This same
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Figure 1 – SIRT1 Regulatory and Downstream Target Pathways
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study also found that mice with high-fat-diet-induced NAFLD exhibited increased miR-181b with a
concomitant decrease in SIRT1 expression [279]. In light of this evidence and the hypothesized
increase in obesity in adults that have been subjected to prenatal cigarette smoke exposure, it is
prudent to examine what role hepatic SIRT1 may play in the manifestation of the Barker
Hypothesis and the development of adulthood metabolic disease.

Study Objectives
The objective of this study was to elucidate the neonatal and adult sex-specific
phenotypic characteristics of mouse offspring exposed in utero to cigarette smoke. The study
documented herein was designed using a model of murine whole-body inhalation exposure to in
utero cigarette smoke via the use of the Teague TE-10C cigarette smoking apparatus. Metabolic
characteristics were recorded since this is important in establishing whether an altered metabolic
phenotype, as predicted by the Barker Hypothesis, does manifest in our model.
Due to the importance of SIRT1 in regulating the metabolic response of the liver to a lowenergy state, hepatic expression of SIRT1 and the expression of hepatic genes and proteins in
related metabolic pathways were examined. These pathways include glucose, lipid, and bile acid
metabolic processes known to be modulated by SIRT1 activity. The characterization of these
hepatic gene and protein changes during the neonatal period, post-weaning, and during
adulthood will allow us to determine if any early changes observed in the liver are associated with
perturbations found during adulthood, especially in conjunction with high-fat diet feeding. There
are future studies currently ongoing observing adult siblings of the neonatal offspring described in
this dissertation. Ultimately, conducting this study will allow insight into how in utero cigarette
smoke exposure alters the hepatic metabolic phenotype and fulfills the prediction of the Barker
Hypothesis of obesity development during adulthood. The objectives of the study are as follows:

1) Establish whether in utero CSE results in sex-specific diet-induced obesity coupled to impaired
SIRT1 expression during adulthood.
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2) Determine the sex-specific impact of prenatal cigarette smoke exposure on SIRT1-related
hepatic gene and protein expression at 1.5 weeks, an age at which catch-up growth has
occurred, and liver development is still ongoing.

3) Determine the sex-specific impact of prenatal cigarette smoke exposure on SIRT1-related
hepatic gene and protein expression at weaning in both the fed and fasted state.
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CHAPTER II: PRENATAL CIGARETTE SMOKE EXPOSURE IMPACTS ADULTHOOD WEIGHT
GAIN AND SIRT1-ASSOCIATED METABOLIC PATHWAYS DISTINCTLY BY SEX
Introduction
In 2016, 7.2% of U.S. women reported smoking at any point during pregnancy [47]. This
rate translates to at least 284,000 fetuses per year exposed to in utero to cigarette smoke [47].
Although many states have reported smoking prevalence in expectant mothers of 5% or less,
several states have rates above 15% with Kentucky (18.4%) and West Virginia (25.1%) being the
highest [47]. An analysis of 1999-2006 NHANES data indicated a significant level of underreporting
of smoking by pregnant women (22.9%) after confirming serum cotinine levels [51]. Assuming this
figure is still accurate for 2016, this means as many as 22901 out of 55449 infants born in Kentucky
in 2016 were exposed to in utero cigarette smoke [47].
A significant primary outcome of cigarette smoke exposure (CSE) during gestation in
infants is intrauterine growth restriction (IUGR), which presents as low birth weight [28, 29]. A
Meta-analysis found that in utero cigarette smoke exposure increases the rate of various congenital
disabilities, including orofacial clefts, congenital heart defects, gastroschisis, craniosynostosis,
clubfoot, anorectal atresia, musculoskeletal defects, hernias, and undescended testes [31]. It has
been found that the risk of Sudden Infant Death Syndrome was more than double with children
exposed to secondhand smoke in utero through active maternal smoking [32]. Murine models of
prenatal CSE exhibit low birth weight [35], decreased crown-rump length [41] as well as decreased
somite number [42]. The majority of murine [35-41] as well as rodent [43] models of prenatal CSE
exhibit a similar low birth weight phenotype.
The Barker Hypothesis proposes that caloric restriction during pregnancy, resulting in low
birth weight, increases the risk of obesity [111], heart disease [115], diabetes [115, 119-122], and
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hypertension [115, 123-125].

Further studies in animals [126-129], as well as human

epidemiological studies [32-45], support the Barker Hypothesis by illustrating instances of caloric
insufficiency leading to manifestations of metabolic disease later in life. The Barker Hypothesis
predicts, in the context of prenatal CSE, that the fetus will respond to maternal smoking in a manner
that is analogous to calorie restriction [150].
Nicotine, acting as a vasoconstrictor, limits blood flow from the mother to the placenta and
in doing so, results in caloric restriction of the developing fetus [150]. Prenatal exposure to other
cigarette smoke constituents have been shown to be associated with low birth weight or fetuses
presenting with small for gestational age including carbon monoxide exposure [280, 281],
benzo(a)pyrene [89], volatile organic compounds [94] including specifically formaldehyde [95] and
benzene [96], polycyclic aromatic hydrocarbons [87, 88], and heavy metals like cadmium [282285].

As a result of the fetus developing metabolic adaptations to survive nutrient scarcity,

subsequent exposure to a postnatal environment of calorie-dense food induces catch-up growth in
these low birth weight offspring which simultaneously increases the risk of developing metabolic
syndrome in response to a high-fat Western diet [150, 286, 287]. Further, this hypothesis predicts
that male offspring will be more adversely affected by prenatal CSE since they are more vulnerable
to starvation during development [150].
Children exposed to active maternal smoking during pregnancy [138-142], as well as to
environmental tobacco smoke after birth [143-147], have been found to have an increased risk of
obesity and metabolic syndrome. Defining metabolic syndrome in children is complicated by the
fact that the biomarkers used as criteria naturally vary with age [288]. To illustrate how ill-advised
applying adult criteria onto pediatric cases is, a cross-sectional study examining metabolic
syndrome prevalence in children age 10 to 18 years using multiple definitions found that the
prevalence ranged from 0.9-11.4% depending on the definition used [289]. In light of this, the
International Diabetes Federation has attempted to set age-specific criteria: for 10-16 year olds,
use IDF criteria set for adults except use the age-specific 90th percentile for waist circumference
cut-off instead of a specific circumference; for children 16 years and older, use the normal adult
IDF criteria; for 6-10-year-olds, they state it simply cannot be diagnosed in this age range, but it
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should be noted if there is an age-specific waist circumference above 90th percentile [290]. One
study that has examined the effects of in utero cigarette smoke exposure on cardiovascular disease
in weaned offspring in a murine model found that female CSE offspring fed a high-fat diet for two
weeks gained more weight than male CSE offspring and perturbed total cholesterol and highdensity lipoprotein levels [46]. Additionally, our lab has also contributed several murine studies of
combined pre- and postnatal exposure to cigarette smoke that induced low birth weight along with
altered organ-specific proteomic changes after weaning [35-37] and later in adulthood [38-40] that
show alterations in metabolic pathways.
Maternal stress and glucocorticoid levels are potential mediators of the Barker Hypothesis,
as well. A report by the CDC found that in 2010, 70.2% of women experience at least on stressful
life event in the year before the birth of their child [291]. Maternal depression, another factor thought
to influence offspring outcomes, in 2015 occurred at a rate of 28.7 per 1000 delivery
hospitalizations, according to a recent study [292]. Although it is not agreed on exactly how the
hypothalamus-pituitary-adrenal (HPA) axis is affected in offspring following elevated maternal
stress or glucocorticoid levels during pregnancy, there have been numerous studies documenting
effects on offspring HPA axis function from these maternal exposures [293]. Of note is a study
where the offspring of Wistar rats injected with nicotine twice daily (1.0 mg/kg) from gestational day
11 until parturition and subjected to chronic stress exhibited exacerbated HPA-axis response in
addition to the sensitization of the HPA-axis caused by the chronic maternal stress [68]. Given this
study, it should be investigated if prenatal CSE exerts similar effects on the HPA-axis.
SIRT1 is a NAD+-dependent enzyme that deacetylates proteins [255]. SIRT1 activity is
induced through the sensing of low energy status through levels of NAD+/NADH to induce
increased deacetylation of various transcription factors [255]. This deacetylation action results in
the induction of gluconeogenesis, fatty acid oxidation, as well as the suppression of lipogenesis
[255]. Conversely, the high energy status observed during a fed state, or consumption of a highfat diet, results in lower levels of NAD+ and thus lowers the activity of SIRT1 [255]. Placental
samples showing IUGR gathered from patients experiencing preeclampsia exhibited decreased
expression of Sirt1 [294] but appears to be unchanged in the fetal liver in a sheep model of placental
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insufficiency IUGR [295]. A model using in utero calorie restriction of Wistar rats found that when
21-day-old male offspring but not female offspring exhibited lower levels of hepatic Sirt1 expression
[296]. In a Sprague Dawley rat model of in utero food restriction, low birth weight offspring exhibited
increased prenatal hepatic SIRT1 activity with decreased hepatic SIRT1 activity at one day and
three months of age [297]. Increased levels of histone H3 acetylation have been found in the livers
of 21 day-old rat offspring subjected to IUGR [298]. Considering how both nutrient restriction in
utero, as well as IUGR, modulate SIRT1 expression and their similarity in birth outcomes to in utero
cigarette smoke exposure, it is pertinent to examine the role SIRT1 plays in prenatal cigarette
smoke exposure. A study conducted by our lab utilizing murine in utero and postnatal exposure to
cigarette smoke observed that exposed offspring exhibited decreased birth weight with persistent
weight decrements and decreased hepatic SIRT1 expression at six months of age [40]. This
provides rationale for further investigating the role of SIRT1 in mediating the impact of in utero
cigarette smoke exposure as well as whether it influences weight gain from high-fat diet
consumption in adulthood.
In this study, we utilized an established mouse inhalation model of cigarette smoke
exposure that mimics active maternal smoking during pregnancy spanning from preimplantation
throughout organogenesis and into late-stage fetal maturation (GD6-GD19). This period would be
approximately gestational day 13.5 to approximately the end of the first trimester in humans [299].
In terms of liver development, this would correspond to liver development through hepatoblast
differentiation into hepatocytes and cholangiocytes in both mice and humans, and the beginning of
bile duct formation in mice [168]. We characterized the impact CSE has on model phenotypic
characteristics, including hepatic protein expression of key metabolic enzymes, including SIRT1
following a high-fat diet challenge. We focused on impacts on the liver due to the critical role it
plays in regulating metabolic processes including glucose and lipid metabolic pathways. This study
was conducted to shed light on the impact of prenatal CSE-induced perturbation of SIRT1associated liver metabolic regulatory pathways.

Methods
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Animal Exposure
Female C57BL/6 mice maintained on LabDiet 5015 were mated overnight (two females
to one male) and checked the following day for the presence of a vaginal plug. Vaginal sperm
positive status was considered gestational day (GD) 0. On GD6, female C57BL/6 mice were
placed into either a cigarette smoke exposure (CSE) chamber or a Sham exposure (ambient
filtered room air) chamber for six hours/day daily on GD1 through GD19. Before exposure, each
day, fresh cages with approximately 2-3 grams of food and unlimited water were provided for the
duration of the exposure. Whole-body cigarette smoke exposure was carried out utilizing a
Teague TE-10C exposure apparatus (Teague Industries) using a standardized FTC method of
smoking one 2-second puff per minute, nine puffs per cigarette. Two packs of cigarettes were
used per day. The cigarettes used were Marlboro Red™, which was the most commonly smoked
cigarette in reproductive-aged women at the time of model development. In order to quantify the
composition of the cigarette smoke achieved, levels of CO and total suspended particulates
(TSPs) were measured daily in each exposure chambers. Plasma cotinine was used as a
measure of the internalization of cigarette smoke components since it is the primary metabolite of
nicotine.
After parturition, dams with litters were maintained on LabDiet 5015 containing 12% fat.
After weaning at three weeks of age, the offspring were maintained on the same diet until six
months of age, at which age offspring entered the diet challenge. For the diet challenge, Sham
and CSE offspring were assigned to maintenance on a low-fat control diet (CD, TestDiet 5TJS) or
a high-fat diet (HFD, TestDiet 5TJN). The CD and HFD contained 5.1 % and 19.9% fat,
respectively. Other notable differences between diets include 70.1% carbohydrate, 15.5%
protein, and 5.7% fiber content in the low-fat control diet versus 51.3% carbohydrate, 18.0%
protein, and 6.7% fiber content in the high-fat diet. Offspring were maintained on these diets with
unrestricted access for three months. Offspring weights were recorded weekly. During the diet
challenge, selected offspring from the same prenatal exposure group were cohoused. No more
than two animals of the same sex were cohoused together in a single cage during the duration of
the diet challenge. At the end of the diet challenge, offspring were euthanized following a 4-hour
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fast by asphyxiation by carbon dioxide. The excised liver was flash-frozen in liquid nitrogen and
stored at -80°C.
Animals were housed and maintained at the University of Louisville Research Resources
Center, an Association for Assessment and Accreditation of Laboratory Animal Care accredited
facility. All protocols were approved by the UofL Institutional Animal Care and Use Committee.
Cages for animal housing were changed weekly, unlimited food and water provided, and
maintained in an environment with a 12-hour light/dark cycle with controlled temperature and
humidity.

Characterization of Offspring Body Weight, Calorie Consumption, Fat Mass, and General
Activity Levels
Body weight and food consumption of offspring were measured once a week during the
3-month diet challenge. The body weight for each offspring was measured while food
consumption was recorded on a per cage basis. The first week of body weight and food
consumption was excluded from analyses to avoid the effects of acclimation to a new diet from
confounding the statistical analyses. Offspring fat mass was measured via Dual-Energy X-Ray
Absorptiometry (DEXA) using the Lunar PIXImus Densitometer (GE Medical Systems).
Within one week before the termination of the diet challenge, offspring (aged nine
months) maintained on a high-fat diet were placed into a clean open arena and allowed to move
freely for a trial time of 30 minutes with movement recorded by video. The video of each open
field trial was analyzed utilizing open-source MATLAB-based software developed for the
automation of the scoring of various behavioral assays [300]. Movement of individual mice during
the trials was tracked in order to calculate the total distance traveled, speed, and as a measure of
anxiety, the time spent in the inner versus the periphery of the arena.

Cigarette Smoke Exposure Monitoring via Plasma Cotinine Measurement, Carbon
Monoxide, and Total Suspended Particulates
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In order to quantitate the magnitude of cigarette smoke dams were exposed to, cotinine,
the primary metabolite of nicotine, was measured during the cigarette smoke exposure period.
Tail vein blood was collected from dams within 30 minutes of the end of exposure into
heparinized capillary tubes and was subsequently centrifuged at 10,000 x g for 10 minutes. The
collected plasma fractions were stored at -20 °C until ready for cotinine measurement. Using the
Cotinine Direct Elisa Kit (Immunalysis, Pomona CA), the collected plasma fractions were assayed
for the concentration of cotinine following the manufacturer’s instructions. Data was reported as
nanograms per milliliter. Levels of plasma cotinine greater than or equal to 50 ng/mL were
considered sufficient to simulate active maternal smoking during pregnancy. Twice daily, the
level of CO within each exposure chamber was recorded on a carbon monoxide detector with a
digital readout in parts per million. TSPs were recorded twice daily by drawing air from each
exposure chamber via a sampling port through a preweighed piece of filter paper. Each piece of
filter paper was then reweighed, and the calculated difference pre- and post-sampling was
divided by the volume of air that was drawn in an interval of five minutes while sampling each
chamber.

Western Blotting
Approximately 0.3 grams of liver was homogenized in 500 µL of ice-cold buffer [100 mM
PO4 Buffer, 150 NaCl, 0.1% Tween, 0.1% SDS, 0.5M Tris pH 8.0, 2 tabs per 10 mL phosphatase
and protease inhibitor cocktails, 10 µL per 10 mL EDTA, 7.5 mg/mL dithiothreitol (DTT)] using a
Tissue-Tearor homogenizer in 2 sec on/off pulses over the span of 1 minute. The sample was
kept on ice during homogenization. The concentration of protein in each sample was measured
by the Bradford method [301]. Liver homogenates (1000 µg of total protein per sample in a total
volume of 240 µL) were mixed with Laemmli buffer (0.25M Tris pH 6.8, glycerol, 10% SDS, trace
bromophenol blue), reduced with DTT (1g/5mL) then heated at 70° C for 10 minutes for a final
concentration of 4.2 µg/µL. Thirty-five µg total protein was applied to 10% acrylamide gels with
separation at 100V (~ 2hours) in Tris-glycine run buffer (25 mM Tris, 192 mM glycine, pH 8.3)
followed by transfer to PVDF membrane at 70V for 2 hours in non-reducing buffer (Tris-Glycine
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buffer; 25 mM Tris; 192 mM glycine, pH 8.3 with 20% ethanol). Following blocking in 5% non-fat
dry milk in TBS-T solution (Tris-buffered Saline-Tween; 137 mM NaCl, 20 mM Tris-Base pH 7.6,
0.1% Tween-20), the blots were incubated overnight at 4°C with primary antibody (SIRT1 Santa
Cruz #sc-15404, 1/500 dilution; PEPCK Santa Cruz #sc-271029, 1/500 dilution; GAPDH Cell
Signaling #5174S, 1/5000 dilution; NAMPT Thermo-Fisher #PA5-23198, 1/1000 dilution;
SULT2A1 Thermo-Fisher #PA5-12243, 1/1000 dilution; CYP8B1 Thermo-Fisher #PA5-37088,
1/1000 dilution; Catalase Cell Signaling #14097, 1/5000 dilution; SOD2 Cell Signaling #13194,
1/1000 dilution) diluted in non-fat dry milk in TBS-T. After three 10-minute washes in TBS-T,
blots were incubated with secondary antibody complexed to horseradish peroxidase (anti-mouse,
Thermo #32430; anti-rabbit, Cell Signaling #7074S) in 5% non-fat dry milk diluted in TBS-T at
room temperature for 3 hours. After three successive washes in TBS-T, blots were developed
with LumiGLO chemiluminescent reagent and peroxide (Cell Signaling Technology #7003S,
Danvers, MA), and visualized with a Bio-Rad Gel Doc XR+ system (Bio-Rad Laboratories,
Hercules, CA). Following visualization, blots were washed briefly in TBS-T and incubated with
Coomassie stain (0.1% Coomassie Brilliant Blue G250 Dye in 1:1 methanol:water) for 10
minutes, followed by two 10 minute washes in destaining solution (5:4:1 ethanol:water:acetic
acid), and a final wash for 5 minutes in deionized water. Blots were briefly air-dried, placed on a
scanner, then scanned into a digital format for import into ImageJ. Quantification of total protein
staining and target protein bands was performed in ImageJ by measuring pixel density for each
sample. The expression of the target protein was normalized per sample by the pixel density of
the total protein stain for each sample.

Liver Triglyceride Assay
Liver tissue (approximate weight of 0.10 grams) was incubated in 350 µL of ethanolic
NaOH at 55 ˚C overnight with periodic vortexing. The following morning, sample volume was
adjusted to 1000 µL with 1:1 H2O:70% reagent grade EtOH then centrifuged for 5 minutes at
4500 g. The supernatant was placed into a new tube, diluted to 1200 µL with 1:1 H2O: 70%
reagent grade EtOH and vortexed. Two hundred microliters of the diluted supernatant were
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mixed with 215 µL of MgCl2. After incubating on ice for 10 minutes, the sample was centrifuged
for 5 minutes, followed by placing the supernatant into a new tube.
Six microliters of sample or glycerol standard (Sigma #G7793) were mixed with 194 µL of
free glycerol reagent (Sigma #F6428) and assayed with free glycerol reagent used as a blank.
The microtiter plate was incubated at 37˚C for 15 minutes, and then absorbance was read at 540
nm. Triolein equivalents in samples were calculated as mg triglyceride/gram tissue.

Linear Mixed-Effects Modeling
Linear mixed-effects modeling using the lme4 R package [302] was conducted to assess
the independent and synergistic effects of prenatal CSE, postnatal adult diet, and sex of the
offspring on phenotypic characteristics and hepatic protein expression levels. Repeated
measures analysis was also incorporated. The general equation utilized to model the repeated
measures data is given by:

Eq. 1: Variable of Interest ~ 1 + Week*Sex*Exposure*Diet +
(Week|Litter/Individual Offspring) + (Week|Litter:Sex) + (Week|Litter:Diet)

Where Week*Sex*Exposure*Diet indicates modeling of fixed effects for the week of diet
challenge, sex of the offspring, prenatal exposure, and postnatal diet. All possible interactions
between the four fixed effects were considered with offspring treated as individuals. The
(Week|Litter/Individual Offspring) term indicates the weeks of the diet challenge set as a random
slope and the identity of individual offspring within each litter set as a random intercept. The
random intercept was set this way to account for the fact that each individual offspring is more
likely to be similar to other littermates than offspring from different litters. The goal of this was to
help control potential confounding of results due to potential natural variance between litters. The
Week variable was set as a random slope to account for the fact that the rate of change from one
week to the next may be variable and not constant. For the (Week|Litter:Sex) and
(Week|Litter:Diet) terms, the random intercept was modeled as a separate random litter intercept
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per sex and diet. These additional random intercept terms were used to account for potential
baseline differences due to the litter that offspring belong to with respect to the sex of the
offspring and what diet they were maintained on. The general equation used for endpoint data
(body weight and total calories consumed at the end of the diet challenge, offspring activity, body
fat tissue percentage, liver triglyceride assay, and hepatic protein expression) is given by:

Eq. 2: Variable of Interest ~ 1 + Sex*Exposure*Diet + (1|Litter) + (1|Litter:Sex) + (1|Litter:Diet)

The above equation 2 is similar to 1 but without the Week variable. For each analysis conducted,
there were issues with fitting random effects models due to the occurrence of singular fits. For
the general models listed above, random effects terms were systematically removed until each
model successfully converged and no longer resulted in singular fits. Any non-significant random
effects, interaction terms, or fixed effects were systematically tested for using ANOVA and
removed using AIC and BIC as the criteria for a good model fit to the data. After this process the
most parsimonious model was considered finalized for downstream analysis. Post-hoc testing
was conducted using t-tests for specific a priori contrasts of interest using the finalized models
with the emmeans R package [303] in which multiple testing was corrected for using the HolmBonferroni method [304]. One of the sets of contrasts tested for was the effect of CSE versus
Sham exposure: the effect of CSE versus Sham within Male offspring on a Control Low-fat Diet,
Male offspring on a High-fat Diet, Female offspring on a Control Low-fat Diet, and Female
offspring on a High-fat Diet. The second set of contrasts tested for the effect of High-fat Diet
versus Control Low-fat Diet: High-fat Diet vs Control Low-fat Diet within Male Sham offspring,
Male CSE offspring, Female Sham offspring, and Female CSE offspring. The last set of
contrasts tested for the effect of the sex of the offspring: Female versus Male offspring within
Sham offspring on a Control Low-fat Diet, Sham offspring on a High-fat Diet, CSE offspring on a
Control Low-fat Diet, and CSE offspring on a High-fat Diet. These sets of contrasts were chosen
since they were salient to the hypotheses to be tested. The first week and the first two weeks of

41

the weight and calorie consumption data, respectively, were removed to control for acclimation
effects to new diets.

Results
Cigarette Smoke Exposure Conditions and Birth Weight of Offspring
The carbon monoxide level in the cigarette smoke exposure chamber was 110.88 ppm +/8.096 ppm while total suspended particulates averaged 29.14 mg/m 3 +/- 8.34 mg/m3. These values
are consistent with previous cigarette smoke exposures performed by the Neal and Pisano labs
(138 ppm +/- 19.8 ppm CO and 25.4 mg/m3 +/- 6.5 mg/m3 TSP [40]; 128 ppm +/- 3.0 ppm CO and
29.2 mg/m3 +/- 2.6 mg/m3 TSP [41]). The values of each of these measures of CSE were below
the limit of detection in the Sham chamber. Plasma cotinine levels in sperm positive females were
84.57 ng/ml +/- 8.34 ng/mL. Plasma cotinine exceeded 50 ng/ml, one accepted cutoff to designate
a woman as an active smoker [305]. The plasma cotinine levels in the Sham sperm positive dams
were below the limit of detection of 4 ng/mL. The CSE offspring exhibited a low birth weight
phenotype with a ~15% reduction in birth weight similar to that found in our prior studies [35-37].
Catch-up growth was evident in the CSE offspring by the initiation of diet challenge (Figure 2).
Male and female offspring did not vary in weight on week one based on prenatal exposure.
Offspring subjected to in utero cigarette smoke exposure exhibited the classic phenotype of low
birth weight followed by subsequent catch-up growth as predicted by the Barker Hypothesis.

CSE-Induced Offspring Body Weight Perturbations Modulated by Diet and Sex of Offspring
As shown in Figure 2, throughout the 3-month diet challenge, male CSE offspring exhibited
a trend toward weekly weight gain both on a low-fat control and a high-fat diet (p = 0.06 for both).
Male offspring exhibited increased weight gain when maintained on a high-fat diet regardless of
prenatal exposure (p < 0.05). Female offspring exposed to cigarette smoke during gestation
exhibited a significant increase in body weight gain when maintained on a high-fat diet (p < 0.05)
while no difference in weight was observed when female offspring exposed in utero to cigarette
smoke were maintained on a low-fat control diet. Female offspring exhibited increased weight gain
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Figure 2 – CSE exacerbates diet-modulated sex-specific weight gain – The body weight of

offspring was recorded weekly after the initiation of the diet challenge. Prenatal exposure
to cigarette smoke exacerbated weight gain in female offspring maintained on a high-fat
diet. Prenatal exposure to cigarette smoke resulted in a trend toward increased weight
gain in male offspring when maintained on either diet. Maintenance of offspring on a highfat diet resulted in increased weight gain regardless of prenatal exposure or sex. Male
offspring maintained on a high-fat diet gained weight more rapidly than female offspring
on the same diet. * p < 0.05, + p < 0.1.
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when maintained on a high-fat diet regardless of prenatal exposure (p < 0.05). Male offspring
gained weight more rapidly than female offspring when maintained on a high-fat diet (p < 0.05).
There was not an evident difference in weight gain between male and female offspring when
maintained on a low-fat control diet. There was no impact of prenatal exposure on weight gain
between male and female offspring. When subjected to only in utero cigarette smoke exposure,
female offspring appear resistant to the increased weight gain evident in male offspring, but this
resistance was not observed when female offspring were maintained on a high-fat diet.
In Figure 3, at the end of the 12-week diet challenge period at nine months of age,
maintenance of all male offspring on a high-fat diet resulted in a significant increase in body
weight gain regardless of prenatal exposure (p < 0.05). Male offspring exposed in utero to
cigarette smoke and then maintained on a high-fat diet exhibited a trend toward increased body
weight (p = 0.06). Male CSE offspring maintained on a control low-fat diet exhibited no difference
in body weight. Female CSE offspring maintained on a high-fat diet exhibited a significant
increase in body weight compared to female Sham offspring maintained on a high-fat diet (p <
0.05). There was no impact of prenatal CSE on body weight in female offspring maintained on a
low-fat control diet. Female CSE offspring on a high-fat diet exhibited a significant increase in
body weight compared to female CSE offspring maintained on control low-fat diet (p < 0.05).
Sham female offspring maintained on a high-fat diet exhibited a trend toward increased body
weight compared to Sham female offspring maintained on a low-fat control diet (p < 0.10). In all
instances, male offspring were significantly heavier than female offspring regardless of prenatal
exposure or diet (p < 0.05). The manifestation of the Barker Hypothesis in female offspring
subjected to in utero cigarette smoke exposure was conditional on the composition of the diet in
adulthood. These female offspring outcomes were in contrast to the consistent manifestation of
the Barker Hypothesis in the male offspring exposed in utero to cigarette smoke regardless of the
diet they were maintained on in adulthood.

Impact of Prenatal Cigarette Smoke Exposure and Adult Diet Challenge on Calorie
Consumption and Measures of Offspring Activity
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Figure 3 – CSE-induced increase in sex-specific weight and modulated by diet – By the end
of the 12-week diet challenge, all offspring maintained on a high-fat diet exhibited increased weight
as compared to those offspring maintained on a low-fat control diet, except the female Sham
offspring. When maintained on a high-fat diet, male offspring subjected in utero to cigarette smoke
resulted in a trend toward increased weight, whereas the corresponding female offspring exhibited
a significant increase in weight. In all instances, male offspring were heavier than female offspring.
* p < 0.05.
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As shown in Figure 4, the average total calories (kcals) consumed per animal during the 12-week
diet challenge did not differ based on prenatal exposure or sex of the offspring. Consumption of a
high-fat diet, however, resulted in significantly more kcals consumed by both male and female
offspring as compared to male and female offspring maintained on a control diet (p < 0.05). The
calories consumed weekly were monitored during the 12-week diet challenge (Figure 5). Male
offspring exposed in utero to cigarette smoke and maintained on a high-fat diet, at the time of diet
challenge at age six months, exhibited lower weekly consumption of diet over time compared to
male Sham offspring maintained on a high-fat diet (p < 0.05). There was no impact of prenatal
CSE on weekly consumption in male offspring maintained on a low-fat control diet. There was no
impact of a high-fat diet on weekly consumption in male offspring. Female offspring exposed in
utero to cigarette smoke and maintained on a high-fat diet exhibited lower weekly consumption of
diet over time compared to female Sham offspring maintained on a high-fat diet (p < 0.05).
Female Sham offspring maintained on a high-fat diet consumed fewer calories over time
compared to female Sham offspring maintained on a low-fat control diet (p < 0.05). Female
offspring maintained on a high-fat diet consumed more calories over time compared to male
offspring when maintained on a high-fat diet (p 0.05). It should be noted that in Figure 5, the
magnitude of all significant differences amounted to less than 1 kcal/week. Overall, the one
notable change observed in calorie consumption was the greater total calories consumed by
offspring maintained on a high-fat diet versus a low-fat control diet during the entire 12-week diet
challenge. Although there were minor differences as a result of prenatal exposure to cigarette
smoke, it seems that calorie consumption did not have a meaningful impact on prenatal CSEinduced weight gain observed in exposed offspring.
One potential mediator of offspring body weight differences, general activity level, was
assessed by open-field activity in the offspring. Only the offspring maintained on a high-fat diet
underwent open-field testing. As shown in Figure 6A, prenatal CSE did not affect the speed of
offspring maintained on a high-fat diet compared to Sham offspring maintained on a high-fat diet.
Female Sham offspring maintained on a high-fat diet exhibited a trend toward increased activity
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Figure 4 – High-fat diet results in greater calorie consumption – The number of calories (kcal)
consumed throughout the diet challenge was monitored. Neither sex of the offspring nor prenatal
exposure influenced the total amount of calories consumed for the duration of the diet challenge.
All offspring that were fed a high-fat diet consumed more total calories than those offspring
maintained on a low-fat control diet. * p < 0.05.
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Figure 5 – Minor effect of CSE on the rate of calorie consumption modulated by diet – The
number of calories (kcal) consumed weekly were tracked throughout the diet challenge. Week 1
was excluded to allow for acclimation to a new diet. When maintained on a high-fat diet, offspring
with prenatal exposure to cigarette smoke consumed calories at a lower rate. Female offspring fed
a high-fat diet consumed more calories at a higher rate than male offspring maintained on a highfat diet. Female offspring fed a high-fat diet consumed calories at a higher rate than female
offspring maintained on a low-fat control diet. All effect sizes were < 1 calorie/week. * p < 0.05.
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Figure 6A – Female CSE offspring traveled more quickly on HFD than male CSE offspring Open field assessment was used to determine the average speed of individual offspring while
traveling in the arena. Female offspring exposed in utero to cigarette smoke and maintained on a
high-fat diet were more active than male CSE offspring maintained on a high-fat diet. Female Sham
offspring maintained on a high-fat diet resulted in a trend toward increased activity compared to the
male Sham offspring maintained on a high-fat diet. * p < 0.05, + p < 0.1.
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compared to male Sham offspring maintained on a high-fat diet (p = 0.08). Female CSE offspring
maintained on a high-fat diet were significantly more active than male CSE offspring maintained
on a high-fat diet (p < 0.05). As shown in Figure 6B, the distance each offspring traveled
mirrored the speed each offspring traveled in Figure 6A. Female CSE offspring maintained on a
high-fat diet traveled more than male CSE offspring maintained on a high-fat diet (p < 0.05). As
shown in Figure 6B, female Sham offspring maintained on a high-fat diet exhibited a trend toward
increased distance traveled compared to male Sham offspring maintained on a high-fat diet (p =
0.07). In Figure 6C, the percentage of trial duration spent in the inner region of the arena, a
measure of anxiety where mice naturally try to minimize the time spent in the center of the arena,
was increased in female CSE offspring maintained on a high-fat diet compared to female Sham
offspring maintained on a high-fat diet (p < 0.05). Female CSE offspring maintained on a high-fat
diet spent more of the trial in the inner region of the arena compared to male CSE offspring
maintained on a high-fat diet (p < 0.05). The absence of effects of prenatal CSE on the level of
activity suggests a lack of contribution to the increased weight gain observed in Figure 2 in
offspring subjected to in utero cigarette smoke exposure.

CSE-Induced Sex-Specific Effect on Offspring Adiposity is Modulated by Diet
Body composition (lean and fat tissue mass, bone mass, and density) was assessed by
DEXA scanning. As shown in Figure 7, male CSE offspring maintained on a low-fat control diet
exhibited a trend toward an increased percentage of fat tissue compared to Sham male offspring
maintained on the same diet (p = 0.06). Male CSE offspring maintained on a high-fat diet
exhibited no difference compared to male Sham offspring maintained on a high-fat diet. Male
offspring maintained on a high-fat diet exhibited increased body fat compared to male offspring
maintained on a low-fat control diet regardless of prenatal exposure (p < 0.05). Female CSE
offspring on a high-fat diet exhibited an increased percentage of body fat tissue compared to
Sham female offspring maintained on a high-fat diet (p < 0.05). There was no impact of prenatal
CSE on body fat in female offspring maintained on a low-fat control diet. Female offspring
maintained on a high-fat diet exhibited increased body fat compared to female offspring
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Figure 6B – Female CSE offspring traveled more on HFD than male CSE offspring – Open
field assessment was used to determine the distance individual offspring traveled in the arena.
Female offspring exposed in utero to cigarette smoke and maintained on a high-fat diet traveled
more than male CSE offspring maintained on a high-fat diet. Female Sham offspring maintained
on a high-fat diet resulted in a trend toward increased distance traveled compared to the male
Sham offspring maintained on a high-fat diet. * p < 0.05, + p < 0.1.
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Figure 6C – Female CSE offspring on HFD display less anxious behavior than male CSE
offspring – Open field assessment was used to determine the level of anxiety behavior in individual
offspring. Female CSE offspring maintained on a high-fat diet spent a greater duration of the trial
in the inner portion of the arena compared to female Sham offspring maintained on a high-fat diet,
thereby displaying less anxiety behavior. Female offspring exposed in utero to cigarette smoke
and maintained on a high-fat diet spent in the inner portion of the arena was increased compared
to male CSE offspring maintained on a high-fat diet. * p < 0.05.
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Figure 7 – Prenatal CSE increases body fat accumulation in female CSE offspring
maintained on a HFD – DEXA scanning was used to characterize the body composition of the
offspring, including fat, lean, and bone mass. Male offspring exposed in utero to cigarette smoke
and maintained on a low-fat control diet resulted in a trend toward increased percentage body fat.
An increase in percentage body fat was observed in female CSE offspring maintained on a highfat diet. A high-fat diet increased the percentage of body fat in all offspring regardless of prenatal
exposure or sex of the offspring. Male CSE offspring maintained on a low-fat control diet had a
greater percentage of body fat compared to female CSE offspring maintained on a low-fat control
diet. Male Sham offspring maintained on a high-fat diet exhibited an increased percentage of body
fat compared to female Sham offspring maintained on a high-fat diet. * p < 0.05, + p < 0.1.
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maintained on a low-fat control diet regardless of prenatal exposure. Sex had no impact on body
fat Sham offspring maintained on a low-fat control diet. Female Sham offspring maintained on a
high-fat diet exhibited a decreased percentage of body fat tissue compared to male Sham
offspring maintained on a high-fat diet (p < 0.05). Female CSE offspring maintained on a control
low-fat control diet exhibited a lower percentage of body fat tissue compared to male CSE
offspring maintained on a control low-fat control diet (p < 0.05). Sex had no impact on body fat of
CSE offspring maintained on a high-fat diet. It was not surprising that Sham offspring maintained
on a high-fat diet for 12 weeks resulted in fat accumulation; what was surprising is the impact in
utero cigarette smoke exposure had on fat accumulation in male Sham offspring maintained on a
low-fat control diet, and female CSE offspring maintained on a high-fat diet. Our results
demonstrated that in utero exposure to cigarette smoke in conjunction with maintenance on a
high-fat diet caused exacerbated body fat accumulation in female offspring, mirroring the
exacerbation of weight gain in female CSE offspring maintained on a high-fat diet.
Considering that maintenance on a high-fat diet can result in the development of fatty
liver disease, liver triglycerides were measured in offspring at the end of the diet challenge. We
anticipated that three months of being maintained on a high-fat diet should induce fatty liver in all
male offspring as this is an established phenomenon [306-312]. As shown in Figure 8, liver
triglycerides were significantly increased in all male offspring maintained on a high-fat diet
compared to male offspring maintained on a control diet regardless of prenatal exposure (p <
0.05). Prenatal CSE had no impact on liver triglyceride levels in offspring maintained on control
low-fat diet. Neither prenatal exposure or diet had an impact on liver triglyceride levels in female
offspring. There was no impact of the sex of offspring on liver triglyceride levels in offspring
maintained on a low-fat control diet. Female offspring maintained on a high-fat diet had
significantly lower levels of liver triglycerides compared to male offspring maintained on a high-fat
diet regardless of prenatal exposure (p < 0.05). Despite the exacerbation of weight gain and
body fat accumulation seen in female CSE offspring maintained on a high-fat diet, they appeared
to be resistant to developing liver lipid accumulation, suggesting an innate resistance of female
offspring to fatty liver development. It was evident for male offspring that in utero exposure to
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Figure 8 – Male offspring maintained on a low-fat diet do not exhibit liver fat deposition in
response to prenatal CSE – Total liver triglycerides were measured from the livers of offspring.
Prenatal exposure to cigarette smoke did not affect liver triglyceride concentrations. Male offspring
maintained on a high-fat diet had significantly higher liver triglyceride levels than male offspring fed
a low-fat control diet. Male offspring maintained on a high-fat diet had significantly higher liver
triglyceride levels than the female offspring maintained on a high-fat diet. Female offspring were
resistant to liver fat deposition. * p < 0.05.
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cigarette smoke did not exert an additional impact on high-fat diet-induced fatty liver.

CSE-Induced Changes in Hepatic Protein Expression of SIRT1-Related Enzymes are
Modulated by Diet
As shown in Figure 9A, hepatic SIRT1 protein expression is lower in male CSE offspring
maintained on a low-fat control diet compared to male Sham offspring maintained on a low-fat
control diet (p < 0.05). Prenatal CSE had no impact on SIRT1 expression in male offspring
maintained on a high-fat diet. High-fat diet feeding in male offspring resulted in decreased
hepatic protein expression of SIRT1 regardless of prenatal exposure (p < 0.05). Hepatic SIRT1
expression in female offspring was unaffected by either prenatal exposure or diet. In males,
prenatal CSE followed by low-fat diet maintenance results in a similar reduction in hepatic SIRT1
when maintained on a high-fat diet.
Figure 9B shows the hepatic expression of NAMPT, an enzyme responsible for
generating NAD+, a necessary cofactor for many cellular processes, including SIRT1 deacetylase
activity. Hepatic expression of NAMPT in male offspring is unimpacted by either prenatal
exposure or diet. In female offspring, the hepatic expression of NAMPT was unaffected by
prenatal CSE when maintained on either diet. Female offspring maintained on a high-fat diet
exhibit increased hepatic expression of NAMPT compared to female offspring maintained on a
low-fat control diet regardless of prenatal exposure (p < 0.05). It was anticipated that the hepatic
expression of NAMPT would be decreased in response to high-fat diet maintenance having been
maintained on a high-fat diet for 12-weeks, but unexpectedly male offspring were unaffected
while female offspring exhibited increased NAMPT expression
The hepatic expression of GAPDH, an essential regulatory enzyme in glycolysis, which is
downregulated by SIRT1 through the deacetylation of PGC-1α, is shown in Figure 10A. In male
CSE offspring maintained on a low-fat control diet, hepatic GAPDH expression was decreased
compared to male Sham offspring maintained on a low-fat control diet (p < 0.05). Hepatic
GAPDH expression was increased in male CSE offspring maintained on a high-fat diet compared
to male Sham offspring maintained on a high-fat diet (p < 0.05). High-fat diet maintenance in
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Figure 9A – Prenatal CSE or high-fat diet independently decrease hepatic SIRT1 protein expression in male offspring – Male CSE offspring
maintained on low-fat control diet exhibited decreased hepatic SIRT1 expression compared to male Sham offspring maintained on a low-fat control
diet. Male offspring maintained on a high-fat diet exhibited decreased hepatic SIRT1 expression compared to male offspring maintained on a lowfat control diet regardless of prenatal exposure. In male offspring, maintenance on a high-fat diet resulted in decreased expression of SIRT1
irrespective of prenatal exposure. There was no observed difference in hepatic SIRT1 expression in female offspring regardless of either prenatal
exposure or diet. * p < 0.05.
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Figure 9B – Prenatal CSE does not impact hepatic NAMPT expression, while HFD increases NAMPT expression in female offspring –
Prenatal CSE had no observable effect on hepatic NAMPT levels in offspring. High-fat diet maintenance in female offspring increased hepatic
NAMPT levels compared to low-fat control diet maintenance in female offspring. Hepatic NAMPT levels in male offspring were not impacted by
either prenatal exposure or diet. * p < 0.05.
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Figure 10A – The impact of prenatal CSE on hepatic GAPDH expression is highly modulated by diet in male offspring – Male CSE offspring
maintained on a low-fat control diet exhibited decreased hepatic GAPDH expression compared to male Sham offspring maintained on a low-fat
control diet. Male CSE offspring maintained on a high-fat diet exhibited increased hepatic GAPDH expression compared to male Sham offspring
maintained on a high-fat diet. High-fat diet decreased hepatic GAPDH protein expression in male Sham offspring compared to the low-fat control
diet in male Sham offspring. A high-fat diet also increased hepatic GAPDH expression in male CSE offspring compared to the low-fat control diet
in male CSE offspring. A high-fat diet also increased GAPDH expression in female CSE offspring compared to low-fat control diet in female CSE
offspring. * p < 0.05.
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male Sham offspring decreased hepatic GAPDH expression relative to control low-fat control diet
maintenance in male Sham offspring (p < 0.05). High-fat diet maintenance in male CSE offspring
increased hepatic GAPDH protein expression relative to low-fat control diet maintenance in male
CSE offspring (p < 0.05). Prenatal CSE had no impact on hepatic GAPHD expression in female
offspring maintained on either diet. High-fat diet maintenance had no impact on hepatic GAPDH
expression on female Sham offspring. High-fat diet maintenance in female CSE offspring
increased hepatic GAPDH expression compared to low-fat control diet maintenance in female
CSE offspring (p < 0.05). Our results demonstrate that in male offspring, the impact of in utero
cigarette smoke exposure on hepatic GAPDH expression was conditional on diet. The
expression of GAPDH in male offspring mirrored that of SIRT1 in Figure 9A except male CSE
offspring maintained on a high-fat diet where SIRT1 expression was decreased while GAPDH
expression was increased. These results appear to be a mismatch in expression levels in male
offspring since we anticipated GAPDH levels to be in opposition to SIRT1 levels based on the
typical inhibitory action of SIRT1 activity on GAPDH levels. In female offspring maintained on a
high-fat diet, the increase in NAMPT expression seems inconsistent with the high levels of
GAPDH since NAMPT, an enzyme whose activity is increased in a low-energy state, would seem
in opposition to the promotion of glycolytic pathways.
PEPCK is a regulatory gluconeogenic enzyme that catalyzes the conversion of
oxaloacetate into phosphoenolpyruvate during gluconeogenesis and is upregulated by SIRT1
activity. As seen in Figure 10B, male CSE offspring maintained on a low-fat control diet exhibited
decreased hepatic PEPCK expression relative to male Sham offspring maintained on a low-fat
control diet (p < 0.05). Prenatal CSE exhibited no impact on hepatic PEPCK expression in male
offspring maintained on a high-fat diet. High-fat diet maintenance in male Sham offspring
decreased hepatic PEPCK hepatic expression compared to low-fat control diet maintenance in
male Sham offspring (p < 0.05). High-fat diet maintenance exhibited no impact on the hepatic
expression of PEPCK in male CSE offspring. The hepatic expression of PEPCK in female
offspring was entirely unaffected by either prenatal exposure or diet. Similar to the results seen in
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Figure 10B – Prenatal CSE and high-fat diet independently decrease PEPCK expression in male offspring – Male CSE offspring maintained
on a low-fat control diet exhibited decreased hepatic PEPCK expression compared to male Sham offspring maintained on a low-fat control diet.
High-fat diet maintenance in male Sham offspring exhibited decreased PEPCK expression compared to low-fat control diet maintenance in male
Sham offspring. PEPCK expression was not impacted in female offspring by either prenatal exposure or diet. * p < 0.05.
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Figure 9A, hepatic PEPCK expression in male offspring was decreased independently by in utero
cigarette smoke exposure or maintenance on a high-fat diet. The expression of SIRT1 and
PEPCK should match in general due to the stimulatory effect SIRT1 activity has gluconeogenic
pathways. The results suggest that whenever SIRT1 expression was decreased in male
offspring, SIRT1 activity was likely to be decreased as well since a concomitant decrease in
PEPCK was observed as well. These results also mean that since SIRT1 and PEPCK were
unaffected in female offspring, SIRT1 activity and gluconeogenesis pathways were relatively
unimpacted.
The hepatic expression of SULT2A1, CYP8B1, SOD2, and Catalase was also measured.
No impact of prenatal cigarette smoke exposure was observed for these for proteins. High-fat
diet maintenance increased expression of SULT2A1 and CYP8B1 in female offspring and
decreased expression of SULT2A1 in male offspring regardless of prenatal exposure (data not
shown, p < 0.05). In the context of fatty liver disease, lipid accumulation in the liver results in the
production of ROS induced by the peroxidation of lipids. One way the liver mitigates this
phenomenon is by converting excess fatty acids into cholesterol and then into bile acids. In light
of this, female offspring maintained on a high-fat diet on our study exhibited increased expression
of both CYP8B1 and SULT2A1, two enzymes that are important in the bile acid synthetic
pathway. These results may reflect the resistance of female offspring to lipid accumulation, which
is in agreement with the lack of liver triglycerides in female offspring maintained on a high-fat diet.
Conversely, the decreased expression of SULT2A1 in male offspring maintained on a
high-fat diet may be reflective of increased susceptibility to lipid accumulation in the liver, which is
in agreement with the observed increase in liver triglycerides observed in male offspring
maintained on a high-fat diet. Another process that often occurs to mitigate ROS generation from
lipid peroxidation is the induction of antioxidant enzymes to neutralize ROS, such as SOD2 or
Catalase. However, the lack of any impact on the expression of either of these enzymes
suggests that if lipid accumulation was occurring in any of the offspring, they have not progressed
to the later stages of fatty liver disease. It is evident that in light of the results observed in our
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study, none of the offspring appear to be in later stages of fatty liver disease that are typically
characterized by oxidative damage to hepatic tissues.

Discussion
In our current study, the presence of a low birth weight phenotype in the murine model of
gestational CSE (GD1-19) was detected with subsequent catch-up growth by the initiation of the
diet challenge (six months of age). The serum cotinine levels present in the cigarette smokeexposed dams exceeded 50 ng/mL, a cutoff that is indicative of active maternal smoking [305].
The low birth weight phenotype that was observed in our gestation-only exposure model is similar
to that observed in other models of murine CSE [35-41]. Unlike models of both pre- and
postnatal exposure to cigarette smoke (GD6-PD21) in which offspring exhibited low birth weight
and had not caught up by six months of age [35-40], the exposed offspring in our gestation-only
CSE model did exhibit catch-up growth by six months of age in both male and female offspring.
Other studies using a gestation-only model of cigarette smoke exposure found a decrease in
body weight of 10—12% that persisted 14 [313] and 30 days [314] after birth. The model
showing a persistent weight decrement at 14 days after birth was exposed only from E8-E20, with
urine cotinine levels in the dams of 5,800 ng/mL [313]. The study showing decrements at 30
days utilized a nose cone-based inhalation model where the mothers were exposed for three
weeks before breeding [314] that could have impacted neonatal growth. That same study could
have confounding introduced by the animal restraint that needs to be used to conduct a nosecone inhalation exposure. According to their methodology, before breeding, females were
subjected to two exposure sessions of varying duration per day [314]. Additionally, they did not
define duration in terms of time, but in the number of puffs per session (24 puffs per session
throughout gestation) [314]. A study examining the effects of neonatal thirdhand cigarette smoke
exposure in C57BL/6 mice found that offspring housed with terrycloth exposed to 5600 mg of
cigarette smoke particulate material from birth to three weeks after birth had decreased weight at
3-weeks old and complete catch-up growth at 5-weeks old [315]. It appears that the overall
duration, intensity, timing, and maternal or paternal-only exposure to cigarette smoke exposure
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may play a role in whether catch-up growth occurs in affected offspring. It is evident that other
models of pre- and periconception CSE also found low birth weight with persistent decrements in
weight. The current study, which monitored weights for a considerably greater length of time,
found catch-up growth. It should be noted that these studies vary in type of cigarette smoke
exposure (nose cone or whole body) and other measures of duration and quantity of cigarette
smoke exposure. The current model of prenatal cigarette smoke exposure does fit the Barker
Hypothesis with prototypical low birth weight followed by subsequent catch-up growth in exposed
offspring.
It was clear from the data presented from our current study that in utero cigarette smoke
exposure exacerbates sex-specific weight gain in sexually mature mice with modulation by
postnatal diet. This finding is similar to a study by Ng et al. that found that 13- to 14-week old
mouse female offspring exposed in utero to cigarette smoke and maintained on a control diet were
heavier than air-exposed offspring [46].

They also found that female CSE offspring, when

maintained on a high-fat diet for two weeks, were not different from air-exposed female offspring
[46]. That same study found male offspring exposed in utero to cigarette smoke and maintained
on a high-fat diet weighed more than air-exposed male offspring, with no impact of prenatal CSE
when male offspring were fed a control diet [46]. However, in our study it was the female offspring
exposed to prenatal cigarette smoke and high-fat diet maintenance that exhibited elevated body
weight gain with no impact of prenatal CSE when maintained on a control diet. There are several
methodological differences between our study and the Ng et al. study that complicates the
comparison of outcomes. For example, the cigarette smoke produced in the Ng et al. study resulted
in a lower CO level (23.4 ppm vs. 110.88 ppm), a lower total suspended particulate level (17.1
mg/m3 vs 29.14 mg/m 3), used a different strain of mice (B6C3F1 vs C57BL/6), different start of
gestational exposure (4 days after mating vs 6 days after mating), different timing and duration of
diet challenge (began at 11-12 weeks and lasted for 2 weeks vs began at 6 months and lasted for
3 months), and different fat percentage content of the high-fat diet fed to offspring (21.2% fat versus
19.9 % fat) [46]. Despite methodological differences, it is evident that in our study adult female
offspring subjected to in utero cigarette smoke exposure and maintained on a high-fat diet are more
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impacted than were the male offspring. Overall, we found that the impact of in utero cigarette
smoke exposure in sexually mature mice results in differential weight gain that is modulated by
both the postnatal diet and sex of the offspring.
In the current study, prenatal cigarette smoke exposure had a limited impact on the total
quantity of calories consumed during the diet challenge. Maintenance of offspring on a high-fat diet
increased the total amount of calories consumed by offspring regardless of prenatal exposure. As
far as we know, there has not been a published study before ours that observed calorie intake of
adult offspring maintained on various diets in an animal model of prenatal CSE. One study has
found that children exposed in utero to cigarette smoke had higher fat consumption and total body
fat [316]. A cross-sectional study found that adolescent children subjected to in utero cigarette
smoke exposure consume more fat through epigenetic modification of Oprm1 [317]. In the current
study, we were not able to recapitulate the effects of prenatal cigarette smoke exposure on calorie
consumption found in the literature. However, the fact that calorie consumption was tracked on a
per-cage basis rather than on an individual basis weakens the interpretation of our findings. Future
studies should track individual calorie consumption in order to fully determine the role of prenatal
cigarette smoke exposure on eating habits during adulthood.
The current study documents that female offspring exposed in utero to cigarette smoke did
display less anxiety behavior, as demonstrated by more time spent in the central region in an open
field assessment.

We did not characterize differences in offspring anxiety in CSE offspring

maintained on a low-fat control diet. Unlike our study, a prospective cohort study found that
prenatal exposure to cigarette smoke was associated with children age two to three years exhibiting
more anxiety behavior, particularly in girls [318].

Similar to our study, a study utilizing both pre-

and postnatal cigarette smoke exposure in mice found that exposed female offspring were less
anxious [44]. Similar to our study, rats exposed in utero to 5mg/kg/day to nicotine through an
implanted minipump from gestational day 8-20 exhibited less anxiety behavior at 12-14 months of
age [319]. It is evident that prenatal CSE or nicotine influences anxiety behavior; however, the
directionality and which sex is more affected appears to vary. Even though our results are not
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entirely consistent with the literature, it is clear that in utero cigarette smoke exposure impacts
neurobehavioral development.
The current study also found that female offspring exposed in utero to cigarette smoke and
maintained on a high-fat diet were more active than the corresponding male offspring both in terms
of average speed traveled, and the total distance traveled. Similar to the outcomes in our study, a
prospective cohort study found that children subjected to prenatal cigarette smoke exposure were
more hyperactive [320]. Unlike our study, however, the male offspring were more affected and had
more attention and aggression behavioral problems [320].

A previously mentioned pre- and

postnatal exposure found prenatal CSE offspring were more active anxious [44], much like the
female CSE offspring from our current study. A study found male B6C3F1 mice exposed in utero to
cigarette smoke from GD4 to parturition exhibited increased locomotor activity at four weeks after
birth and 4-6 months of age, similar to our current findings, and was found to co-occur with
increased aggression [321]. A mouse model using C57BL/6 mice found that prenatal exposure to
nicotine resulted in increased male offspring locomotor activity [322], unlike our study, where it was
female offspring that displayed increased locomotor activity. The only notable difference seen
concerning in utero cigarette smoke exposure was the decreased anxious behavior seen in female
CSE offspring when maintained on a high-fat diet. We did not characterize differences in offspring
activity in CSE offspring maintained on a low-fat control diet. It did not appear from our results that
activity mediated the impact of in utero cigarette smoke exposure on exacerbated weight gain in
female offspring with high-fat diet maintenance. Despite the increased levels of activity seen in
female CSE offspring compared to male CSE offspring, female CSE offspring still experienced a
significant increase in weight gain when fed a high-fat diet while male CSE offspring only exhibited
a trend toward increased weight gain when maintained on a high-fat diet. This exemplifies just how
profoundly the metabolism of CSE female offspring is adversely affected with respect to resisting
high-fat diet induced weight gain.
The current study demonstrates that male offspring exposed to in utero cigarette smoke
exhibited differences in hepatic protein expression of several key metabolic enzymes involved with
glucose metabolism, including decreased SIRT1, GAPDH, and PEPCK expression whereas livers
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of female offspring were unaffected. The literature has examples of decreased SIRT1 and NAMPT
expression in the liver of mice fed a high-fat diet [261, 262]; however, in the current study, high-fat
diet consumption resulted in no impact on hepatic NAMPT expression in male offspring and
increased hepatic NAMPT expression in female offspring. The current study did replicate in the
male offspring the decrease in hepatic SIRT1 expression with high-fat diet feeding that is seen in
the literature [261, 262], but not for female offspring maintained on a high-fat diet. In a murine
model of pre- and postnatal cigarette smoke exposure, decreased hepatic SIRT1 expression in 6month old offspring was observed but increased PEPCK expression [40]; however, that study used
mice in a fed state whereas the current study the offspring were in a fasted state before
euthanization. Fasting state is essential to consider when interpreting these results since a typical
fasting response includes increased SIRT1 expression and activity along with increased
gluconeogenic activity via increased expression and activity of PEPCK and GAPDH in the
gluconeogenesis direction.
A remaining question about SIRT1 and Sirt1 expression is whether the change is due to
the intrauterine growth restriction or directly by the cigarette smoke exposure. One study found in
C57BL/6 mice given twice daily nicotine plus fed a high-fat diet for ten weeks had both reduced
hepatic SIRT1 protein and RNA expression [323]. Male A/J mice injected with nicotine three times
a week for ten weeks after an initial injection with NNK 2 weeks before that exhibited decreased
SIRT1 expression in the lung [324]. A more recent study found that ApoE-/- mice subjected to ecigarette exposure containing 2.4% nicotine for 12 weeks exhibited decreased hepatic SIRT1
expression along with a decreased ratio of NAD+/NADH and increased hepatic PARP1 (a known
consumer of NAD+) expression [325]. Although these studies were not prenatal exposures like in
our studies, they offer some evidence that cigarette smoke may be able to influence SIRT1 levels
directly rather than indirectly by causing intrauterine growth restriction. Given the evidence, it
seems probable that the hepatic SIRT1 decrease in expression seen in the male offspring in our
current study could be due to direct effects of cigarette smoke on hepatic tissue that remain all the
way into adulthood, however, more studies need to be done to determine whether this is a direct
action of cigarette smoke or indirectly via intrauterine growth restriction.
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There were several limitations to the current study that prevented extracting as much
information as we could have. For example, tracking individual offspring weight from birth until the
end of the study was not conducted. This tracking would have allowed the determination of
associations between magnitudes of low birth weight and subsequent expression of hepatic
proteins and phenotypic characteristics at adulthood. In future studies, we plan to take measures
to allow weight tracking across the entire lifetime of offspring to strengthen the outcomes observed.
Another limitation was not observing the expression of SIRT1 and other hepatic proteins in sibling
animals at six months of age, before the initiation of the diet challenge. Taking note of this would
have provided information on the expression of SIRT1 on a diet that was intermediate in fat content
(~12%) and any change in expression after three months of maintenance on a low-fat control diet
(~5% fat) or a high-fat diet (~20% fat). Taking note of this would also be essential to note since
this design would have allowed us to investigate how prenatal CSE impacted modulation of SIRT1
on these diets. In a currently ongoing experiment, we have modified our design presented here to
record differences in hepatic protein expression at a point before induction of a diet challenge in
order to address this issue. Using a low-fat diet as a control for the diet challenge may have
complicated the interpretation of our results by modulating the total calories consumed. The choice
of control diet is an essential distinction since, as mentioned earlier in this report, SIRT1 is a sensor
of the current cellular energy status where its activity is classically upregulated in a low-energy
status. As a result, our choice of a low-fat diet as the control of the high-fat diet potentially
exacerbated any differences in SIRT1 expression and the expression of related glucose metabolic
enzymes. In the future, we plan to modify our experimental design to use a more appropriate
control for high-fat diet maintenance. Despite these limitations, we think the data presented here
provide new insight into the sex-specific impacts on the liver in a model of in utero cigarette smoke
exposure and how this is modulated by adulthood diet.
Our model of prenatal cigarette smoke exposure (from gestational day 6-19) resulted in
sexually dimorphic weight gain and hepatic SIRT1 protein and enzyme expression associated with
glucose metabolism. The low birth weight predicted by the Barker Hypothesis was apparent. The
resistance to perturbation by prenatal cigarette smoke exposure observed in female offspring is
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potentially due in part to increased levels of estrogen signaling in females. We hypothesize that
females may be more resistant to developing non-alcoholic fatty liver disease in part due to being
able to resist perturbation of hepatic SIRT1 expression and subsequent modulation of glucose
metabolic pathways. Future studies could confirm this by examining levels of estrogen signaling
activation in offspring exposed in utero to cigarette smoke and search for correlations with the
phenotypes demonstrated in the current study. Future studies should examine whether the effects
on hepatic protein expression observed here also are present at earlier time points in the lifecycle
of in utero cigarette smoke-exposed offspring such as at weaning or during the perinatal period.
The possibility that the perturbations induced by prenatal cigarette smoke exposure occurs
regardless of the current energy status of the animal or specifically disrupts the fasting response to
a low-energy state is the focus of subsequent chapters.
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CHAPTER III: IN UTERO CIGARETTE SMOKE EXPOSURE PERTURBS HEPATIC
EXPRESSION OF METABOLIC PATHWAYS IN A SES-DEPENDENT MANNER SHORTLY
AFTER BIRTH
Introduction
The reported rate of smoking during pregnancy in the U.S. has fallen over the years. The
earliest recorded data from 1967 and 1980 National Natality Surveys show the rate of smoking
while pregnant in women age 20 years or older dropped from 40% to 25% in Caucasian women
and from 33% to 23% in African American women [326]. It has continued to fall since, with the
overall rate of smoking during pregnancy in the U.S. being 18.4% [50], 12.2% [327], and 10.7%
[328] in 1990, 2000, and 2010, respectively. According to the latest data available in the United
States, smoking during pregnancy has fallen from a rate of 8.4% to 7.2% from 2014 to 2016 [47,
48]. An initial examination makes it seem as though public health campaigns to inform the public
about the adverse effects of in utero cigarette smoke exposure to the developing fetus have been
successful.

Examining the data from Kentucky and West Virginia however reveals maternal

smoking during pregnancy occurs at a rate of 18.4% and 25.1%, respectively [47]. It is evident that
although overall the rate of smoking during pregnancy has gone down dramatically, there are still
states that have disproportionately higher rates than others.
A point of concern is that most of this data is highly dependent on self-reported smoking
during pregnancy. For example, a study utilizing NHANES data from 1999-2006 found that 22.9%
of pregnant women fail to disclose their current smoking status, which was confirmed by serum
cotinine levels that exceeded a defined cut-off for actively smoking [51]. Underreporting of smoking
during pregnancy was also evident in a study comparing 2003 data from the Pregnancy Risk
Assessment Monitoring System (PRAMS) and from states that had implemented the revised 2003
standard birth certificate. In that study, it was shown that PRAMS found that 14.0% of women
smoked during pregnancy while data from the revised 2003 standard birth certificate found that
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11.3% of women smoked during pregnancy [329]. Another example is a study utilizing data from
New York City and Vermont, where the rate of smoking during pregnancy was 10.4% using the
2003 U.S. Standard Birth Certificate and 14.1% using medical records [330]. Utilizing data that
relies on self-reported maternal smoking habits potentially results in significantly underreporting the
rates of smoking during pregnancy. It is hypothesized that a reason for this phenomenon of
underreporting is due to more well-educated women being concerned about being judged by their
peers more harshly than less-educated women are [48]. For example, the study utilizing data from
New York City and Vermont found a significantly higher discrepancy between birth certificate and
medical records; the more educated the mother was and if they had private insurance vs Medicaid
coverage [330]. These studies make evident that if proper care is not taken to collect data
accurately, we risk significantly underestimating the rate of smoking during pregnancy, and by
extension, the number of infants exposed in utero to cigarette smoke.
A significant primary outcome of cigarette smoke exposure (CSE) during gestation in
infants is intrauterine growth retardation, which presents as low birth weight [28, 29, 138-142].
Models of mice [35-41], as well as rats [43], also exhibit this phenotype. As described in the
Introduction of Chapter II, the Barker Hypothesis predicts increased metabolic disease during
adulthood as a result of prenatal exposures such as maternal caloric restriction. As mentioned in
Chapter II, the similarities between prenatal cigarette smoke/nicotine exposure and maternal
caloric restriction result in a common manifestation of low birth weight and catch-up growth
phenotypes. These similarities in phenotypes between prenatal cigarette smoke exposure and
maternal caloric extension, by extension results in similar risks for metabolic disease in adulthood.
Although the impact of prenatal cigarette smoke exposure has been documented in epidemiological
studies, not much has been done to examine precisely how the metabolism of offspring exposed
in utero to cigarette smoke on a mechanistic level. In studies previously conducted by our lab with
a mixed-sex murine model using pre- and postnatal exposure to cigarette smoke, it was found that
exposed offspring had a perturbed metabolism [35, 331]. Our lab showed that exposed offspring
at PD21 experience decrements in glucose, lipid, and amino acid metabolic proteins according to
proteomic analysis [35]. Specifically, in a fed state, 6-month-old exposed offspring had decreased
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levels of hepatic SIRT1 protein as well as increased levels of PEPCK and PGC1α protein and
decreased serum glucose levels [331]. Exposed offspring also exhibited oxidative stress in the
form of depleted glutathione [331]. One crucial facet of the Barker hypothesis that is not addressed
by these studies is the examination of the sex-specific impact of prenatal CSE on liver metabolism.
Additionally, these studies do not address whether liver metabolic changes can be detected in the
perinatal period and whether these changes persist into adulthood. Determining this would allow
for the possible development of targeted early-life interventions in cases of prenatal exposure to
cigarette smoke.
As mentioned previously in Chapter II, SIRT1 is a NAD+-dependent enzyme that
deacetylates acetyllysine residues on proteins and is induced through the sensing of low energy
status through levels of NAD+ [255].

As an essential sensor of low-energy status, SIRT1

deacetylates key transcription factors in order to promote the hepatic fasting response, including
induction of gluconeogenic and lipolytic processes while inhibiting glycolytic and lipogenic
processes [255]. After deacetylating transcription factors responsible for the regulation of these
metabolic processes, these modified transcription factors result in the induction or inhibition of key
metabolic enzymes. For example, SIRT1-mediated deacetylation of FOXO1 [332] and PGC-1α
[333] leads to enhanced transcription of selected gluconeogenic enzymes such as PEPCK.
Seemingly paradoxically, SIRT1 deacetylation of the gluconeogenic transcription factor CRTC2
promotes its degradation [258]; however, this is thought to occur in order to sustain
gluconeogenesis at a steady rate during a prolonged fasting response [334].

Through

deacetylation, SIRT1 also enhances the activity of PPARα [335, 336], a critical transcription factor
for promoting transcription of lipolytic enzymes such as EHHADH and MCAD. Further, in support
of the fasting response, SIRT1 deacetylates the lipogenic transcription factor SREBP-1c [337],
which results in lower transcription of lipogenic enzymes such as FAS in order to avoid conflicting
with lipolytic processes. There are additional metabolic processes that SIRT1 influences, such as
the bile acid sensor and transcription factor FXR, where deacetylation promotes protein stability,
thereby enhancing its transactivation function on downstream targets such as SHP [256], an
essential negative regulator of CYP7A1 expression.
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The objective of this study was to characterize the sex-specific impact of prenatal CSE on
hepatic SIRT1 expression on target gene expression during the neonatal period, at a time at which
low birth weight is no longer evident (1.5 weeks of age). We utilized an established mouse
inhalation model of cigarette smoke exposure that mimics active maternal smoking during
pregnancy throughout the entire fetal development period (GD1-GD19).

The mRNA gene

expression levels for SIRT1 targets, which are indicative of activation or suppression, are indirect
indicators of SIRT1 activity. A similar in utero cigarette smoke exposure paradigm leads to sexspecific modulation of fat deposition, weight gain, liver SIRT1, GAPDH, and PEPCK protein
expression, as seen in Chapter II.

Methods
Animal Exposure
Female C57BL/6 mice maintained on breeder chow (LabDiet 5015) were mated overnight
and checked the following day for the presence of vaginal sperm. Sperm positive status was
considered gestational day (GD) 0 for the exposure timing. On GD1, female C57BL/6 mice were
placed into either a cigarette smoke exposure (CSE) chamber or a sham exposure (ambient
filtered room air) chamber for 6 hours/day daily from GD1 to GD19. Cigarette smoke exposure
was carried out using a Teague TE-10C exposure apparatus (Teague Industries) smoking
Marlboro Red cigarettes, which was the most commonly smoked cigarette at the time of model
development, using the FTC method of smoking (2-second puff per minute). After parturition,
dams with litters were maintained on breeder chow. At 1.5 weeks of age, representative offspring
of each litter were euthanized by carbon dioxide asphyxiation. At euthanization, the excised liver
was frozen on dry ice and stored at -80°C.

Cigarette Smoke Exposure Monitoring via Measurement of Carbon Monoxide, Total
Suspended Particulates, and Plasma Cotinine
At the start of each day of exposure, the level of CO within the cigarette smoke exposure
chamber was allowed to increase rapidly by fully closing the dilutor valve until the level reached
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110 parts per million (ppm) as detected with a commercially available carbon monoxide detector
with a digital readout. Once this level was reached, CO levels were further adjusted by opening
and closing the dilutor valve as appropriate to maintain a target CO level ranging between 110 to
150 ppm. At the end of exposure each day, the dilutor valve was fully opened to allow rapid
dissipation of any remaining CO in the cigarette smoke exposure chamber. TSPs were recorded
twice daily by drawing air from each exposure chamber via a sampling port through a preweighed
piece of filter paper. The filter paper was then reweighed, and the pre- and the post-sampling
difference was divided by the volume of air drawn through the sampling device in five minutes.
Levels of CO were also recorded at the time of TSP recordings. In order to quantitate the
magnitude of cigarette smoke exposure, cotinine, the primary metabolite of nicotine, was
measured in representative females immediately after cessation of the exposure period on days
14-18. Tail vein blood was collected from dams within 30 minutes of the end of exposure into
heparinized capillary tubes and was subsequently centrifuged at 10,000 x g for 10 minutes. The
collected plasma fractions were stored at -20 °C until ready for cotinine measurement. Using the
Cotinine One-Step ELISA Detection Kit (International Diagnostic Systems; St. Joseph, MI), the
collected plasma fractions were assayed for the concentration of cotinine following the
manufacturer’s instructions. The absorbance of the reaction substrate was measured at 450 nm
using a SpectraMax 190 Microplate Reader (Molecular Devices, San Jose, CA) and reported as
nanograms per milliliter. Levels of plasma cotinine greater than or equal to 50 ng/mL were
considered sufficient to simulate active maternal smoking during pregnancy.

Offspring Health and Serum Glucose Measurement
Animals were housed and maintained at the University of Louisville Research Resources
Center, an Association for Assessment and Accreditation of Laboratory Animal Care accredited
facility. All protocols were approved by the UofL Institutional Animal Care and Use Committee.
Cages for animal housing were changed weekly, unlimited food and water provided, and
maintained in an environment with a 12-hour light/dark cycle with controlled temperature and
humidity. Offspring were weighed daily and checked for health indicators such as levels of
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activity and eye-opening. Blood was collected from offspring after euthanization via cardiac
puncture using heparinized syringes. Blood samples were subsequently centrifuged at 10,000 x
g for 10 minutes, and the separated plasma fraction was collected and stored at -80 °C.
Using the Glucose (HK) Assay Kit (Catalog # GAHK20; Sigma-Aldrich; St. Louis MO), the
collected plasma fractions were diluted 50-fold and were assayed for the concentration of glucose
following the manufacturer’s instructions. The absorbance of the reaction substrate was
measured at 340 nm using a SpectraMax 190 Microplate Reader (Molecular Devices, San Jose,
CA) and reported as mg glucose/mL.

Western Blotting
Liver was homogenized in ice-cold buffer [100 mM PO4 Buffer, 150 NaCl, 0.1% Tween,
0.1% SDS, 0.5M Tris pH 8.0, 2 tabs per 10 mL phosphatase and protease inhibitor cocktails, 10
µL per 10 mL EDTA, 7.5 mg/mL dithiothreitol (DTT)] using a Tissue-Tearor homogenizer in 2second on/off pulses over the span of 1 minute. The concentration of protein was measured by
the Bradford method [301]. Liver homogenates were mixed with Laemmli buffer (0.25M Tris pH
6.8, glycerol, 10% SDS, trace bromophenol blue), reduced with DTT (1g/5mL) then heated at 70°
C for 10 minutes. Thirty-five µg total protein was applied to 10% acrylamide gels with separation
performed at 100V for 2 hours in Tris-glycine buffer (25 mM Tris, 192 mM glycine, pH 8.3)
followed by transfer to PVDF membrane at 70V for 2 hours in a non-reducing buffer [Tris-Glycine
buffer (25 mM Tris, 192 mM glycine, pH 8.3) with 20% ethanol]. Following blocking in 5% non-fat
dry milk in TBS-T solution (Tris-Buffered Saline-Tween, 137 mM NaCl, 20 mM Tris-Base pH 7.6,
0.1% Tween-20), the blots were incubated overnight at 4°C with primary antibody (SIRT1 1/500,
Santa Cruz #sc-15404; PEPCK 1/500, Santa Cruz #sc-271029; HK 1/500, Cell Signaling #2024;
NAMPT 1/1000, Thermo-Fisher #PA5-23198; ac-lysine 1/250, Millipore #AB3879; ac-FKHR
1/250, Santa Cruz #sc-49437; FKHR 1/500, Santa Cruz #sc-11350) diluted in non-fat dry milk in
TBS-T. After three washes of 10 minutes each in TBS-T, blots were incubated with secondary
antibody complexed to horseradish peroxidase (anti-mouse, Thermo #32430; anti-rabbit, Cell
Signaling #7074S) in non-fat dry milk diluted in TBS-T at room temperature for 3 hours. After
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three successive washes in TBS-T, blots were developed with LumiGLO chemiluminescent
reagent and peroxide (Cell Signaling Technology #7003S, Danvers, MA), and visualized with a
Bio-Rad Gel Doc XR+ system (Bio-Rad Laboratories, Hercules, CA). Following visualization,
blots were washed briefly in TBS-T and incubated with Coomassie stain (0.1% Coomassie
Brilliant Blue G250 Dye in 1:1 methanol:water) for 10 minutes, followed by two 10 minute washes
in destaining solution (5:4:1 ethanol:water:acetic acid), and a final wash for 5 minutes in
deionized water. Blots were briefly air-dried and scanned for quantitation of total protein.

Real-Time Quantitative PCR (RT-qPCR)
At euthanization, a section of the liver was equilibrated overnight in RNAlater at 4°C, after
which it was placed into long term storage at -80°C. A portion of RNAlater-stabilized liver was
used for RNA extraction using the Qiagen RNeasy Mini Kit (Qiagen, Germantown, MD) per
manufacturer’s instructions. The final elution was carried out using two aliquots of nuclease-free
water and was stored at -80°C. RNA concentration was determined using a NanoDrop 8000
Spectrophotometer (Thermo Scientific, Waltham, MA). Using two µg of each isolated RNA
sample as input, cDNA was synthesized using the High-Capacity cDNA Reverse Transcription Kit
following the manufacturer instructions (Applied Biosystems cat# 4368813). cDNA reactions
were carried out as 20 µL reactions in PCR tubes placed in a Bio-Rad MyCycler (Bio-Rad
Laboratories, Hercules, CA). The cDNA reactions were set for an initial 10 minutes at 25°C,
followed by 2 hours at 37°C and 5 minutes at 85°C. The cDNA reaction tubes were held at 4°C
until placed into storage at -20°C.
Mouse 18S rRNA gene was used as the reference gene for RT-qPCR. The genes of
interest have the forward and reverse primer sequences listed in Table 1. PCR reactions were
carried out as 10 µL reactions in 96 well plates and ran using a Bio-Rad iQ5 Multicolor Real-Time
PCR Detection System (Bio-Rad Laboratories, Hercules, CA) in 96 well plates. The PCR
reactions were set for an initial 3 min at 95°C, followed by 40 cycles of 15 sec at 95°C and 1 min
at 60°C using SsoAdvanced Universal SYBR Green Supermix (Bio-Rad Laboratories, Hercules,
CA). Each PCR plate was filled out with three technical replicates per sample and three
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#
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33

Name
Forward Primer
SIRT1
GCAGGTTGCGGGAATCCAA
NAMPT
CATAGGGGCATCTGCTCATT
PGC-1A
ATGTGTCGCCTTCTTGCTCT
CRTC2
GCCACATTGACAGTTCTCCA
SREBP-1C
ATGGATTGCACATTTGAAGACATGCTC
PPARa
AGAAGTTGCAGGAGGGGATT
FGF21
CAAATCCTGGGTGTCAAAGC
FGFR4 GACCAAACCAGCACCGTGGCTGTGAAGATG
B-Klotho
CGAGCCCATTGTTACCTTGT
CYP7A1
CAGGGAGATGCTCTGTGTTCA
CYP8B1
TTCGACTTCAAGCTGGTCGA
SHP
AAGGGCACGATCCTCTTCAA
BSEP
CTGCCAAGGATGCTAATGCA
OSTB
GATGCGGCTCCTTGGAATTA
GAPDH
AAATGGTGAAGGTCGGTGTGAAC
PEPCK
TATGCTGATCCTGGGCATAA
G6Pase
TCTGTCCCGGATCTACCTTG
HK
TATGAAGACCGCCAATGTGA
PKM2
TCGCATGCAGCACCTGATT
EHHADH
CCGGTCAATGCCATCAGT
FAS
GCTGCGGAAACTTCAGGAAAT
MCAD
GGTTTGGCTTTTGGACAATG
FXR
TCCACAACCAAGTTTTGCAG
LXR-a
TGAGAGCATCACCTTCCTCA
LRH1
AACGATGTCCCTACTGTCGATT
HNF4A
CAGCAATGGACAGATGTGTGA
IL-6
CTGCAAGAGACTTCCATCCAG
MCP-1
CAGGTCCCTGTCATGCTTCT
TNF-a
AAGCCTGTAGCCCACGTCGTA
COL1A1
TAGGCCATTGTGTATGCAGC
PDK-4
GCCTTGGGAGAAATGTGTGT
P53
GTCACAGCACATGACGGAGG
18S
CTCAACACGGGAAACCTCAC

Table 1: Forward and reverse primer pairs for RT-qPCR
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Reverse Primer
GGCAAGATGCTGTTGCAAA
GCTGCTGGAACAGAATAGCC
ATCTACTGCCTGGGGACCTT
AAGTGTCTTGGGGGTTAGGG
CCTGGGCTGCTGGGGCCTG
TCGGACTCGGTCTTCTTGAT
ATTGTAACCGTCCTCCAGCA
GTTTCCCTTGGCGGCACATTCCACAATCAC
CTCCAAAGGTCTGGAAGCAG
AGGCATACATGCAAAACCTCC
CAAAGCCCCAGCGCCT
CTGTTGCAGGTGTGCGATGT
CGATGGCTACCCTTTGCTTC
GGAGGAACATGCTTGTCATGAC
CAACAATCTCCACTTTGCCACTG
CACGTTGGTGAAGATGGTGT
GTAGAATCCAAGCGCGAAAC
TTTCCGCCAATGATCTTTTC
CCTCGAATAGCTGCAAGTGGTA
CTAACCGTATGGTCCAAACTAGC
AGAGACGTGTCACTCCTGGACTT
TGACGTGTCCAATCTACCACA
TCTCTGTTTGTTGTACGAATCCA
TGGAGAACTCAAAGATGGGG
CATGCGGTCGGCTCTTAC
TGGTGATGGCTGTGGAGTC
AGTGGTATAGACAGGTCTGTTGG
GAGGATCACCAGCAGCAGGT
AGGTACAACCCATCGGCTGG
ACATGTTCAGCTTTGTGGACC
CACTGGCTTTTTGAGTGCAA
TCTTCCAGATGCTCGGGATAC
CGCTCCACCAACTAAGAACG

template-free controls per primer pair. Data were analyzed using the ΔΔCT method followed by
log2 transformation of fold-change values.

Imputation of Missing Weight Data
Offspring weights were recorded from PD1 (the day after birth) until weaning (PD19).
Occasionally, throughout the neonatal monitoring period, recording of daily weighs was missed.
In order to utilized linear mixed-effects modeling, imputation was performed. Imputation was
accomplished using the mice R package [338] by the predictive mean matching method utilizing a
value of m, the number of datasets to impute, of 50 with 100 max iterations. At the end of the
imputation procedure, all 50 potential imputed values generated for each missing value were
averaged together and merged back with the original dataset to render it complete. This
completed dataset was then used for offspring weight analyses.

Linear Mixed-Effects Modeling
Linear mixed-effects modeling using the lme4 R package [302] was conducted to assess
the effect of prenatal CSE on hepatic protein and mRNA expression levels. The general mixedeffects equation utilized to model the data is given by:

Eq. 1: Variable of Interest ~ 1 + Exposure + (1|Cohort)

Where Exposure indicates modeling of fixed effects for prenatal exposure. The (1/Cohort) term
indicates the identity of the cohort set as a random intercept. The random intercept was set this
way to account for the fact that each individual offspring is more likely to be similar to other
littermates than offspring from different litters. The goal of this was to help control potential
confounding of results due to potential natural variance between litters. In instances where all
individuals within each comparison to be done were all from the same cohort, the following
equation was used instead:
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Eq. 2: Variable of Interest ~ 1 + Exposure

The above equation 2 is similar to 1 but without the (1|Cohort) random intercept term. For some
analyses, fitting random-effects models were not possible due to the occurrence of singular fits.
For the models using Eq. 1 listed above that resulted in a singular fit, Eq. 2 was instead used.
Post-hoc testing was conducted using t-tests for specific a priori contrasts of interest using the
finalized models with the emmeans R package [303]. The contrast of interest for all RT-qPCR
experiments was CSE versus Sham. For analysis of RT-qPCR data, log2 transformed foldchange values were used while Western blot analysis used protein expression values normalized
by total protein.

Results
Cigarette Smoke Exposure Parameters and Low-Birth Weight Phenotype
The average carbon monoxide level in the cigarette smoke exposure chamber was 147
ppm +/- 43 ppm, while total suspended particulates averaged 26.8 mg/m3 +/- 7.5 mg/m3. Plasma
cotinine levels in sperm positive females averaged 68.17 ng/ml +/- 12.1 ng/mL, though not all
potential pregnancies resulted in the delivery of live litters. Plasma cotinine exceeded 50 ng/ml, a
level sufficient to designate a human as an active smoker [305]. The values of each of these
measures of CSE were below the limit of detection in the Sham chamber. The plasma cotinine
levels in the Sham sperm positive dams were below the limit of detection of 4 ng/mL.
In Figure 11A, there was no difference in the weight trajectory between prenatal CSE and
Sham offspring. During the first four days after birth, the low-birth-weight phenotype remained
evident in the prenatal CSE offspring, after which there was no longer a significant difference
between weights in the prenatal CSE and Sham offspring groups. These results demonstrate a
phenotype of low-birth-weight with subsequent catch-up growth in offspring exposed in utero to
cigarette smoke. In Figure 11B, the serum glucose levels of female CSE offspring were
significantly lower compared to female Sham offspring (p < 0.05). Serum glucose levels in male
offspring were not impacted by prenatal CSE. It should be noted that this decrement in serum
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Figure 11A – Offspring exposed in utero to cigarette smoke exhibit a phenotype of low
birth weight followed by subsequent catch-up growth – Offspring were subjected to prenatal
CSE from GD1-GD19 daily. After birth, the average weight of offspring in each litter was tracked
for the first 19 days. The inset chart represents the same data in the main chart but zoomed in on
the first six days. CSE offspring had lower birth weight than Sham offspring, which persisted
through day 4 (p < 0.05), after which there was no longer a statistical difference between
exposure. Significant results had a p-value < 0.05, which is denoted with an * in the figure.

80

Figure 11B – Female offspring exposed in utero to cigarette smoke exhibit decreased
serum glucose levels – Serum glucose was measured using collected serum from offspring at
euthanization via a colorimetric assay. One-way ANOVA (p = 0.03) followed by posthoc testing,
found that female CSE offspring exhibited decreased serum glucose compared to female Sham
offspring (p < 0.05). No other differences were detected. Significant results had a p-value < 0.05,
which is denoted with an * in the figure.
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glucose levels occurred in a fed state. The key phenotypic changes present in models of in utero
cigarette smoke exposure conform to the Barker Hypothesis.

Prenatal CSE Modulates the Acetylation Status of Proteins and Enhances Hepatic SIRT1
and NAMPT Expression in Male Offspring
In Figure 12, male offspring exposed in utero to cigarette smoke exhibited increased
hepatic expression of SIRT1 and NAMPT (p < 0.05). A generalized decrease in protein
acetylation was evident in both male and female offspring exposed in utero to cigarette smoke (p
< 0.05). Neither male nor female CSE offspring exhibited any change in the level of acetylated
FKHR, a known SIRT1 target protein. The increase in SIRT1 and NAMPT expression in male
CSE offspring support the decrease in acetylated lysine protein residues found. However, female
CSE offspring did not exhibit changes in the expression of SIRT1 or NAMPT. Neither male nor
female CSE offspring exhibited changes in the expression of PEPCK or HK. These data suggest
that the decrease in protein acetylated lysine residues observed in female prenatal CSE offspring
is mediated in a manner independent of SIRT1 or NAMPT expression.

Effects of Prenatal CSE on Offspring Hepatic SIRT1 Regulatory Loop and Metabolic Gene
Expression Modulated are by Sex
Examining the effects of prenatal CSE on the hepatic expression of SIRT1 and related
metabolic genes revealed marked differences between male and female offspring. In Figure 13A,
male offspring exposed to in utero cigarette smoke have increased expression of both Sirt1,
Nampt, Pepck, Crtc2, and Pkm2 (p < 0.05), with a trend toward increased Ehhadh and Cyp7a1
expression (p < 0.1). In Figure 13B, female offspring exposed to prenatal CSE exhibited lower
expression (p < 0.05) of a gluconeogenic gene (Pepck), fat metabolic genes (Pparα, Ehhadh,
Mcad, Srebp-1c, Fas), genes involved with FXR signaling (Bsep, Fgfr4, β-Klotho, Hnf4a, Lxr-α,
Lrh1, Cyp7a1), and genes in the SIRT1 regulatory loop (Nampt, Fxr, p53). Female offspring
subjected to in utero cigarette smoke also saw a trend toward decreased Sirt1, Hk, and Ost-β
expression (Figure 13B, p < 0.01). As seen in Figure 11B, the serum glucose levels of female
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12A

Figure 12A – Exposure in utero to cigarette smoke alters hepatic expression of SIRT1 and
NAMPT in male offspring and decreases acetylation of lysine residues in all offspring –
Protein expression was measured using the livers of male offspring euthanized on either
postnatal day 9 or 10 in a fed state. A) Images of Western Blots – Western blots of hepatic
protein expression of both male and female offspring with the name of the protein probed in each
image and its corresponding molecular weight (MW = Molecular weight marker). Band intensities
in each lane were normalized to the total protein present in each lane after Coomassie staining.
The Coomassie-stained image presented is a representative image of all blots done.
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12B

Figure 12 – Exposure in utero to cigarette smoke alters hepatic expression of SIRT1 and
NAMPT in male offspring and decreases acetylation of lysine residues in all offspring –
Protein expression was measured using the livers of male offspring euthanized on either
postnatal day 9 or 10 in a fed state. B) Quantitation of Western Blots – Prenatal cigarette
smoke exposure decreased the hepatic expression of proteins containing acetylated lysine
residues. In male offspring exposed to cigarette smoke in utero, the hepatic expression of both
SIRT1 and NAMPT was increased, mirroring the increased expression of Sirt1 and Nampt
observed. Significant results had a p-value < 0.05, which is denoted with an * in the figure.
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Figure 13A – Prenatal cigarette smoke exposure in male offspring increased hepatic gene
expression of Sirt1, Nampt, and key regulatory gluconeogenic enzymes – mRNA expression
of genes was measured using the livers of male offspring euthanized on either postnatal day 9 or
10 in a fed state. The expression of Sirt1, Nampt, Pepck, Crtc2, and PKM2 were significantly
increased in male offspring in response to in utero cigarette smoke exposure, while Ehhadh and
Cyp7a1 exhibited a trend toward increased expression. Results are presented as the difference
between the group means of log2 transformed data. Significant results had a p-value < 0.05
while trends had a p-value < 0.1.
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Figure 13B – Prenatal cigarette smoke exposure in female offspring decreased hepatic
expression of SIRT1-regulatory loop genes, as well as related groups of metabolic genes –
mRNA expression of genes, was measured using the livers of female offspring euthanized on
either postnatal day 9 or 10 in a fed state. The expression of numerous genes in the SIRT1regulatory loop (not including Sirt1 itself), fat metabolism, FXR signaling, and glucose metabolism
was significantly downregulated. Results are presented as the difference between the group
means of log2 transformed data. Significant results had a p-value < 0.05 while trends had a pvalue < 0.1.
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CSE offspring were lower compared to female Sham offspring, indicating a functional impact of
decreased Pepck expression on systemic glucose availability. Overall, it is apparent that female
offspring experienced a more extensive array of hepatic gene expression changes after being
exposed to cigarette smoke in utero. For genes that were impacted by prenatal CSE in both male
and female offspring, the directionality of these changes was in opposition.

Discussion
In the present current study, offspring subjected to in utero cigarette smoke exhibited a
low-birth-weight phenotype. After PD4, there was no longer a significant difference between
prenatal CSE and Sham exposures indicating an early catch-up growth. In Chapter II, offspring
exposed in utero cigarette smoke also exhibited low birth weight with catch-up growth. The lowbirth-weight phenotype that was observed in our gestation-only active cigarette smoke exposure
model is similar to that observed in other models of murine CSE [35-41]. A low-birth-weight
phenotype with subsequent catch-up growth was observed in the current study as well as the
cohort from Chapter II, which demonstrates that our gestation-only exposure to cigarette smoke
consistently induces a phenotype indicating the applicability of the Barker Hypothesis. Unlike
models with both pre- and postnatal exposure to cigarette smoke where offspring that exhibited a
low-birth-weight and did not exhibit catch-up growth by six months of age [35-40], the offspring in
our gestation-only CSE model did exhibit catch-up growth in both male and female offspring.
Passive, or environmental, cigarette smoke exposure throughout gestation in a murine model has
also been shown to produce a low birth weight phenotype [41]. The overall duration and dose of
cigarette smoke play a role in whether or not catch-up growth occurs in affected offspring.
As described herein, prenatal cigarette smoke exposure affects the hepatic expression of
SIRT1 and related metabolic genes in a sex-dependent manner. Male offspring exposed to
cigarette smoke in utero exhibited increased hepatic expression of SIRT1 and NAMPT. This
observed increase mirrors the increase in hepatic Sirt1 and Nampt in the current study in male
offspring subjected to prenatal cigarette smoke. Levels of hepatic proteins with acetylated lysineresidues were also decreased in male offspring in response to prenatal cigarette smoke exposure.
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All this data indicates a generalized decrease in the acetylation of proteins in male offspring during
the early neonatal period. There is the probability that the decreased acetylated protein expression
observed with in utero cigarette smoke-exposed male offspring in the current study is in part due
to other deacetylase enzymes or a decrease in acetylation activity in enzymes such as P300.
Male offspring subjected to prenatal cigarette smoke exposure exhibited increased hepatic
expression of both Sirt1 and Nampt. Knowing that Sirt1 is typically upregulated during a fasting
response [255], and Nampt promotes SIRT1-induced deacetylation via increased levels of NAD +
[255] and that the offspring from the current study were in a fed state when euthanized, this is
indicative of an inappropriately timed fasting response in male offspring when exposed in utero to
cigarette smoke. An inappropriately timed fasting response in male offspring in response to
prenatal cigarette smoke exposure is further supported by the upregulation of both the
gluconeogenic enzyme Pepck and gluconeogenesis-promoting transcription factor Crtc2. Male
offspring also exhibited increased Pkm2 when subjected to prenatal cigarette smoke. Pyruvate
kinase, which Pkm2 encodes, is an essential final regulatory step for glycolysis and acts as the
final step of glycolysis. Normally Pkm2 would be inhibited when gluconeogenic processes are
occurring, but the presence of upregulation in both gluconeogenic-related genes and Pkm2 further
support the notion of inappropriately timed gluconeogenesis in male offspring when subjected to in
utero cigarette smoke. A previous publication from our lab examining hepatic proteomic changes
in response to in utero cigarette smoke exposure, lower protein expression of gluconeogenic
enzymes Fructose 1,6-Bisphosphatase and Pyruvate Carboxylase was evident in CSE offspring at
weaning, but there was only a trend toward decreased activity of those enzymes [35]. However,
that study did not examine proteomic changes on a sex-specific basis [35], so those results are not
directly comparable to the findings in the current study. Male offspring exposed in utero to cigarette
smoke exhibited signs of inappropriately timed-induction of gluconeogenic gene expression.
Whether this hepatic molecular phenotype persists into later life stages will be critical in determining
how manifestations of the Barker Hypothesis develop in adulthood.
Female CSE offspring in the current study exhibited no changes in hepatic protein
expression or acetylated FKHR. However, female CSE offspring did exhibit decreased expression
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of proteins with acetylated-lysine residues. In light of the gene expression changes observed in
female prenatal CSE offspring, it appears that there are additional mechanisms at play that are
influencing gene expression other than SIRT1 activity by modulation of SIRT1 protein or mRNA
levels. SIRT1 is known to have its activity modulated by post-translational modification [339], such
as by increasing nuclear localization or increasing its enzymatic activity. SIRT1 also is modulated
by factors such as AROS, which, when bound, improves the deacetylase activity of SIRT1 [271].
SIRT1 is negatively regulated by the microRNA miR-34a [262] as well as the long non-coding RNAs
MALAT1 [340] and FLRL2 [341]. Regardless of the mechanism, it is evident that female offspring
exposed in utero to cigarette smoke possibly have perturbed acetylation or deacetylation processes
that impacted the acetylation status of proteins.
Female offspring exposed in utero to cigarette smoke exhibited decreased expression of
several Sirt1-related genes, including Nampt, Fxr, and P53, with a trend decrease in Sirt1.
Downregulation of FXR-signaling, glucose metabolism, and fat metabolism was also observed in
female offspring subjected to prenatal cigarette smoke. We also found that female CSE offspring
exhibited decreased serum glucose levels in a fed state. One possibility for these results is that
the inherent female resistance predicted by the Barker Hypothesis becomes true later in their
lifetime but not before sexual maturity when estrogen signaling in female offspring begins in
earnest.

Considering how in utero exposure to cigarette smoke induces intrauterine growth

restriction [28, 29], it is possible that the number of downregulated hepatic gene expression in
conjunction with decreased serum glucose levels in a fed state is a reflection of delayed functional
liver ontogeny. These results may be reflective of either an underdeveloped liver or a failure in
adequately detecting serum glucose or insulin levels, considering the importance of the liver in
maintaining serum glucose levels.
Male offspring had a higher number of protein expression changes relative to females in
response to in utero cigarette smoke exposure. However, female offspring have a higher number
of affected hepatic genes (17 genes in female offspring versus 7 genes in male offspring). These
results were surprising considering the Barker Hypothesis suggests that male offspring should be
more affected by in utero environmental perturbations compared to female offspring [150]. The
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data presented in the present current study suggests that the sex-specific manifestations of the
Barker Hypothesis may be conditional on the life stage being examined. Our findings of in utero
CSE-induced sex-dependent hepatic protein and gene expression changes in offspring shortly after
birth is novel. These findings represent a step forward in characterizing the impact of maternal
smoking during pregnancy on offspring liver molecular phenotype.
At the time of writing, no other published study has examined the sex-specific impact of
prenatal cigarette smoke exposure on the expression of genes in the liver shortly after birth.
Several studies have looked at gene expression changes occurring in fetal liver tissues [342-344],
but not shortly after birth. In one of those studies, prenatal CSE in human fetal liver (11-21 weeks
gestation) altered the mRNA expression of enzymes from the 1-carbon cycle such that naturally
occurring differences were abolished as well as reducing mRNA transcript levels of IGF2 in male
offspring to levels closer to female offspring via increased methylation of related sites [342]. A
proteomics study using human fetal liver tissue after 12-16 weeks of gestation showed in response
to prenatal CSE affected pathways in glucose metabolism disorder in females and pathways in
apoptosis, inflammation, cell proliferation and homeostasis in males [343]. In a study using human
fetal liver tissue from the second trimester, prenatal CSE induced increased mRNA expression of
phase I metabolic enzymes such as Cyp1a1 and Ephx1 in males in addition to Cyp3a7 and Ephx1
in females [344]. One study using a C67BL/6 model of prenatal cigarette smoke exposure found
that there are histological changes that were present 24 hours after birth, such as increased
numbers of immune cells and decreased glycogen deposition, but they did not measure gene
expression [345]. Together, these studies show that exposure in utero to cigarette smoke has a
sex-specific impact on the hepatic molecular phenotype before even the neonatal period examined
in the present current study. Future studies with our model should include characterization of the
changes to the hepatic molecular phenotype of fetal tissue in order to investigate any association
with later life stages. Our current model represents progress in elucidating how hepatic gene
expression of metabolically relevant proteins are impacted by in utero exposure to cigarette smoke.
Some limitations were present in the present current study. For example, not tracking
individual offspring weight from birth until the end of the study limited the ability to associate the
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magnitude of prenatal CSE-induced low birth weight with specific hepatic molecular phenotypes.
In future studies, we plan on taking measures to allow weight tracking across the entire lifetime of
offspring to strengthen the outcomes observed. Another limitation was the present current study
looking at a single time point. The phenotype that manifests as predicted by the Barker process is
one that is long-term in nature and does not manifest fully until adulthood.
Additionally, the changes that were observed in the present current study in the neonatal
period begs the question of whether these changes persist into the future or if the hepatic molecular
phenotype is altered further. This limitation will be addressed in part in Chapter IV, where siblings
of the offspring in the present current that have been weaned were examined. There are also
ongoing studies that are being conducted in adult siblings of the offspring in the present current
study before and after being subjected to a diet challenge, which will further address the continuity
of the observed hepatic molecular phenotype during the neonatal period. Despite these limitations,
we believe the data presented here provide new insight into the hepatic molecular phenotype
induced by in utero exposure to cigarette smoke in a sex-dependent manner.
We confirmed in our novel study that prenatal cigarette smoke exposure resulted in
sexually dimorphic hepatic gene and protein expression alterations with no difference in gross
physical appearance in the liver, but histopathological examination has not been done. The lowbirth-weight with subsequent catch-up growth predicted by the Barker Hypothesis was present.
Sexually distinct responses to in utero cigarette smoke exposure exist during the early neonatal
period. It has been demonstrated that male rodents experience a short-lived surge of androgens
on postnatal day 1 [346-348] as well as increased testosterone levels on day 18 of gestation [349].
It should be investigated if prenatal cigarette smoke exposure contributes to the sexually dimorphic
changes observed in exposed offspring in the present current study by disrupting these elevations
in testosterone in male offspring and contribute to sexually dimorphic changes observed in exposed
offspring in our current study. Future studies should examine whether the effects on hepatic gene
and protein expressions seen here also are present at subsequent time points in the lifecycle of in
utero cigarette smoke-exposed offspring such as at weaning or during adulthood. The effect of
current energy status in offspring exposed in utero cigarette smoke should be examined as well to
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confirm if prenatal cigarette smoke results in an inappropriately timed fasting response occur
independently of whether offspring are in a fed or fasted state. Our study presents novel insights
into the hepatic molecular phenotype induced by in utero exposure to cigarette smoke in a sexdependent manner.

92

CHAPTER IV: IN UTERO EXPOSURE TO CIGARETTE SMOKE EXACERBATES THE
HEPATIC FASTING RESPONSE IN OFFSPRING AND CAUSES POORLY TIMED FASTING
RESPONSE IN FEMALE OFFSPRING
Introduction
In 2016, 7.2% of U.S. women reported smoking at any point during pregnancy [47]. This
rate of exposure translates to at least 284,000 per year exposed to in utero to cigarette smoke [47].
Although the overall rate of smoking during pregnancy has steadily decreased from the previous
rate of 8.4% overall in 2014 [48] 9.7% overall in 2008 [49], it is evident that this trend does not fit
for all states. Using Kentucky as an example, the rate of smoking during pregnancy was 28.5% in
1990 [50], 24.5% in 1999 [50], 25.1% in 2008 [49], 20.7% in 2014 [48], and 18.4% in 2016 [47],
showing an overall decrease over time. With an initial examination, it seems that the rate of
smoking during pregnancy in West Virginia decreased over time as well, with the rate being 27.8%
in 1990 [50], 26.1% in 1999 [50], 27.1% in 2014 [48], and 25.1% in 2016 [47]. However, examining
the rate of smoking during the last 3 months of pregnancy from the PRAMS dataset, the rate varies
greatly from 2000-2010 with the rate ranging from 24.5%-31.9%, with a significant overall increase
in the rate from the 2000 rate of 24.5% to the 2010 rate of 30.5% [328]. It is evident that some
states like Kentucky have a significant rate of smoking during pregnancy despite a decrease in the
rate over time, while others like West Virginia have a wildly varying rate that does not appear to be
significantly decreasing over time. In light of this, it is evident that exposure to cigarette smoke in
utero in some states will continue to be a highly significant public health problem for years to come
unless drastic measures are taken to curb smoking while pregnant.
In Chapter II, we addressed how the primary outcome of cigarette smoke exposure is low
birth weight followed by subsequent catch-up growth, and that this phenotype is a classical
outcome with the Barker Hypothesis. In Chapter III, we examined the impact of in utero cigarette
smoke exposure on sex-specific low birth weight phenotypes and how this is associated with
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changes in neonatal hepatic SIRT1-related gene and protein expression. However, this leaves
unanswered how the impact of in utero cigarette smoke exposure manifests during adolescence.
The literature provides several examples of how the impact of exposure in utero to cigarette smoke
can be observed during adolescence. For example, a study examining a cohort of 10-year-old
children found that prenatal and postnatal CSE was associated with a lower z-score for height-forage that persisted into adolescence [350]. Another study using a cohort of children in Brazil found
that prenatal CSE was associated with decreased height-for-age z-score at birth, one-year-old, 4years-old, 11-years-old, and 15-years old [351]. Another cohort study of children in Brazil found
that in utero exposure to cigarette smoke was associated with a more significant change in body
mass index between 10 and 17 years old [352]. A study utilizing the Isle of Wight cohort found that
the risk of early obesity in children between 1 and 4 years of age that persists to 18 years of age
was 2.16 times higher if their mother smoked during pregnancy [353]. Those same children also
were at increased risk of other adverse health outcomes at 18 years of age including 2.15 times
higher risk for asthma, a 3.2% decrease in lung function as defined by the FEV1/FVC ratio, and an
average elevated systolic and diastolic blood pressure of 11.3 and 12.0 mm Hg, respectively [353].
It is evident from the literature that prenatal cigarette smoke exposure manifests in perturbed
metabolic health not just in adulthood but also during adolescence. However, there have yet to be
definitive studies on the molecular phenotype during adolescence as a result of in utero cigarette
smoke exposure.
In a study previously conducted by our lab with a mixed-sex murine model using pre- and
postnatal exposure to cigarette smoke, our lab observed that exposed offspring at PD21 experience
decrements in glucose, lipid, and amino acid metabolic proteins according to hepatic proteomic
analysis [35].

It was also found that 6-month-old prenatal CSE offspring had a perturbed

expression of metabolic enzymes utilizing the same study design [331]. Specifically, in a fed state,
6-month-old prenatal CSE offspring had decreased levels of hepatic SIRT1 protein as well as
increased levels of PEPCK and PGC1α protein [331]. Prenatal CSE offspring also exhibited
oxidative stress in the form of depleted glutathione levels and experienced decreased serum
glucose levels [331]. In Chapter II, we observed that 9-month old male offspring subjected to in
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utero cigarette smoke exposure exhibited decreased hepatic SIRT1 protein expression while
female offspring were unaffected. In Chapter III, we demonstrated that 1.5-week old male offspring
exposed in utero to cigarette smoke exhibited increased expression of hepatic SIRT1 protein and
mRNA while female CSE offspring exhibited no change in SIRT1 protein and a trend toward
decreased Sirt1 mRNA expression with decrements in many SIRT1-related genes. We also
observed in Chapter III that female CSE offspring exhibited a decrement in serum glucose levels
despite being in a fed state. Despite all this data previously generated by our lab, the hepatic
molecular phenotype manifested due to prenatal cigarette smoke exposure still has not been
examined on a sex-specific basis or how it is modulated by a fed versus a fasted state.
There are several pressing questions to be answered still. Are the perinatal sex-specific
changes observed in Chapter III still present after weaning? Do the changes observed depend on
the current fasting status of the offspring? Does the sex of the offspring modulate the impact of
prenatal CSE on metabolic function? Does prenatal cigarette smoke exposure result in a perturbed
fed or fasted state response? Do female CSE offspring still exhibit a decrement in serum glucose
levels? Answering these questions would allow for a more thorough understanding of the increased
risk of metabolic diseases in exposed offspring and facilitate the possible development of targeted
early-life interventions and is the aim of the present current chapter.
The objective of this study was to characterize the sex-specific impact of prenatal CSE on
hepatic SIRT1 expression and on target gene expression in weanling mice, at a time which low
birth weight is no longer evident and have not yet reached full sexual maturity (19 days of age), in
either a fed or fasted state. We utilized an established mouse inhalation model of cigarette smoke
exposure that mimics active maternal smoking during pregnancy throughout the entire fetal
development period (GD1-GD19). The mRNA gene expression levels for SIRT1 targets, which are
indicative of activation or suppression, are indirect indicators of SIRT1 activity. The offspring in the
present current study are siblings to the neonatal offspring examined in Chapter III.

Methods
Animal Exposure
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Female C57BL/6 mice maintained on breeder chow (LabDiet 5015) were mated overnight
and checked the following day for the presence of vaginal sperm. Sperm positive status was
considered gestational day (GD) 0 for the exposure timing. On GD1, female C57BL/6 mice were
placed into either a cigarette smoke exposure (CSE) chamber or a sham exposure (ambient
filtered room air) chamber for 6 hours/day daily from GD1 to GD19. Cigarette smoke exposure
was carried out using a Teague TE-10C exposure apparatus (Teague Industries) smoking
Marlboro Red cigarettes, which was the most commonly smoked cigarette at the time of model
development, using the FTC method of smoking (2-second puff per minute). After parturition,
dams with litters were maintained on breeder chow. Offspring were weaned by PD19. On PD19,
representative offspring of each litter were euthanized by carbon dioxide asphyxiation either
immediately or following a ~4 hour fast. At euthanization, the excised liver was frozen on dry ice
and stored at -80°C.

Cigarette Smoke Exposure Monitoring via Measurement of Carbon Monoxide, Total
Suspended Particulates, and Plasma Cotinine
At the start of each day of exposure, the level of CO within the cigarette smoke exposure
chamber was allowed to increase rapidly by fully closing the dilutor valve until the level reached
110 parts per million (ppm) as detected with a commercially available carbon monoxide detector
with a digital readout. Once this level was reached, CO levels were further adjusted by opening
and closing the dilutor valve as appropriate to maintain a target CO level ranging between 110 to
150 ppm. At the end of exposure each day, the dilutor valve was fully opened to allow rapid
dissipation of any remaining CO in the cigarette smoke exposure chamber. TSPs were recorded
twice daily by drawing air from each exposure chamber via a sampling port through a preweighed
piece of filter paper. The filter paper was then reweighed, and the pre- and post-sampling
difference was divided by the volume of air drawn through the sampling device in a five minute
interval In order to quantitate the magnitude of cigarette smoke exposure, cotinine, the primary
metabolite of nicotine, was measured in representative females immediately after cessation of the
exposure period on days 14-18. Tail vein blood was collected from dams within 30 minutes of the
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end of exposure into heparinized capillary tubes and was subsequently centrifuged at 10,000 x g
for 10 minutes. The collected plasma fractions were stored at -20 °C until ready for cotinine
measurement. Using the Cotinine One-Step ELISA Detection Kit (International Diagnostic
Systems; St. Joseph, MI), the collected plasma fractions were assayed for the concentration of
cotinine following the manufacturer’s instructions. The absorbance of the reaction substrate was
measured at 450 nm using a SpectraMax 190 Microplate Reader (Molecular Devices, San Jose,
CA) and reported as nanograms per milliliter. Levels of plasma cotinine greater than or equal to
50 ng/mL were considered sufficient to simulate active maternal smoking during pregnancy.

Offspring Health and Serum Glucose Measurement
Animals were housed and maintained at the University of Louisville Research Resources
Center, an Association for Assessment and Accreditation of Laboratory Animal Care accredited
facility. All protocols were approved by the UofL Institutional Animal Care and Use Committee.
Cages for animal housing were changed weekly, unlimited food and water provided, and
maintained in an environment with a 12-hour light/dark cycle with controlled temperature and
humidity. Offspring were weighed daily and checked for health indicators such as levels of
activity and eye-opening. Blood was collected from offspring after euthanization via cardiac
puncture using heparinized syringes. Blood samples were subsequently centrifuged at 10,000 x
g for 10 minutes, and the separated plasma fraction was collected and stored at -80 °C.
Using the Glucose (HK) Assay Kit (Catalog # GAHK20; Sigma-Aldrich; St. Louis MO), the
collected plasma fractions were diluted 50-fold and were assayed for the concentration of glucose
following the manufacturer’s instructions. The absorbance of the reaction substrate was
measured at 340 nm using a SpectraMax 190 Microplate Reader (Molecular Devices, San Jose,
CA) and reported as mg glucose/mL.

Western Blotting
Liver was homogenized in ice-cold buffer [100 mM PO4 Buffer, 150 NaCl, 0.1% Tween,
0.1% SDS, 0.5M Tris pH 8.0, 2 tabs per 10 mL phosphatase and protease inhibitor cocktails, 10
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µL per 10 mL EDTA, 7.5 mg/mL dithiothreitol (DTT)] using a Tissue-Tearor homogenizer in 2second on/off pulses over the span of 1 minute. The concentration of protein was measured by
the Bradford method [301]. Liver homogenates were mixed with Laemmli buffer (0.25M Tris pH
6.8, glycerol, 10% SDS, trace bromophenol blue), reduced with DTT (1g/5mL) then heated at 70°
C for 10 minutes. Thirty-five µg total protein was applied to 10% acrylamide gels with separation
performed at 100V for 2 hours in Tris-glycine buffer (25 mM Tris, 192 mM glycine, pH 8.3)
followed by transfer to PVDF membrane at 70V for 2 hours in a non-reducing buffer [Tris-Glycine
buffer (25 mM Tris, 192 mM glycine, pH 8.3) with 20% ethanol]. Following blocking in 5% non-fat
dry milk in TBS-T solution (Tris-Buffered Saline-Tween, 137 mM NaCl, 20 mM Tris-Base pH 7.6,
0.1% Tween-20), the blots were incubated overnight at 4°C with primary antibody (SIRT1 1/500,
Santa Cruz #sc-15404; PEPCK 1/500, Santa Cruz #sc-271029; HK 1/500, Cell Signaling #2024;
NAMPT 1/1000, Thermo-Fisher #PA5-23198; ac-lysine 1/250, Millipore #AB3879; ac-FKHR
1/250, Santa Cruz #sc-49437; FKHR 1/500, Santa Cruz #sc-11350) diluted in non-fat dry milk in
TBS-T. After three washes of 10 minutes each in TBS-T, blots were incubated with secondary
antibody complexed to horseradish peroxidase (anti-mouse, Thermo #32430; anti-rabbit, Cell
Signaling #7074S) in non-fat dry milk diluted in TBS-T at room temperature for 3 hours. After
three successive washes in TBS-T, blots were developed with LumiGLO chemiluminescent
reagent and peroxide (Cell Signaling Technology #7003S, Danvers, MA), and visualized with a
Bio-Rad Gel Doc XR+ system (Bio-Rad Laboratories, Hercules, CA). Following visualization,
blots were washed briefly in TBS-T and incubated with Coomassie stain (0.1% Coomassie
Brilliant Blue G250 Dye in 1:1 methanol:water) for 10 minutes, followed by two 10 minute washes
in destaining solution (5:4:1 ethanol:water:acetic acid), and a final wash for 5 minutes in
deionized water. Blots were briefly air-dried and scanned for quantitation of total protein.

Real-Time Quantitative PCR (RT-qPCR) for mRNA Expression
At euthanization, a section of the liver was equilibrated overnight in RNAlater at 4°C, after
which it was placed into long term storage at -80°C. A portion of RNAlater-stabilized liver was
used for RNA extraction using the Qiagen RNeasy Mini Kit (Qiagen, Germantown, MD) per
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manufacturer’s instructions. The final elution was carried out using two aliquots of nuclease-free
water and was stored at -80°C. RNA concentration was determined using a NanoDrop 8000
Spectrophotometer (Thermo Scientific, Waltham, MA). Using two µg of each isolated RNA
sample as input, cDNA was synthesized using the High-Capacity cDNA Reverse Transcription Kit
following the manufacturer instructions (Applied Biosystems cat# 4368813). cDNA reactions
were carried out as 20 µL reactions in PCR tubes placed in a Bio-Rad MyCycler (Bio-Rad
Laboratories, Hercules, CA). The cDNA reactions were set for an initial 10 minutes at 25°C,
followed by 2 hours at 37°C and 5 minutes at 85°C. The cDNA reaction tubes were held at 4°C
until placed into storage at -20°C.
Mouse 18S rRNA gene was used as the reference gene for RT-qPCR. The genes of
interest have the forward and reverse primer sequences listed in Table 2. PCR reactions were
carried out as 10 µL reactions in 96 well plates and ran using a Bio-Rad iQ5 Multicolor Real-Time
PCR Detection System (Bio-Rad Laboratories, Hercules, CA) in 96 well plates. The PCR
reactions were set for an initial 3 min at 95°C, followed by 40 cycles of 15 sec at 95°C and 1 min
at 60°C using SsoAdvanced Universal SYBR Green Supermix (Bio-Rad Laboratories, Hercules,
CA). Each PCR plate was filled out with three technical replicates per sample and three
template-free controls per primer pair. Data were analyzed using the ΔΔCT method followed by
log2 transformation of fold-change values.

Real-Time Quantitative PCR (RT-qPCR) for miRNA Expression
At euthanization, a section of the liver was equilibrated overnight in RNAlater at 4°C, after
which it was placed into long term storage at -80°C. A portion of RNAlater-stabilized liver was
used for miRNA extraction using the Qiagen miRNeasy Mini Kit (Qiagen, Germantown, MD) per
manufacturer’s instructions. The final elution was carried out using two aliquots of nuclease-free
water and was stored at -80°C. RNA concentration was determined using a NanoDrop 8000
Spectrophotometer (Thermo Scientific, Waltham, MA). Using two µg of each isolated total RNA
sample as input, cDNA was synthesized using the miScript II RT Kit following the manufacturer
instructions using miScript HiSpec Buffer included in the kit to selectively convert mature miRNA
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#
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35

Name
Forward Primer
SIRT1
GCAGGTTGCGGGAATCCAA
NAMPT
CATAGGGGCATCTGCTCATT
PGC-1A
ATGTGTCGCCTTCTTGCTCT
CRTC2
GCCACATTGACAGTTCTCCA
SREBP-1C
ATGGATTGCACATTTGAAGACATGCTC
PPARa
AGAAGTTGCAGGAGGGGATT
FGF21
CAAATCCTGGGTGTCAAAGC
FGFR4 GACCAAACCAGCACCGTGGCTGTGAAGATG
B-Klotho
CGAGCCCATTGTTACCTTGT
CYP7A1
CAGGGAGATGCTCTGTGTTCA
CYP8B1
TTCGACTTCAAGCTGGTCGA
SHP
AAGGGCACGATCCTCTTCAA
BSEP
CTGCCAAGGATGCTAATGCA
OSTB
GATGCGGCTCCTTGGAATTA
GAPDH
AAATGGTGAAGGTCGGTGTGAAC
PEPCK
TATGCTGATCCTGGGCATAA
G6Pase
TCTGTCCCGGATCTACCTTG
HK
TATGAAGACCGCCAATGTGA
PKM2
TCGCATGCAGCACCTGATT
EHHADH
CCGGTCAATGCCATCAGT
FAS
GCTGCGGAAACTTCAGGAAAT
MCAD
GGTTTGGCTTTTGGACAATG
FXR
TCCACAACCAAGTTTTGCAG
LXR-a
TGAGAGCATCACCTTCCTCA
LRH1
AACGATGTCCCTACTGTCGATT
HNF4A
CAGCAATGGACAGATGTGTGA
IL-6
CTGCAAGAGACTTCCATCCAG
MCP-1
CAGGTCCCTGTCATGCTTCT
TNF-a
AAGCCTGTAGCCCACGTCGTA
COL1A1
TAGGCCATTGTGTATGCAGC
PDK-4
GCCTTGGGAGAAATGTGTGT
P53
GTCACAGCACATGACGGAGG
18S
CTCAACACGGGAAACCTCAC
miR-34a
GCAGTGTCTTAGCTGGTTG
miR-152
AGTGCATGACAGAACTTGG

Table 2: Forward and reverse primer pairs for RT-qPCR
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Reverse Primer
GGCAAGATGCTGTTGCAAA
GCTGCTGGAACAGAATAGCC
ATCTACTGCCTGGGGACCTT
AAGTGTCTTGGGGGTTAGGG
CCTGGGCTGCTGGGGCCTG
TCGGACTCGGTCTTCTTGAT
ATTGTAACCGTCCTCCAGCA
GTTTCCCTTGGCGGCACATTCCACAATCAC
CTCCAAAGGTCTGGAAGCAG
AGGCATACATGCAAAACCTCC
CAAAGCCCCAGCGCCT
CTGTTGCAGGTGTGCGATGT
CGATGGCTACCCTTTGCTTC
GGAGGAACATGCTTGTCATGAC
CAACAATCTCCACTTTGCCACTG
CACGTTGGTGAAGATGGTGT
GTAGAATCCAAGCGCGAAAC
TTTCCGCCAATGATCTTTTC
CCTCGAATAGCTGCAAGTGGTA
CTAACCGTATGGTCCAAACTAGC
AGAGACGTGTCACTCCTGGACTT
TGACGTGTCCAATCTACCACA
TCTCTGTTTGTTGTACGAATCCA
TGGAGAACTCAAAGATGGGG
CATGCGGTCGGCTCTTAC
TGGTGATGGCTGTGGAGTC
AGTGGTATAGACAGGTCTGTTGG
GAGGATCACCAGCAGCAGGT
AGGTACAACCCATCGGCTGG
ACATGTTCAGCTTTGTGGACC
CACTGGCTTTTTGAGTGCAA
TCTTCCAGATGCTCGGGATAC
CGCTCCACCAACTAAGAACG
AATCGAGCACCAGTTACG
AATCGAGCACCAGTTACG

(Qiagen, Germantown, MD). cDNA reactions were carried out as 20 µL reactions in PCR tubes
placed in a Bio-Rad MyCycler (Bio-Rad Laboratories, Hercules, CA). The cDNA reactions were
set for 60 minutes at 37°C and 5 minutes at 95°C. The cDNA reaction tubes were held at 4°C
until placed into storage at -20°C.
Mouse miR-152 miRNA gene was used as the reference gene for RT-qPCR for miRNA
expression. The miRNA gene of interest have the forward and reverse primer sequences listed in
Table 2. PCR reactions were carried out as 10 µL reactions in 96 well plates and ran using a BioRad iQ5 Multicolor Real-Time PCR Detection System (Bio-Rad Laboratories, Hercules, CA) in 96
well plates. The PCR reactions were set for an initial 3 min at 95°C, followed by 40 cycles of 15
sec at 95°C and 1 min at 60°C using SsoAdvanced Universal SYBR Green Supermix (Bio-Rad
Laboratories, Hercules, CA). Each PCR plate was filled out with three technical replicates per
sample and three template-free controls per primer pair. Data were analyzed using the ΔΔCT
method followed by log2 transformation of fold-change values.

Imputation of Missing Weight Data
Offspring weights were recorded from PD1 (the day after birth) until weaning (PD19).
Occasionally, throughout the neonatal monitoring period, recording of daily weighs was missed.
In order to utilized linear mixed-effects modeling, imputation was performed. Imputation was
accomplished using the mice R package [338] by the predictive mean matching method utilizing a
value of m, the number of datasets to impute, of 50 with 100 max iterations. At the end of the
imputation procedure, all 50 potential imputed values generated for each missing value were
averaged together and merged back with the original dataset to render it complete. This
completed dataset was then used for offspring weight analyses.

Linear Mixed-Effects Modeling
Linear mixed-effects modeling using the lme4 R package [302] was conducted to assess
the effect of prenatal CSE on hepatic protein and mRNA expression levels. The general mixedeffects equation utilized to model the data is given by:

101

Eq. 1: Variable of Interest ~ 1 + Exposure + (1|Cohort)

Where Exposure indicates modeling of fixed effects for prenatal exposure. The (1/Cohort) term
indicates the identity of the cohort set as a random intercept. The random intercept was set this
way to account for the fact that each individual offspring is more likely to be similar to other
littermates than offspring from different litters. The goal of this was to help control potential
confounding of results due to potential natural variance between litters. In instances where all
individuals within each comparison to be done were all from the same cohort, the following
equation was used instead:

Eq. 2: Variable of Interest ~ 1 + Exposure

The above equation 2 is similar to 1 but without the (1|Cohort) random intercept term. For some
analyses, fitting random-effects models were not possible due to the occurrence of singular fits.
For the models using Eq. 1 listed above that resulted in a singular fit, Eq. 2 was instead used.
Post-hoc testing was conducted using t-tests for specific a priori contrasts of interest using the
finalized models with the emmeans R package [303]. The contrast of interest for all RT-qPCR
experiments was CSE versus Sham. For analysis of RT-qPCR data, log2 transformed foldchange values were used while Western blot analysis used protein expression values normalized
by total protein.

Results
Cigarette Smoke Exposure Parameters and Low-Birth Weight Phenotype
The carbon monoxide level in the cigarette smoke exposure chamber was 147 ppm +/43 ppm while total suspended particulates averaged 26.8 mg/m3 +/- 7.5 mg/m3. Plasma cotinine
levels in sperm positive females were 68.17 ng/ml +/- 12.1 ng/ml. Plasma cotinine exceeded 50
ng/ml, a level sufficient to designate a human as an active smoker [305]. The values of each of
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these measures of CSE were below the limit of detection in the Sham chamber. The plasma
cotinine levels in the Sham sperm positive dams were below the limit of detection of 4 ng/mL.
The data present in Figure 14 is from siblings of offspring from Chapter III. In Figure 14,
there was no difference in the weight trajectory between prenatal CSE and Sham offspring. As
mentioned in Chapter III, low birth weight was evident in the prenatal CSE offspring that persists
until day 5, after which there is no longer a significant difference between prenatal CSE and
Sham offspring groups. There continued to be no difference between prenatal CSE and Sham
offspring at PD19 when the offspring have been weaned. There was also no difference in serum
glucose levels between prenatal exposure groups at PD19 (data not shown). These results
demonstrate a phenotype of low birth weight with subsequent catch-up growth in offspring
exposed in utero to cigarette smoke with no detectable difference after weaning. These results
recapitulate fundamental phenotypic changes present in models of in utero cigarette smoke
exposure and what is predicted by the Barker Hypothesis.

Offspring subjected to in utero cigarette smoke exposure modulated hepatic expression of
SIRT1, NAMPT, and acetylated proteins in a sex- and fasting status-specific manner
We examined the effects of in utero cigarette smoke exposure on hepatic expression of
SIRT1 and related proteins in weanling offspring in both a fed and fasted state. As shown in
Figure 15, the hepatic expression of NAMPT was decreased in male CSE offspring in a fed state
(p < 0.05) while the expression of SIRT1, PEPCK, HK, acetylated-FKHR, and acetylated-lysine
residues were unchanged. As shown in Figure 16, male offspring in a fasted state and subjected
to in utero cigarette smoke exposure exhibited increased hepatic expression of SIRT1 and
decreased expression of NAMPT (p < 0.05). Male CSE offspring in a fasted state also exhibited
a trend toward decreased expression of FKHR and proteins with acetylated lysine residues (p <
0.10). Hepatic expression of PEPCK and HK were unchanged in male CSE offspring in a fasted
state.
In Figure 15, female CSE offspring in a fed exhibited increased hepatic expression of
SIRT1 and decreased expression of NAMPT (p < 0.05) with a trend toward increased HK
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Figure 14 – Offspring exposed in utero to cigarette smoke exhibit catch-up growth by
weaning – Offspring were subjected to prenatal CSE from GD1-GD19 daily for 6 hours. After
birth, the average weight of offspring in each litter was tracked each postnatal day (PD). CSE
offspring exhibited no difference from Sham offspring on PD19.
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15A

Figure 15 – Exposure in utero to cigarette smoke increased expression of SIRT1 in fed
female offspring and decreased hepatic expression of NAMPT in all fed offspring – Protein
expression was measured using the livers of male offspring euthanized on postnatal day 19 in a
fed state. A) Images of Western Blots – Western blots of hepatic protein expression of both
male and female offspring with the name of the protein probed in each image and its
corresponding molecular weight (MW = Molecular weight marker). Band intensities in each lane
were normalized to the total protein present in each lane after Coomassie staining. The
Coomassie-stained image presented is a representative image of all blots done.
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15B

Figure 15 – Exposure in utero to cigarette smoke increased expression of SIRT1 in fed
female offspring and decreased hepatic expression of NAMPT in all fed offspring– Protein
expression was measured using the livers of male offspring euthanized on postnatal day 19 in a
fed state. B) Quantitation of Blots – In all offspring in a fed state, in utero exposure to cigarette
smoke decreased the expression of NAMPT. In fed female CSE offspring, the expression of
SIRT1 was increased while the expression of HK exhibited a trend toward increased expression.
Significant results had a p-value < 0.05, which is denoted with an * in the figure. Results
exhibited a trend that had a p-value < 0.10, which is denoted with a + in the figure.
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16A

Figure 16 – Exposure in utero to cigarette smoke altered hepatic expression of SIRT1 and
NAMPT in fasted male offspring – Protein expression was measured using the livers of male
offspring euthanized on postnatal day 19 in a fasted state. A) Images of Western Blots –
Western blots of hepatic protein expression of both male and female offspring with the name of
the protein probed in each image and its corresponding molecular weight (MW = Molecular
weight marker). Band intensities in each lane were normalized to the total protein present in each
lane after Coomassie staining. The Coomassie-stained image presented is a representative
image of all blots done.
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16B

Figure 16 – Exposure in utero to cigarette smoke altered hepatic expression of SIRT1 and
NAMPT in fasted male offspring – Protein expression was measured using the livers of male
offspring euthanized on postnatal day 19 in a fasted state. B) Quantitation of Blots – Fasted
male CSE offspring exhibited increased hepatic expression of SIRT1 and decreased expression
of NAMPT. Fasted male CSE offspring also exhibited a trend toward decreased expression of
proteins with acetylated lysine residues. Fasted female offspring exposed in utero to cigarette
smoke exhibited decreased expression of HK, acetylated-FKHR/FKHR, and proteins with
acetylated lysine residues. Significant results had a p-value < 0.05, which is denoted with an * in
the figure. Results exhibited a trend that had a p-value < 0.10, which is denoted with a + in the
figure.
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expression (p < 0.05). Hepatic expression of PEPCK, HK, ac-FKHR, and acetylated-lysine
residues were unchanged in female CSE offspring in a fed state. In Figure 16, female CSE
offspring exhibited decreased hepatic expression of acetylated FKHR without a concomitant
decrease in FKHR as well as decreased expression of HK and proteins with acetylated lysine
residues (p < 0.05). Female CSE offspring in a fasted state exhibited no difference in the hepatic
expression of SIRT1, NAMPT, or PEPCK. While both male and female CSE offspring in a fed
state exhibited decreased hepatic NAMPT protein expression, only female CSE offspring
exhibited an increase in SIRT1 expression. Conversely, male CSE offspring in a fasted state had
SIRT1 and NAMPT protein expression that mirrored that observed in female CSE offspring in a
fed state. Female CSE offspring in a fasted state were the only offspring to exhibit decreased
hepatic expression of ac-FKHR, acetylated lysine residues, and HK in response to in utero
cigarette smoke exposure. The data suggest that female offspring in a fasted that have been
subjected to cigarette smoke exposure in utero exhibit facets of an exaggerated fasting response
that is independent of SIRT1 liver expression. The current study demonstrates how in utero
cigarette smoke exposure resulted in sex-specific alteration in the hepatic gene and protein
expression of SIRT1 and related proteins.

Offspring exposed to in utero cigarette smoke exhibited altered hepatic expression of Sirt1
and related genes in the SIRT1 regulatory loop according to sex and fasting status
To better contextualize the alterations in the protein expression of SIRT1 and related
metabolic proteins observed in offspring subjected to in utero cigarette smoke exposure, we
measured the mRNA expression of Sirt1 as well as related genes in the SIRT1 regulatory loop.
In Figure 17A, fed male CSE offspring exhibited increased hepatic expression of Sirt1 (p < 0.05)
and a trend toward increased expression of Fxr (p < 0.1). Male CSE offspring in a fed state
exhibited no differences in hepatic mRNA expression for Fxr, Shp, or P53. In Figure 18A, fasted
male CSE offspring exhibited a trend toward decreased hepatic expression of Sirt1 and P53 (p <
0.10). Male CSE offspring in a fasted state exhibited no difference in hepatic mRNA expression
for Nampt, Fxr, or Shp. Male CSE offspring also exhibited no difference in the hepatic expression

109

17A

Figure 17 – Prenatal cigarette smoke exposure in fed offspring increased hepatic gene
expression of Sirt1 and modulates the expression of other related enzymes by sex – mRNA
expression of genes was measured using the livers of offspring euthanized on postnatal day 19 in
a fed state. A) Fed Male Offspring – The expression of Sirt1 was significantly increased in fed
male offspring in response to in utero cigarette smoke exposure, while Fxr exhibited a trend
toward increased expression. Results are presented as the difference between the group means
of log2 transformed data. Significant results had a p-value < 0.05 while trends had a p-value <
0.1.
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17B

Figure 17 – Prenatal cigarette smoke exposure in fed offspring increased hepatic gene
expression of Sirt1 and modulates the expression of other related enzymes by sex – mRNA
expression of genes was measured using the livers of offspring euthanized on postnatal day 19 in
a fed state. B) Fed Female Offspring – Fed female CSE offspring exhibited increased
expression of Sirt1, Fxr, and Shp. Results are presented as the difference between the group
means of log2 transformed data. Significant results had a p-value < 0.05.
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18A

Figure 18 – Prenatal cigarette smoke exposure in fasted offspring modulated hepatic
expression of SIRT1 regulatory loop based on sex– mRNA expression of genes was
measured using the livers of offspring euthanized on postnatal day 19 in a fasted state. A)
Fasted Male Offspring – In fed male offspring subjected to in utero cigarette smoke exposure,
Sirt1 and P53 exhibited a trend toward decreased hepatic expression. Results are presented as
the difference between the group means of log2 transformed data. Trending results had a pvalue < 0.1.
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18B

Figure 18 – Prenatal cigarette smoke exposure in fasted offspring modulated hepatic
expression of SIRT1 regulatory loop based on sex– mRNA expression of genes was
measured using the livers of offspring euthanized on postnatal day 19 in a fasted state. B)
Fasted Female Offspring – Fasted female CSE offspring exhibited increased expression of
Nampt, Shp, and P53, and exhibited a trend toward increased Fxr expression. Results are
presented as the difference between the group means of log2 transformed data. Significant
results had a p-value < 0.05 while trends had a p-value < 0.1.
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of the miRNA miR-34a.
As seen in Figure 17B, fed female CSE offspring exhibited increased hepatic expression
of Sirt1, Fxr, and Shp (p < 0.05). Female CSE offspring in a fed state exhibited no difference in
hepatic mRNA expression for Nampt, or P53. As seen in Figure 18B, fasted female offspring
exhibited increased hepatic expression of Nampt, Shp, and P53 (p < 0.10) and a trend toward
increased expression of Fxr (p < 0.10). Female CSE offspring in a fasted state exhibited no
difference in hepatic mRNA expression for Sirt1 or the expression of the miRNA miR-34a.
Both male and female CSE offspring in a fed state exhibited increased mRNA expression
of Sirt1. However, only fed male CSE offspring exhibited a trend toward increased Nampt mRNA
expression while only fed female offspring exhibited increased Fxr and Shp mRNA expression.
Female CSE offspring in a fasted state exhibited increased mRNA expression of several genes in
the SIRT1 regulatory loop while male CSE offspring in a fasting state showed no significant
difference in mRNA expression in the SIRT1 regulatory loop. It should be noted that there was
no change in the hepatic expression of miR-34a, a well-established microRNA associated with
the suppression of both protein and mRNA expression of SIRT1 and NAMPT in either fasted
male or female offspring subjected to in utero cigarette smoke exposure. These data show that in
a fasted state, any modulation of SIRT1 regulatory loop components as a result of in utero
cigarette smoke exposure was independent of miR-34a. These data suggest that modulation of
SIRT1 regulatory loop components may have been enacted via stimulation from outside of the
primary regulatory loop.
It should be noted that for the hepatic expression of Sirt1 and Nampt, the directionality of
mRNA expression did not always match that of their corresponding protein. For example, in fed
male CSE offspring, SIRT1 protein expression was increased while mRNA was unchanged. Male
CSE offspring in a fed state also exhibited no difference in NAMPT protein expression, while
mRNA expression was increased. The only two instances where the mRNA and protein
expression were matched was in fed female CSE offspring exhibited increased mRNA and
protein expression of SIRT1 and fasted female CSE offspring exhibited no change in mRNA and
protein expression of SIRT1. These results suggest that there may be a disconnect between

114

transcription of mRNA and subsequent translation into protein, or there is a post-translational
factor that is influencing the stability of proteins and their expression levels relative to their mRNA
expression levels.

In utero cigarette smoke exposure resulted in modulation of SIRT1-deacetylated
transcription factors and their downstream targets based on sex and fasting status
Examining the effects of prenatal CSE on the hepatic expression of SIRT1-deacetylated
transcription factors and their downstream targets revealed marked differences between weanling
male and female offspring in a fed state. In Figure 19A, fed male offspring in a fed state exposed
to in utero cigarette smoke have increased expression of Bsep and Cyp8b1 (p < 0.05) while Pgc1α exhibited a trend toward increased expression (p < 0.1). In fed male offspring subjected to in
utero cigarette smoke exposure also exhibited a decrease in Pparα expression (p < 0.05) and a
trend toward decreased Srebp-1c (p < 0.10). No other changes in mRNA expression were
detected in male offspring in a fed state. In Figure 20A, male CSE offspring in a fasted state
exhibit increased hepatic expression of G6pase, Pepck, and Mcad (p < 0.05) while exhibiting a
trend toward increased Cyp7a1 expression and a trend toward decreased β-Klotho expression (p
< 0.10). No other changes were detected in male CSE offspring in a fasted state.
Fed female CSE offspring in Figure 19B exhibited increased hepatic expression (p < 0.05) of fat
metabolic genes (Mcad, Srebp-1c), glucose metabolic genes (Pgc-1α, Crtc2), and genes involved
with FXR signaling (Ost-β, Bsep, Fgfr4, β-Klotho, Hnf4a, Lxr-α, Lrh1, Cyp7a1). Fed female
offspring subjected to in utero cigarette smoke also saw a trend toward increased Pepck and
Ehhadh expression (p < 0.10). Female CSE offspring in a fed state exhibited no other changes in
mRNA expression. As seen in Figure 20B, fasted female offspring subjected to in utero cigarette
smoke exposure exhibited increased hepatic expression of genes (p < 0.05) in glucose
metabolism (Pepck, Crtc2, Gapdh, and Pdk-4), fat metabolism (Pparα, Ehhadh, Srebp-1c, Fas),
and FXR signaling (Bsep and Lrh1). Female CSE offspring in a fasted state also exhibited a
trend toward increased hepatic expression of Pgc-1α, G6pase, and Ost-β (p < 0.10). Female
CSE offspring in a fasted state exhibited no other differences in mRNA expression.
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19A

Figure 19 – Prenatal cigarette smoke exposure in fed offspring differentially modulated
hepatic gene expression of SIRT1-related metabolic processes by sex – mRNA expression
of genes was measured using the livers of offspring euthanized on postnatal day 19 in a fed
state. A) Fed Male Offspring – The expression of Bsep and Cyp8b1 was significantly increased
in fed male offspring in response to in utero cigarette smoke exposure, while Pgc-1α exhibited a
trend toward increased expression. Fed male CSE offspring exhibited decreased expression of
Pparα and exhibited a trend toward decreased Srebp-1c expression. Results are presented as
the difference between the group means of log2 transformed data. Significant results had a pvalue < 0.05 while trends had a p-value < 0.1.
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19B

Figure 19 – Prenatal cigarette smoke exposure in fed offspring differentially modulated
hepatic gene expression of SIRT1-related metabolic processes by sex – mRNA expression
of genes was measured using the livers of offspring euthanized on postnatal day 19 in a fed
state. B) Fed Female Offspring – In fed female offspring subjected to in utero cigarette smoke
exposure, the expression of numerous genes in fat metabolism, FXR signaling, and
gluconeogenic genes were significantly upregulated. Fed female CSE offspring also exhibited a
trend toward increased expression of Ehhadh and Pepck. Results are presented as the
difference between the group means of log2 transformed data. Significant results had a p-value
< 0.05 while trends had a p-value < 0.1.
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20A

Figure 20 – Prenatal cigarette smoke exposure in fasted female offspring exacerbated
fasting response-induced hepatic gene expression – mRNA expression of genes was
measured using the livers of offspring euthanized on postnatal day 19 in a fasted state. A)
Fasted Male Offspring – The expression of gluconeogenic genes G6pase and Pepck in addition
to the lipolytic gene Mcad were significantly increased in male offspring in response to in utero
cigarette smoke exposure. Fasted male CSE offspring exhibited a trend toward increased
Cyp7a1 expression and a trend toward decreased Sirt1, P53, and β-Klotho expression.

Results

are presented as the difference between the group means of log2 transformed data. Significant
results had a p-value < 0.05 while trends had a p-value < 0.1.
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20B

Figure 20 –Prenatal cigarette smoke exposure in fasted female offspring exacerbated
fasting response-induced hepatic gene expression – mRNA expression of genes was
measured using the livers of offspring euthanized on postnatal day 19 in a fasted state. B)
Fasted Female Offspring – The expression of numerous genes in fat metabolism, FXR
signaling, and glucose metabolism were significantly upregulated in fasted female offspring
subjected to in utero cigarette smoke exposure. Fasted female CSE offspring also exhibited a
trend toward increased expression of Pgc-1a, G6pase, Mcad, and Ost-β. Results are presented
as the difference between the group means of log2 transformed data. Significant results had a pvalue < 0.05 while trends had a p-value < 0.1.
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It was evident when comparing the impact of in utero cigarette smoke exposure in male
versus female offspring that mRNA expression of downstream SIRT1 target genes was starkly
different. Overall, weaned female offspring in a fed state experienced a more extensive array of
hepatic gene expression changes after being exposed to cigarette smoke in utero while male
offspring did not appear to be altered much concerning hepatic gene expression. It seems that
the female CSE offspring exhibited exacerbated fed and fasted responses. Male CSE offspring,
however, seemed to not have an exacerbated fed response in a fed state and a mildly
exacerbated fasted response in a fasted state relative to female CSE offspring. The sex-specific
impact of exposure to in utero cigarette smoke is highly modulated by a fed or fasted state,
especially in female CSE offspring.

Discussion
As we observed in Chapter III, offspring subjected to in utero cigarette smoke exhibited a
low birth weight phenotype. After PD4, there was no longer an observable difference between
prenatal CSE and Sham exposures, which was still evident by the time the offspring were weaned
and then euthanized at 19 days of age. As also noted in Chapters II and III, our model of gestational
only cigarette smoke exposure results in a well-defined phenotype of low birth weight followed by
catch-up growth consistent with the Barker Hypothesis.
We observed that the decreased levels of serum glucose that were found in female CSE
offspring 1.5 weeks old in Chapter III are no longer present in the weaned fed female CSE offspring
from the current study. This finding suggests that the potential liver underdevelopment that may
have occurred with female CSE offspring aged nine days was rectified by the time they reach the
weaning stage in their life cycle. After weaning, the offspring subjected to prenatal cigarette smoke
in utero appear normal concerning physical phenotype. This finding is in contrast to human studies,
which show that adolescent children subjected to cigarette smoke in utero not only exhibit
decrements in height-for-age [350, 351] but also an increased risk of obesity [352, 353]. A prior
murine study conducted by our lab examining the impact of pre- and postnatal cigarette smoke
exposure found that at PD21, CSE offspring did not exhibit altered serum glucose levels compared
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to Sham offspring [35]. This absence of serum glucose decrements is similar to the outcomes of
the current present study. Another study from our lab found that at six months of age, offspring
subjected to pre- and postnatal CSE did exhibit decreased serum glucose levels [40]. It seems
that a lack of overt perturbations to physical phenotype shortly after weaning but which manifests
into an altered phenotype later in adulthood in mice subjected to in utero cigarette smoke exposure
is reasonable to conclude based on the evidence from both past and current studies from our lab.
Additionally, this murine pattern to prenatal cigarette smoke exposure-induced phenotypic
development may be a distinct feature from the phenotypic development observed in humans.
These types of observations are critical to note when applying murine findings to humans and for
developing potential health interventions.
We found in our study that male and female CSE offspring in a fed state exhibited
decreased hepatic expression of NAMPT protein. However, in a fasted state, only male CSE
offspring exhibited decreased NAMPT protein expression. It could be inferred from this that a
decrement in NAD+ and thus SIRT1 deacetylase activity would occur; however, the level of
acetylated FKHR, a known target of SIRT1-induced deacetylation, remained unchanged in male
CSE offspring in either a fed or fasted state and in female CSE offspring in a fed state. Male CSE
offspring during a fasted state and female CSE offspring in a fed state exhibited increased
expression of SIRT1 in conjunction with decreased expression of NAMPT. Due to these results,
we currently cannot definitively determine how SIRT1 deacetylase activity was impacted by in utero
cigarette smoke exposure in these offspring. One step that could have helped determine the impact
of NAMPT expression on SIRT1 deacetylase activity is measuring the levels of NAD+. It is crucial
to consider the overall effect of the NAD+ levels on the resultant phenotypes observed in the current
study since, in the context of aging, the cellular pool of NAD+ naturally decays over time and that
anything that accelerates the aging process could, in turn, exacerbate the diminishing of the NAD+
pool [354]. In the context of our experiment, the decrement in hepatic NAMPT expression in fed
and fasted male CSE offspring and fed female CSE offspring could be an indicator of accelerated
aging that will more readily manifest itself later in life in the form of metabolic disease. This process
could also be exacerbated by the consumption of a high-fat diet, which has been reported to
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decrease levels of hepatic NAMPT [262]. This phenomenon may be particularly pertinent for male
CSE offspring since they exhibited a decrement in NAMPT protein expression in either a fed or
fasted state. This decrement that occurred in male CSE offspring regardless of fasting status may
be a manifestation of increased susceptibility of male offspring to in utero cigarette smoke
exposure. The data presented are novel findings that may help explain why the Barker Hypothesis
predicts that male offspring are more susceptible to in utero perturbations.
A significant finding from the current present study was the apparent exacerbated fastinginduced hepatic mRNA expression in response to exposure in utero to cigarette smoke. This
exacerbation was apparent in both male and female CSE offspring but to different degrees. Male
CSE offspring during a fasted state exhibited more signs of an exacerbated fasting response with
an increased hepatic expression of both G6pase and Pepck, two classically upregulated
gluconeogenic enzymes during fasting. Fasted male CSE offspring also exhibited increased
expression of Mcad, a lipolytic enzyme that is upregulated during a fasting response. Initially, these
results seem counter to the fact that fasted male CSE offspring also exhibited decreased Sirt1
expression but also exhibited increased expression of SIRT1. However, fasted male CSE offspring
exhibited decreased expression of NAMPT, so it is unclear how SIRT1 activity was being
functionally impacted. It would seem that looking merely at protein and gene expression of SIRT1
and NAMPT would suggest a downregulation of SIRT1 activity, but there are numerous factors
outside of expression levels that can impact SIRT1 including but not limited to post-translational
modification [339], location within the cell [339], NAD+ levels[262], and interacting proteins that
directly modulate SIRT1’s catalytic activity [271, 272].

Overall, it appears that there is an

exacerbation of the fasting response in fasted male offspring. However, it is not at the level of
exacerbation as exhibited by fasted female CSE offspring.
Fasted weanling female CSE offspring have more genes being upregulated compared to
fasted male CSE offspring in addition to increased lipolytic-related genes. Additionally, fasted
female CSE offspring exhibited increased expression of Gapdh and decreased expression of
Hexokinase.

GAPDH, although an enzyme classically associated with glycolysis, is also an

important enzyme needed for gluconeogenesis to occur effectively via deacetylation of GAPDH
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[355] and its gene expression is upregulated during the early stages of the fasting response in a
murine model [356]. Lower levels of Hexokinase activity are critical during the fasting response
since the downregulation of this enzyme allows glucose to leave the liver to maintain circulating
blood glucose levels [194], and its hepatic protein expression was decreased in the current study
in fasted female CSE offspring. Pdk-4, which inhibits glucose utilization by inhibiting the pyruvate
dehydrogenase complex and is increased during fasting and starvation [357], was also increased
in fasted female CSE offspring. Almost paradoxically, there was the presence of upregulation of
lipogenic genes such as Srebp-1c and Fas in addition to lipolytic genes Pparα, Ehhadh, and a trend
toward upregulation of Mcad. Lipogenic genes are typically upregulated following feeding and
suppressed during fasting [358]. However, it is possible that lower expression or activationresistance of negative upstream regulators of Srebp-1c such as leptin to result in increased
SREBP-1c-induced lipogenesis even when energetically inappropriate [359, 360]. Additionally,
research suggests that cigarette smoking while pregnant reduced umbilical cord levels of leptin
[361, 362]. It is possible that in our current model, in utero cigarette smoke exposure results in
perturbing leptin signaling in offspring and would account for the induction of both lipogenic and
lipolytic genes during fasting that we observed. Collectively, the data show that female CSE
offspring in a fasted state exhibit an exacerbated fasting phenotype above what is found in a normal
fasted state. Overall, we conclude that weaned offspring responded to in utero cigarette smoke
exposure exhibit sex-specific exacerbation of the fasting response, and this could be a novel
mechanism that contributes to sex-specific increases in the risk of metabolic disease later in life as
predicted by the Barker Hypothesis.
Another significant finding from the current present study was the prenatal CSE-induced
sex-specific responses in hepatic mRNA expression during a fed state. In male CSE offspring in a
fed state, there were few changes to hepatic mRNA expression with the notable exceptions of
decreased Pparα and increased Sirt1. There was a trend toward increased expression of Pgc-1α
in addition to a trend toward decreased expression of Srebp-1c that would reflect increased
gluconeogenic and decreased lipogenic activity, respectively, which is what would be expected
during fasting with increased SIRT1 activity. It is not clear whether the changes in hepatic gene
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expression that fed male CSE offspring exhibited result in a functional impact on their metabolic
phenotype.
Conversely, female CSE offspring in a fed state exhibited increased expression of Sirt1related genes as well as increased expression of gluconeogenic and lipolytic genes. Increased
hepatic Sirt1 mRNA expression in female CSE offspring in a fed state along with the upregulation
of Shp expression suggests that the SIRT1 regulatory loop was enhanced in the fed state. These
results suggest that female CSE offspring developed a metabolic phenotype where the current
energy status is not detected correctly.

Additionally, these results indicate that female CSE

offspring exhibit an inappropriately timed hepatic fasting response in a fed state. Additionally, in a
fed state, female CSE offspring exhibit globally increased expression of various Fxr-related genes
including Fxr itself. In particular, there is an increase in the expression of Fgfr4 and β-Klotho which
has been shown in the literature to enhance intestinal Fgf15 signaling [363]. The human analog of
FGF15, FGF19, is essential in inducing glycogenesis after a meal [364]. Once glycogen stores are
replenished, excess glucose is converted to fatty acids through de novo lipogenesis [358]. All this
information together suggests that fed weanling female CSE offspring have their hepatic
metabolism primed to store excess energy from food consumption more efficiently. The results
presented here are a novel finding that may help explain why in Chapter II, female CSE offspring
maintained on a high-fat diet gain weight so rapidly if the hepatic metabolic phenotype observed in
the current present study is propagated into adulthood.
A novel finding from the current present study was the sex-specific prenatal CSE-induced
modulation of acetylated proteins in fasted offspring. Male CSE offspring in a fasted state, despite
the presence of increased hepatic SIRT1 protein expression, exhibited only a trend toward
decreased acetylated lysine residues. This outcome may, in part, be due to male CSE offspring in
a fasted state, also exhibited decreased hepatic NAMPT protein expression. If this decrease in
NAMPT expression negatively impacted NAD+ levels, it could explain why there was no net effect
on protein acetylation. In contrast, female CSE offspring in a fasted state exhibited decreased
hepatic expression of both acetylated FKHR, a known deacetylation target of SIRT1, and acetylated
lysine residues. These results in female CSE offspring suggest that in a fasted state, there is
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something that is influencing the levels of acetylated proteins that is independent of SIRT1 protein
expression levels. Various factors that can influence SIRT1 deacetylase activity were mentioned
earlier in the discussion, but another factor that should be considered in the context of our results
is the cellular pool of Acetyl-CoA that is available. It is known that the levels of available acetyl-CoA
influence the enzymatic activity of acetyltransferase enzymes, such as EP300 [365].

Lower

bioavailability of acetyl-CoA can result in less acetylation of proteins and thus play a role in the
trend toward decreased acetylated lysine residues in fasted male CSE offspring. Lower levels of
available acetyl-CoA are a factor to consider as well in fasted female CSE offspring since they
exhibited decreased expression of both acetylated FKHR and proteins with acetylated lysine
residues without any changes in the protein expression of either SIRT1 or NAMPT. Even though
the results reflect the possibility of increased SIRT1 activity in female CSE offspring in a fasted
state, lower availability of acetyl-CoA could provide an alternative hypothesis as to the apparent
exacerbated fasting response seen in female CSE offspring in a fasted state. This hypothesis is
especially important to consider since acetylated FKHR, and acetylated lysine residues alone do
not confirm that these changes in protein acetylation were due to strictly SIRT1 deacetylase activity.
Lower acetyltransferase activity due to depleted pools of acetyl-CoA [365] also has the potential of
being the cause of decreased protein acetylation seen in the current present study. We conclude
that our results provide evidence that the greater exacerbation of the fasting response seen in
female CSE offspring relative to male CSE offspring is driven in part by decreased protein
acetylation. This decrease in protein acetylation in female offspring subjected to in utero cigarette
smoke exposure provides further evidence of the need to examine sex-specific outcomes with
regard to the Barker Hypothesis.
Future studies will examine siblings from our current study that have reached adulthood
and were maintained on either a low-fat control diet or a high-fat diet in order to determine if the
changes in hepatic expression of SIRT1 and related metabolic enzymes are seen in Chapters III
and IV are correlated with predicted enhanced weight gain in response to high-fat diet feeding.
Future studies will also examine if perturbations to the gut microbiome of offspring occur in
response to prenatal cigarette smoke exposure and high-fat diet maintenance. We confirmed in
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our novel study that prenatal cigarette smoke exposure resulted in sexually dimorphic hepatic gene
and protein expression alterations without overt hepatotoxicity. Sexually distinct responses to in
utero cigarette smoke exposure exist post-weaning and before sexual maturity and are highly
dependent on fasting status.

Our study presents novel insights into the hepatic molecular

phenotype induced by in utero exposure to cigarette smoke in a sex- and fasting state-dependent
manner.
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CHAPTER V: DISCUSSION
The overarching goal of the dissertation work documented here was to characterize the
age-specific as well as the sex-specific impact of in utero cigarette smoke exposure on offspring
hepatic SIRT1-related metabolic function and how this fulfills the Barker Hypothesis-predicted
perturbation of metabolic phenotypes in adulthood.

Experiments in Chapter II aimed to

characterize the sex-specific impact of prenatal cigarette smoke exposure in adult offspring
consuming a high-fat diet on the manifested hepatic molecular phenotype, including hepatic protein
expression of SIRT1 and related enzymes. The goal of the study in Chapter III was to determine
the sex-specific impact of in utero cigarette smoke exposure on offspring hepatic molecular
phenotype through hepatic SIRT1 and related gene and protein expression in the neonatal period.
Chapter IV experiments were designed to determine how prenatal cigarette smoke exposure
influences the hepatic molecular phenotype through hepatic SIRT1 and related gene and protein
expression after weaning based on the sex of the offspring and current fasting status. Collectively
these experiments provide new insight into potential mechanistic pathways of how prenatal
cigarette smoke exposure impacts the hepatic molecular phenotype of offspring at various critical
life stages and provides new observations as to how the Barker Hypothesis results in a sex-specific
impact of in utero cigarette smoke exposure.

Low Birth Weight and Catchup Growth Phenotypes
One of the significant outcomes of this dissertation work is the presence of a low birth
weight phenotype with subsequent catch-up growth, as seen in Chapters II through IV. The
manifestation of this phenotype in response to in utero cigarette smoke exposure agrees with the
basic premise of the Barker Hypothesis, in which prenatal exposure to cigarette smoke results in
perturbed offspring health outcomes [150]. However, comparing the results of this dissertation
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work with the literature illustrates that depending on the timing, duration, and severity of the
exposure, the degree of low birth weight and whether subsequent catch-up growth occurs can vary.
Also complicating this is the potential of maternal and paternal factors to modulate the magnitude
of low birth weight and subsequent catch-up growth.
One retrospective cohort study found that when the BMI of mothers who smoked
increased, the severity of the low birth weight phenotype in offspring decreased [366]. A Japanese
cohort study found that the association between maternal smoking during pregnancy and low birth
weight in offspring increased with maternal age [367]. Even if the low birth weight phenotype is not
present, it is possible for the weight gain of offspring exposed in utero to cigarette smoke to be
affected adversely.

Another Japanese study found a positive dose-response relationship of

smoking during pregnancy to the risk of rapid weight gain during infancy [368]. In terms of paternal
factors, male mice that were exposed to CSC during puberty resulted in offspring that had a lowbirth-weight but still did not exhibit catch-up growth by six weeks after birth [369]. The effect of
paternal exposure to CSC during puberty on catch-up growth was not present when maternal CSC
exposure during pregnancy also occurred [369].
Another factor that could influence low birth weight and catch up growth outcomes is
maternal glucocorticoid usage during pregnancy. Maternal glucocorticoid usage is of particular
concern since glucocorticoid administration is utilized in managing the risk of preterm birth [370],
which is a well-documented risk of prenatal cigarette smoke exposure [371-378]. It has been found
that a single prenatal treatment with glucocorticoids is associated with low birth weight in term
infants [379]. It has also been found that multiple courses of prenatal corticosteroid treatment also
increases the risk of low birth weight [380, 381]. Even increased glucocorticoid levels independent
of synthetic glucocorticoid administration can be sufficient to trigger similar results.

One

prospective longitudinal study that examined levels of placental corticotropin-releasing hormone
(pCRH) and maternal plasma cortisol found that increased pCRH exposure at gestational week 30
was associated with low birth weight and subsequent catch-up growth by either within the first 12
months or within 12 to 24 months [382]. It is clear that to fully characterize how prenatal cigarette
smoke results in low birth weight with subsequent catchup growth, it is necessary to determine how
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a variety of both maternal and paternal factors could modulate the health outcomes of offspring
subjected to in utero cigarette smoke exposure. Doing so has the potential to clarify the reason for
some of the inconsistencies present in the literature regarding low birth weight and subsequent
catchup growth of offspring that are induced by maternal smoking.

Impact of Prenatal CSE on Development of Obesity and Fatty Liver in Adulthood
A hypothesis of interest for this dissertation work was whether there were any indications
of prenatal CSE in inducing a hepatic molecular phenotype that promotes the development of
obesity and fatty liver disease. The early stage of non-alcoholic fatty liver disease (NAFLD) is the
accumulation of lipids in the liver, which is often accompanied by obesity. In Chapter II, we found
that adult male CSE offspring exhibited a trend toward increased weight gain when maintained on
either a low-fat control diet or a high-fat diet. Additionally, we found that male offspring gained
weight at a higher rate if fed a high-fat diet regardless of prenatal exposure. We also found that
male offspring maintained on a high-fat diet exhibited elevated body fat accumulation regardless of
prenatal exposure. We also observed that only male offspring maintained on a high-fat diet
exhibited elevated liver triglycerides with no impact by in utero cigarette smoke exposure. It would
seem that exposure to prenatal cigarette smoke did not enhance the rate of obesity or liver lipid
accumulation in male offspring. However, the lack of an impact of in utero cigarette smoke
exposure on obesity or fatty liver in male offspring could have been in part due to our choice of a
low-fat diet, which contained approximately 5% fat, as the control to the high-fat diet. It is possible
that had we chosen a control diet that had higher levels of fat, we could have observed prenatal
CSE-induced obesity or fatty liver development. Additionally, we did not observe an exacerbation
of the obesity- and fatty liver-inducing effects of a high-fat diet by in utero cigarette smoke exposure
in male offspring. There are two possibilities for this outcome. First, there could be no impact of
prenatal CSE on exacerbating the effects of high-fat diet-induced obesity or fatty liver. Secondly,
the 3-month long duration of the high-fat diet maintenance may have initially revealed some
exacerbation by prenatal CSE but was overtaken by the continued maintenance on a high-fat diet.
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We plan to investigate this factor in currently ongoing studies. Overall, we found that prenatal CSE
did not contribute significantly to the development of either obesity or fatty liver.
In female offspring subjected to in utero cigarette smoke exposure as described in Chapter
II, we did observe an exacerbation of weight gain and body fat accumulation when maintained on
a high-fat diet. No change was detected; however, in female CSE offspring, when maintained on
a low-fat control diet. It is evident that in utero cigarette smoke exposure in female offspring was
capable of acting with high-fat diet maintenance to exacerbate the development of obesity.
However, none of the female offspring exhibited any sign of liver lipid accumulation. Not even
maintenance on a high-fat diet resulted in any change in liver lipid levels. Given the apparent effect
of prenatal CSE on exacerbating the effects of high-fat diet maintenance on developing obesity, it
was surprising to see no impact on liver lipid accumulation. Although surprising to us, these
outcomes in female offspring are consistent with the literature. The literature shows that females,
in general, are more resistant to the acquisition of a NAFLD phenotype. Of note is that women no
longer show this resistance to NALFD development when they are post-menopausal [383] and that
a greater magnitude of estrogen-deficiency (i.e. premature menopause) exacerbates the severity
of NAFLD-related fibrosis independent of age or any other metabolic disease [384]. That estrogen
signaling could be mediating the severity of NAFLD development is also seen in a study in which
ovariectomized mice developed more severe liver injury compared to sham-operated mice when
fed a high-fat-high-cholesterol diet [385]. The same study found that the severity of the diet-induced
liver injury was lessened when the ovariectomized mice were given estrogen treatment [385].
According to one study, this apparent resistance of females to NAFLD development may, in part,
be due to being able to emphasize fatty acid transformation into ketone bodies rather than VLDLtriacylglycerol [386].

Overall, we conclude that the innate resistance of female offspring to

developing fatty liver is present even when exposed in utero to cigarette smoke. This evidence
supports the prediction of the Barker Hypothesis that female offspring are more resistant to the
development of metabolic disease relative to male offspring as a result of prenatal cigarette smoke
exposure.
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A facet of more advanced fatty liver disease is the progression of NAFLD to non-alcoholic
steatohepatitis (NASH), in which the accumulation of lipids in the liver leads to the production of
radical oxidation species (ROS). As a result, it is common to find antioxidant enzymes upregulated
to counteract these effects. To detect whether there may be more advanced fatty liver disease
pathology, we measured in Chapter II the hepatic protein levels of two antioxidant enzymes,
superoxide dismutase (SOD2) and Catalase (CAT). We observed no effect in either male or female
offspring on the hepatic protein expression of either of these enzymes by either prenatal exposure
to cigarette smoke or maintenance on a high-fat diet. In conjunction with our other findings, these
results indicate that the male offspring maintained on a high-fat diet have developed fatty liver
disease. Conversely, female offspring on a high-fat diet did not develop any level of fatty liver
disease, much less the later stages of steatohepatitis. Not even the exacerbation by prenatal CSE
on weight gain and body fat accumulation in female offspring resulted in any progression into fatty
liver disease. Whether the phenotypes that manifested in the current study would eventually
progress given a more prolonged diet challenge remains unanswered. We conclude that given the
current study design, female offspring subjected to prenatal cigarette smoke exposure exhibited
sensitization toward increased high-fat diet-induced obesity and body fat accumulation without
development of fatty liver disease.

Impact of Prenatal CSE on Hepatic Metabolic Phenotype in Neonatal and Weaned Offspring
and Contribution to Future Obesity and Fatty Liver Disease
One question that we wanted to address with this work was whether prenatal cigarette
smoke exposure perturbs the hepatic molecular phenotype at an earlier life stage before adulthood.
This investigation was done to clarify how the perturbed sex-specific metabolic phenotypes
observed in offspring in Chapter II may have developed as a result of prenatal cigarette smoke
exposure. At 1.5 weeks of age, we found that male CSE offspring exhibited increased hepatic
expression of SIRT1 and NAMPT mRNA and protein. This observation was in addition to increased
mRNA expression of PEPCK and CRTC2, two critical genes for gluconeogenesis. Although there
was increased expression of SIRT1 and NAMPT for both mRNA and protein, there did not appear
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to be any noticeable impact on other components of the SIRT1 regulatory loop such as FXR, SHP,
or P53. These results led us to conclude that something may be activating SIRT1-related pathways
independent of the SIRT1-regulatory loop. Additionally, these results led us to conclude that there
may be an appropriately timed fasting response in male offspring during the neonatal period. If
these changes are related to the metabolic phenotype in adulthood, it is conceivable that the
changes in hepatic molecular phenotype seen in male CSE offspring during the neonatal period
could contribute to obesity and fatty liver development in adulthood.
In stark contrast, female CSE offspring exhibited a wide array of mRNA expression
downregulation, including in glucose metabolism, fat metabolism, and FXR signaling. Additionally,
female CSE offspring exhibited decreased mRNA expression of Nampt, Fxr, and P53. This latter
result was surprising since those three genes in conjunction with Sirt1 participate in a regulatory
loop where Sirt1, Nampt, Fxr, and Shp act in opposition to P53 and miR-34a. Due to the fact that
this regulatory loop was globally downregulated in conjunction with several related gene pathways,
we concluded that this was evidence of delayed functional liver ontogeny in female offspring
exposed in utero to cigarette smoke. This delayed functional liver ontogeny was further supported
by our observation of decreased serum glucose levels in female CSE offspring. However, these
neonatal changes in the hepatic molecular phenotype occurred after the resolution of low birth
weight and catch-up growth. We currently are unable to conclude if these changes in female CSE
offspring are beneficial or detrimental to future development of obesity or fatty liver disease.
Another critical life stage to examine for potential contributions to future obesity and fatty
liver disease was immediately after weaning. This allowed us to examine the impact of prenatal
cigarette smoke exposure both in a fed and a fasted state. Male CSE offspring in a fed state
exhibited decreased expression of NAMPT protein accompanied by increased Sirt1 mRNA
expression. No other facets of the SIRT1-regulatory loop were affected in male CSE offspring in a
fed state. The inconsistency between NAMPT protein expression and Sirt1 mRNA expression
suggests that the SIRT1-regulatory loop was not being impacted, and something outside of this
regulatory loop was affecting SIRT1 and NAMPT. Conversely, male CSE offspring in a fasted state
still show decreased expression of NAMPT protein but with increased expression of SIRT1 protein
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and related gluconeogenic genes and Mcad, a typical upregulated lipolytic gene during a fasting
response. However, male CSE offspring in a fasted state did not exhibit significant changes in the
expression of other SIRT1-regulatory loop components, including miR-34a. It is evident that in light
of the hepatic molecular phenotype present that male CSE offspring exhibited an exacerbated
fasting response that appears to be independent of engagement of the SIRT1-regulatory loop. If
the hepatic molecular phenotype observed in weaned male CSE offspring impacts future metabolic
phenotype development, it is plausible that these changes may contribute to the development of
obesity and fatty liver in adulthood.
It is without question that the most impacted offspring in this dissertation work were weaned
females that had been subjected to in utero cigarette smoke exposure. In weaned female CSE
offspring in a fed state, we observed increased protein expression of SIRT1 and decreased protein
expression of NAMPT accompanied by increased mRNA expression of Sirt1, Fxr, and Shp. These
changes appear to be independent of the SIRT1-regulatory loop since there was no change in the
expression of P53 mRNA expression in addition to the decreased protein expression of NAMPT.
We hypothesize that something was activating SIRT1-related pathways independently of the
SIRT1-regulatory loop. Additionally, we observed that female CSE offspring in a fed state exhibited
mRNA upregulation of FXR signaling as well as the gluconeogenic transcription factors Crtc2 and
Pgc-1α. We also observed mRNA upregulation of the lipogenic transcription factor Srebp-1c in
female CSE offspring in a fed state. Overall, we believe that female CSE offspring in a fed state
exhibited an exacerbated fed state with components of an inappropriately-timed fasting response.
If these changes in hepatic molecular phenotype were to be propagated into adulthood, it is
conceivable that female offspring subjected to in utero cigarette smoke exposure could experience
enhanced development of obesity or fatty liver in adulthood.
Weaned female CSE offspring in a fasted state provided a surprising array of changes in
the hepatic molecular phenotype, such as decreased protein expression of acetylated FKHR, a
known SIRT1 deacetylation target that promotes gluconeogenesis, as well as decreased
expression of hexokinase and acetylated-lysine protein residues. These results suggest but do not
confirm the presence of enhanced SIRT1 deacetylation activity in weaned female CSE offspring in
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a fasted state. However, these changes were accompanied by mRNA upregulation of Nampt, Shp,
and P53 without any change in mir-34a. It is evident that if SIRT1-related pathways and SIRT1
deacetylase activity were being upregulated in weaned female CSE offspring in a fasted state, it
was occurring independently of the SIRT1-regulatory loop. It was evident that there was an
exacerbation of the fasting response in mRNA expression in weaned female CSE offspring in a
fasted state with the upregulation of gluconeogenic genes, lipolytic genes, as well as Pdk-4, which
inhibits glucose utilization by inhibiting the pyruvate dehydrogenase complex and is increased
during fasting and starvation [357]. What was surprising was the observed mRNA upregulation of
lipogenic Sreb-1c and Fas in weaned female CSE offspring in a fasted state, which would seem
counter-productive in a fasting response [358]. One potential explanation for this phenomenon
would be a deficiency in leptin levels. Leptin is known to downregulate the expression and activity
of Srebp-1c and thus downregulate the expression of Fas and that suppression of leptin levels or
leptin receptor activity can result in inappropriately timed expression of Srebp-1c [359, 360]. It has
been shown that there are decreased levels of leptin in the umbilical cords of children subjected to
in utero cigarette smoke exposure and that lower levels of leptin are associated with greater
decrements in birth weight in response to intrauterine growth restriction. In light of this evidence, it
is plausible that if the observed changes in hepatic molecular phenotype were to be propagated
into adulthood that female CSE offspring would experience accelerated weight gain and body fat
accumulation in adulthood, which matches what we observed in female CSE offspring maintained
on a high-fat diet in Chapter II.

Overall Strengths and Limitations
One strength of this dissertation is the novelty in examining the hepatic molecular
phenotype through measuring hepatic SIRT1 and related metabolic genes and proteins after being
subjected to cigarette smoke exposure in utero in a strictly gestational model. As noted elsewhere
in this work, our lab has previously demonstrated using a murine exposure model that cigarette
smoke exposure in utero, in addition to postnatal exposure, results in the modulation of SIRT1 and
related metabolic pathways (particularly with glucose metabolism). This dissertation, in addition to
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the past work of our lab, demonstrates that the livers of offspring subjected to in utero cigarette
smoke exposure exhibit protein and gene expression changes related to SIRT1 and closely related
metabolic targets. As far as we know, this dissertation is the first work in the literature to observe
the hepatic molecular phenotype in adulthood as a result of a strictly prenatal cigarette smoke
exposure as predicted by the Barker Hypothesis and explore how hepatic changes are potentially
linked to these adulthood outcomes. Continuing this work will be vital in elucidating the molecular
underpinning of how in utero cigarette smoke exposure translates into an increased risk of
cardiometabolic disease in adulthood. Given how prenatal cigarette smoke exposure drives a low
birth weight phenotype through intrauterine growth restriction [28, 29], this work could also be useful
as a starting point for other in utero exposures to toxicants resulting in intrauterine growth restriction
and the potential impact on health in adulthood. Once the underlying mechanism in our model is
determined, this could provide new avenues for therapeutic interventions for children who are
subjected to in utero cigarette smoke exposure.
Another strength of this study is the use of a whole-body inhalation exposure apparatus to
expose pregnant mice to cigarette smoke. There are numerous studies that examine prenatal
effects of cigarette smoke constituents other than nicotine in isolation on low birth weight including
carbon monoxide [280, 281], benzo(a)pyrene [89], volatile organic compounds [94] including
specifically formaldehyde [95] and benzene [96], polycyclic aromatic hydrocarbons [87, 88], and
heavy metals like cadmium [282-285], but a significant disadvantage to this type of approach is that
it undoubtedly fails to capture the complex interactive effects that each cigarette smoke component
has with the others. Another disadvantage to exposing with individual components is that it involves
either injection or oral ingestion, routes of exposure that have very different toxicological
consequences compared to inhalation. Utilizing a cigarette smoking apparatus that exposes
animals to both mainstream and sidestream smoke via whole-body inhalation provides a more
realistic exposure scenario mimicking mothers who smoke while pregnant. Additionally, our model
utilizes Marlboro Red cigarettes™ instead of a reference cigarette in part due to the presence of
additives typically found in commercial cigarettes that are not present in reference cigarettes [387].
At the time of the development of this model, Marlboro Red™ cigarettes were the most commonly
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smoked cigarette [41]. This figure includes women aged 18-25, which was also the age group most
likely to smoke at any time during pregnancy during this time [41]. This choice in cigarette was
made to simulate a scenario of active maternal smoking while pregnant as accurately as possible.
In our model, a whole-body exposure was used instead of a nose-cone based exposure mainly due
to the usage of animal restraint necessary to ensure that the nose cone delivering cigarette smoke
stays in place throughout the exposure. Given that restraining animals results in increased serum
levels of glucocorticoids [388], in order to avoid the potential confounding effects of elevated
glucocorticoid levels on postnatal health outcomes in the offspring, our model utilizes a whole-body
inhalation exposure approach. A whole-body inhalation-based model has the added benefit of
allowing the efficient exposure of multiple mice simultaneously while keeping them housed in their
cage, which also helps minimize handling stress.
This dissertation work is novel in that it characterizes the hepatic molecular phenotype in
response to prenatal cigarette smoke exposure at multiple key life stages. Although the Barker
Hypothesis predicts that metabolic disease as a result of in utero exposure to cigarette smoke
manifests itself in adulthood, it leaves unanswered if any disease occurs earlier, such as during the
neonatal period or adolescence before sexual maturity. It also does not address if the changes
that result in metabolic disease in adulthood are present at an early age or if the hepatic molecular
phenotype dynamically shifts over the lifetime of the individual that is exposed in utero to cigarette
smoke. This dissertation work addresses these points by characterizing the hepatic molecular
phenotype not only in adulthood after a diet challenge, but also during the neonatal period and just
after weaning. By examining prenatal cigarette smoke-exposed offspring during the neonatal
period, at 1.5 weeks of age, we were able to examine offspring at a time when catch-up growth has
occurred, and low birth weight is no longer evident. This examination provided insight as to the
hepatic molecular phenotypes that are associated with low birth weight and subsequent catch-up
growth. By examining post-weaned offspring, we were able to characterize the hepatic molecular
phenotype in prenatal cigarette smoke-exposed offspring at a time before full sexual maturity as
well as in a fed versus a fasted state. Examining in a fed versus a fasted state was especially
crucial as it allowed us to answer the questions of whether offspring exhibited perturbed hepatic
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fed or fasted responses, gaining insight into the potential factors driving metabolic disease
pathology in adulthood. These facets of our work bring important new findings to the literature
since no one else has attempted to characterize the hepatic molecular phenotype at multiple critical
life stages after being exposed in utero to cigarette smoke and how they relate to the manifestation
of the Barker Hypothesis in adulthood.
What was especially novel about this work was the discovery that even at an early age,
female offspring subjected to cigarette smoke in utero exhibited a greater number of perturbations
in the hepatic molecular phenotype compared to male offspring. Additionally, female CSE offspring
maintained on a high-fat diet experienced greater weight gain that was not present in male CSE
offspring maintained on a high-fat diet. This result was surprising given that the Barker Hypothesis
predicts that male offspring are more impacted by adverse in utero events compared to female
offspring.

However, because these female offspring after weaning appeared otherwise

phenotypically normal, we cannot conclude whether these changes in the hepatic molecular
phenotype are ultimately beneficial or detrimental to metabolic health in adulthood. Our findings
reveal an urgent need to examine more closely at multiple life stages the sex-specific impact of
prenatal cigarette smoke exposure on the hepatic molecular phenotype and any subsequent impact
on developing metabolic disease.
With the current dissertation work, we were able to characterize a large number of gene
expression changes in prenatal cigarette smoke exposed-offspring at various life stages before the
induction of any metabolic disease pathology in adulthood. However, from the results of our study
it is unclear whether the prenatal CSE-induced changes we observed do, in fact, lead to a fatty liver
phenotype. Although adult male offspring maintained on a high-fat diet did develop obesity and
fatty liver, there was no significant impact on these measures based on prenatal CSE. Additionally,
female CSE offspring maintained on a high-fat diet did exhibit increased weight gain and body fat
accumulation, but there there was no effect of prenatal CSE alone. Female offspring also did not
develop fatty liver due to either high-fat diet or prenatal cigarette smoke exposure. We cannot
definitively conclude whether prenatal cigarette smoke exposure, either alone or in conjunction with
maintenance on a high-fat diet, contributes to fatty liver disease pathology in either sex.
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A factor that was not accounted for was observing prenatal CSE-induced low birth weight
and subsequent catchup growth with respect to the sex of the offspring. Recording the sex of
individual offspring from birth to weaning was not done due to the technical difficulty of individually
tracking individual pups in a litter at such a young age as well as the difficulty in accurately sexing
pups at a young age. Had we accomplished these tasks, it would have been possible to associate
the severity of low birth weight with the hepatic molecular phenotype at various life stages and
development of metabolic disease in adulthood. Additionally, we could have identified if there were
offspring that responded strongly to prenatal cigarette smoke exposure versus offspring that
responded weakly to prenatal cigarette smoke exposure. Identifying these “high-responders”
versus “low-responders” would have provided another factor that could have been controlled for to
refine further how the hepatic molecular phenotype is perturbed due to prenatal CSE and how this
is linked to the development of metabolic disease. One downside to this approach is that it would
likely require a larger sample size of offspring in experiments that would be more costly and timeconsuming. However, this is a necessary step to fully unravel the mechanism that drives the
metabolic manifestations of the Barker Hypothesis.
One limitation of this dissertation lies in the duration of the diet challenge for the offspring
in Chapter II. Although we did not observe any significant effects of prenatal CSE alone on weight
gain, body fat accumulation, or fatty liver development, prenatal CSE could have exacerbated the
effects of a high-fat diet at an earlier point in the diet challenge, and we did not observe it. Under
this scenario, it is possible that the effects of long-term maintenance on a high-fat diet eventually
obfuscated any initial effects that prenatal CSE may have contributed to the metabolic phenotype
observed in offspring. Due to this potentially confounding factor, we cannot definitively conclude
that all effects seen in the offspring in Chapter II in response to prenatal cigarette smoke exposure
were not influenced by the prolonged duration of the diet challenge. In future studies we plan to
examine adult offspring exposed in utero to cigarette smoke earlier in adulthood and shorten the
duration of the diet challenge to ensure the potential confounding effects of long-term high-fat diet
feeding do not exert undue influence on metabolic phenotype.
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Another limitation of our work was the choice of a low-fat diet as the control for the high-fat
diet during the diet challenge in Chapter II. This factor is an essential consideration since the
effects of high-fat diet maintenance may have been exacerbated by the low-fat content of the
control diet (approximately 5% and 19% fat content, respectively). One way we could have helped
account for this is by examining the hepatic molecular phenotype before the initiation of the diet
challenge. Doing this may have provided additional context as to how prenatal cigarette smoke
exposure affected the baseline hepatic molecular phenotype and how it is modulated by
maintenance on either a high-fat or low-fat diet. In ongoing studies, we are examining adult siblings
of the offspring from Chapters III and IV at a point before a diet challenge to address this limitation
from Chapter II.
This ties into another limitation from our study; the fact that the adult offspring in Chapter
II are not siblings of the offspring in Chapters III and IV. This factor is a significant limitation because
although the prenatal cigarette smoke exposure parameters of the offspring in Chapters II versus
Chapters III and IV were similar, they are not precisely the same. Although we were confident that
the prenatal exposures were similar enough that it was reasonable to relate the changes seen in
Chapter II to those in Chapters III and IV, we admit that there may be some other underlying
difference between the two cohorts that confounded this comparison. This limitation is being
addressed by currently in-progress studies examining adult siblings of the offspring from Chapters
III and IV.
A factor that was not accounted for was the presence of mismatched levels of protein, and
their corresponding mRNA levels within the same groups. For example, in Chapter III, neonatal
female CSE offspring exhibited decreased hepatic expression of Sirt1, Nampt, Pepck, and Hk
without any change in the corresponding protein levels. In other instances, the mRNA and protein
expression matched each other such as the neonatal male CSE offspring exhibiting increased
SIRT1 and NAMPT expression along with their corresponding mRNA in Chapter III. It is known
that protein levels can be influenced independently from mRNA levels, such as through posttranslational modifications that can result in increased protein stability or promote proteasomal
degradation, and SIRT1 is no exception to these naturally-occurring processes [339]. Additionally,
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it has been shown that levels of mRNA can be influenced by micro-RNAs, such as miR-34a being
responsible for suppressing the expression of Sirt1 and Nampt, along with the corresponding
proteins [262]. We attempted to look at the potential effects of miR-34a to modulate levels of Sirt1
and Nampt expression in fasted offspring in Chapter IV but found no difference in miR-34a levels
despite changes in fasted male offspring exhibiting increased levels of SIRT1 and decreased levels
of NAMPT while fasted female CSE offspring exhibited increased levels of NAMPT. These results
suggest that levels of SIRT1, NAMPT, and their corresponding proteins were not subjected to
modulation by CSE via a miR-34a-related pathway.

We conclude from these data that the

mismatched levels of SIRT1, NAMPT, and their corresponding mRNA is not due to modulation of
the central SIRT1 regulatory pathway that includes miR-34a as a central component. In future
studies, it is necessary to look at other pathways that interact with SIRT1, such as the mTORC
pathways or mechanism involving post-translational modifications other than acetylation.
Tied into the previous limitation, we did not measure levels of either NADH/NAD + or
ATP/AMP. Measuring these would have provided valuable information as to the current cellular
stores of energy in offspring subjected to in utero exposure to cigarette smoke. We observed that,
for weaned female offspring in particular, there were signs of an exacerbated hepatic fasting
response with respect to mRNA expression in response to prenatal cigarette smoke exposure. One
possible explanation for this exacerbated fasting response in weaned female CSE offspring could
have been that current cellular energy stores were being improperly sensed. If improper sensing
of current cellular energy stores was occurring, this would provide novel insight into why the hepatic
molecular phenotype is altered and would provide a potential mechanism to investigate further.
Additionally, measuring levels of NAD+ could have helped clarify how SIRT1 deacetylase activity
was being impacted. In instances such as the weaned female CSE offspring in a fasted state
exhibiting decreased hepatic protein expression of acetylated FKHR and acetylated lysine residues
without a change in the protein expression of either SIRT1 or NAMPT, knowing the levels of NAD+
present could have allowed us to conclude better if this change in protein acetylation was due to a
change in SIRT1 deacetylation activity.
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Another factor that we did not examine is the impact of cigarette smoke exposure on the
quality of milk from the exposed dams. It is noted in the literature that smoking negatively impacts
breastfeeding in a variety of ways, including but not limited to lower milk production [389], earlier
weaning [389, 390], lower duration of breastfeeding [391], lower-fat concentration [389, 392, 393],
altered breast milk lipid profile [394], lower cholesterol [395], lower protein [392, 395], heavy metal
contamination [396-398], and lower antioxidative properties [399]. Additionally, smoking effectively
cancels out the protective effects of breastfeeding on the risk of sudden infant death syndrome
[400] and respiratory disorders [401]. Although we ceased exposure of pregnant dams to cigarette
smoke at GD19, pups born to exposed dams could be adversely affected through the dams’ milk
for as long as cigarette smoke constituents and metabolites were still present within the dams. In
future studies, it may be beneficial to conduct an experiment to determine what impact breast milk
from cigarette exposure has on perinatal outcomes through a cross-fostering experiment. This
experiment would allow for separation of the impact of in utero exposure to cigarette smoke from
any confounding effect from altered milk quality or nursing behaviors.

Future Directions
One of the future studies that can be done to elucidate further how in utero cigarette smoke
exposure modulates cardiometabolic perturbation in offspring would be via a systems biology
approach that looks for associations with other body systems in exposed offspring. For example,
examining changes in the brain, particularly in the hypothalamus, could be especially illuminating.
It has been shown that in utero cigarette smoke exposure perturbs neurological development [402,
403] and given the importance of specific structures of the brain in controlling body-wide
metabolism it would be prudent to interrogate if changes occur in these metabolic regulatory
centers in response to prenatal cigarette smoke and if so, if these changes are related to the hepatic
changes we have observed in our murine model. As mentioned previously, sex-specific secretion
patterns of growth hormone are vital in determining the metabolic phenotype of the liver, and that
perturbation of these secretion patterns can modulate the sex-specific imprinting of hepatic
metabolic enzyme expression [242-244]. If changes to the growth hormone secretion pathway are
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apparent and associated with some of the hepatic changes we observed in our murine model, this
could provide valuable insight into the hepatic and cardiometabolic pathology of the Barker
Hypothesis as well as a potential avenue for therapeutic interventions of individuals affected by in
utero cigarette smoke exposure.
A potential future study could further examine the SIRT1 regulatory pathway that includes
miR-34a to confirm the importance of this pathway. Such an approach could include transgenic
mice that would allow at-will perturbation of Sirt1 or miR-34a expression. An alternative approach
to also test this could be the treatment of offspring with a SIRT1 promoter such as resveratrol or a
SIRT1 inhibitor. Another way that could indirectly test the importance of the SIRT1 regulatory
pathway would be to supplement the NAD+ pool using nicotinamide mononucleotide (NMN), a
precursor molecule for NAD+. Since SIRT1’s deacetylase activity is dependent on NAD+ as a
cofactor, scenarios that affect levels of NAD+ can have a net result of decreasing SIRT1 activity.
Examples of this include NAD+ consumers such as PARP1 increasing their activity [255] or the
activity of NAMPT decreasing [262] result in decreased SIRT1 activity. Manipulating the NAD+ pool
in addition to quantifying base levels of NAD+ without supplementation could also help in
determining whether the activity of SIRT1 is being modulated in our murine prenatal CSE model
and thus contributing to the observations detected in the study.
Given the alarming rise in the rate of electronic cigarette and vaporizer use [4], especially
in teenagers [5], it would be prudent to examine if similar changes we observed in this dissertation
work were also present as a result in utero exposure to e-cigarette- or vaporizer-produced aerosols.
Even if one only considered the effects of nicotine and none of the other components of e-cigarette
solutions, there is an abundance of evidence that prenatal exposure to nicotine alone has
numerous adverse effects, such as lower fetal body weight in addition to decreased fetal brain
weight, loss of brain cells, and histological abnormalities in the brain [71]. These findings are not
surprising given that nicotine acts as a vasoconstrictor, which limits blood flow from the mother to
the placenta, thereby inducing intrauterine growth restriction [150]. Even if the resultant phenotype
in e-cigarette/vaporizer aerosol-exposed offspring is not as severe as that induced by cigarettes,
the upward trajectory of e-cigarette/vaporizer use indicates the possibility of a large number of
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individuals being affected, especially given the perception among some of the public that ecigarettes are inherently less harmful than cigarettes [404]. The implications of this on prenatal
exposure to nicotine are potentially dire if expectant mothers who find themselves unable to wean
off cigarettes instead switch to e-cigarettes due to perceived lower risk to health, which would still
result in a significant number of fetuses being exposed to nicotine in utero. We are currently
planning studies that will adapt our current murine in utero cigarette smoke exposure to utilize ecigarettes in order to characterize exposed offspring in the same manner we have in this
dissertation work.

Summary and Conclusions
The unifying goal of the dissertation work described herein was to provide novel
characterization the impact of in utero cigarette smoke exposure on the murine hepatic molecular
phenotype via the expression of SIRT1-related gene and proteins at several life stages in
conjunction with sex-specific altered metabolic phenotypes during adulthood as modulated by
maintenance on a high-fat diet. This work was necessary to provide further evidence for how an
in utero toxicant exposure results in a perturbed metabolic phenotype during adulthood, as
predicted by the Barker Hypothesis. The study described in Chapter II of this dissertation provided
initial support of how a gestation-only exposure to cigarette smoke-induced low birth weight with
catch-up growth as well as other sex-specific metabolic, behavioral, and hepatic molecular
phenotype changes in adulthood and how these phenotypic outcomes are modulated by the fat
content of the diet the adult offspring consumed. Chapter II helped support the Barker Hypothesis
by showing that gestational exposure to prenatal cigarette smoke exposure resulted in perturbed
hepatic molecular phenotype in a sex-specific manner. These initial experiments inspired us to
examine the hepatic molecular phenotype via SIRT1-related hepatic gene and protein expression
in the liver at a young age shortly after birth in Chapter III. The findings in Chapter III suggest that,
even as early as 1.5 weeks of age, the hepatic expression of SIRT1-related genes and proteins
was perturbed in a sex-specific manner. These results suggest that future studies need to examine
the sexual differentiation processes that occur perinatally. Chapter IV took the findings in Chapters
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II and III further by examining hepatic molecular phenotype through SIRT1-related gene and protein
expression changes in response to in utero cigarette smoke exposure in weaned offspring in either
a fed or a fasted state. Once again, there were apparent sex-specific perturbations in SIRT1related hepatic gene and protein expression with additional modulation based on fasting status.
Offspring subjected to in utero cigarette smoke exposure, especially female offspring, have
abnormal fed and fasted responses, but exactly how these particular changes are related to the
altered metabolic phenotypes during adulthood that we observed in Chapter II will be the subject
of future studies. The findings of this dissertation work have provided the initial characterizing steps
necessary to more thoroughly investigate and probe the underlying mechanistic pathway that
facilitates the adulthood metabolic manifestations of in utero cigarette smoke exposure as predicted
by the Barker Hypothesis.
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